matchedPattern,context,lineNumber,columnNumber,publicationName
p.V600E,"...quently found in cutaneous melanomas (c.1799 T>A, p.V600E), raising the question whether this is a m...",3,2201,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Pro,...able 3). All mutations were present in codon 209 (p.Gln209Pro and p.Gln209Leu) and were somatic muta...,81,162,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,"...BRAF gene revealed one BRAF mutation (c.1799 T>A, p.V600E), in a melanoma. No HRAS or NRAS mutations...",81,801,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Gln209Leu,14	MC	c.626 A>T (p.Gln209Leu)	wt	wt	wt,97,18,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.V600E,"... with a BRAF point mutation (case 15; c.1799 T>A, p.V600E) might be a metastasis rather than a prima...",114,857,Acta_Neuropathol_2010_Mar_22_119(3)_317-323.txt
p.Val600Lys,...d M Iacopetta B Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 1...,152,84,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.Val600Lys,...d M Iacopetta B Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 1...,152,84,Acta_Neuropathol_Commun_2013_May_30_1_20.txt
p.Gly6976Gly,...acheostomy.	Yes From 1 month	ex139; c.20928G > T; p.Gly6976Gly	RTPCR and Sanger sequencing of cDNA s...,46,389,Acta_Neuropathol_Commun_2014_Apr_12_2_44.txt
p.V600E,"... KIAA1549-BRAF fusions are found in PAs, and BRAF:p.V600E mutations are frequently detected in PXAs ...",17,414,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF: p.V600E,27,7,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF: p.V600E,27,7,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF: p.V600E,27,7,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF:p.V600E mutations were detected in 7 of 16 (43%) g...,123,6,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,BRAF:p.V600E mutations were detected in 7 of 16 (43%) g...,123,6,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...1, RNF130, CLCN6, MKRN1 and GNAI1[17,19,21]. BRAF:p.V600E mutations occur in PXAs (~70%), gangliogli...",133,512,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,...ere unable to show a KIAA1549-BRAF fusion or BRAF:p.V600E mutation. Low-grade neuroepithelial tumors...,133,925,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,...not characterized by KIAA1549-BRAF fusion or BRAF:p.V600E mutation [27],133,1448,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...tures of a classic ganglioglioma, harbored a BRAF:p.V600E mutation. This mutation is the most common...",135,239,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.V600E,"...tures of a classic ganglioglioma, harbored a BRAF:p.V600E mutation. This mutation is the most common...",135,239,Acta_Neuropathol_Commun_2014_Feb_14_2_18.txt
p.Phe91Ile,"...atients 1 and 2s had novel mutations, c.271 T > A p.Phe91Ile, and c.273C > G p.Phe91Leu, respectivel...",118,194,Acta_Neuropathol_Commun_2015_Jul_25_3_44.txt
p.K510E,"...gically, including cases with the newly described p.K510E mutation and a case with both a known p.P5...",5,897,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...p.P525L mutation in the FUS gene and a truncating p.Y374X mutation in the TARDBP gene,5,993,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,...p.P525L mutation in the FUS gene and a truncating p.Y374X mutation in the TARDBP gene,5,993,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...red both a p.P525L FUS mutation and also a TARDBP p.Y374X truncation mutation, the latter of which h...",34,666,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...red both a p.P525L FUS mutation and also a TARDBP p.Y374X truncation mutation, the latter of which h...",34,666,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,"...red both a p.P525L FUS mutation and also a TARDBP p.Y374X truncation mutation, the latter of which h...",34,666,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,5	15	c.1562G>A	p.R521H	35	F	>36	NA	Yes	L	No,41,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R514G,7	15	c.1540A>G	p.R514G	60	M	>96	NA	Yes	B	No,45,16,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ion (arrow) in an anterior horn neuron in case 6 (p.P525L and p.Y374X TARDBP mutation). This contras...,121,239,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,...ion (arrow) in an anterior horn neuron in case 6 (p.P525L and p.Y374X TARDBP mutation). This contras...,121,239,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R495X,...in the anterior horns of the spinal cord. Case 1 (p.R495X). Anti p62. d-f. Reveal the differing shap...,121,582,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.P525L,"...ilarly Baumer et al. illustrated 2 cases with the p.P525L mutation, one of whom had no UMN features ...",135,1549,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521C,"...t, and slower progression (including 2 cases with p.R521C mutations). Our findings do not fit neatly...",135,3462,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R521H,...nto this distinct grouping. Whereas case 5 with a p.R521H mutation would certainly appear to partial...,135,3564,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.Y374X,.... Daoud et al. have described the genetics of the p.Y374X TARDBP mutation and have predicted this to...,135,5525,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.R514G,The p.R514G missense mutation again has been detected ...,139,5,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.N352S,...anese familial amyotrophic lateral sclerosis with p.N352S mutation in TARDBP Neuropathol Appl Neurob...,187,179,Acta_Neuropathol_Commun_2015_Oct_9_3_62.txt
p.A31P,...cance of being homozygous or heterozygous for the p.A31P cMyBP-C mutation in young to middle-aged ca...,4,704,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...s that were homozygous for the mutation had fHCM. p.A31P heterozygosity was not associated with a si...,10,360,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...tution of an alanine for a proline at residue 31 (p.A31P) of the cMyBP-C protein. Affected cats exhi...,22,217,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...tution of an alanine for a proline at residue 31 (p.A31P) of the cMyBP-C protein. Affected cats exhi...,22,217,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...M and MC cats heterozygous and homozygous for the p.A31P cMyBP-C mutation in a large cohort of MC ca...,24,126,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...es. There was tendency to an increasing effect of p.A31P cMyBP-C homozygosity with age, though the t...",44,255,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,p.A31P cMyBP-C genotypin,132,1,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...lated for heterozygous and homozygous carriers of p.A31P cMyBP-C between fHCM affected and non-affec...,140,188,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...lated for heterozygous and homozygous carriers of p.A31P cMyBP-C between fHCM affected and non-affec...,140,188,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...cance of being heterozygous or homozygous for the p.A31P cMyBP-C mutation in a cohort of young MC ca...,162,87,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...d in heterozygous cats. This again indicated that p.A31P cMyBP-C associated fHCM was a disease with ...,166,396,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... homozygous for the mutation. We propose that the p.A31P cMyBP-C mutation results in an inheritance ...,166,602,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... homozygous for the mutation. We propose that the p.A31P cMyBP-C mutation results in an inheritance ...,166,602,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,".... Very recently, Wess et al. [11] stated that the p.A31P mutation is less pathogenic than reported s...",168,480,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...ociated HCM [22]. It can not be excluded that the p.A31P cMyBP-C mutation may exhibit a dominant pat...,170,188,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...at those pedigrees with cats heterozygous for the p.A31P mutation and affected with fHCM may represe...,170,467,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...her yet undiscovered mutation is present with the p.A31P cMyBP-C mutation. Digenic or compound heter...,170,627,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,The p.A31P cMyBP-C genotype distribution was not in Ha...,180,5,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,...roduction. That the prevalence of fHCM and of the p.A31P cMyBP-C mutation found in our cohort is sim...,180,885,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,"...ould be avoided. Thus, although genotyping of the p.A31P cMyBP-C mutation can not stand alone in lim...",183,678,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.A31P,... left ventricular inner diameter; MC: Maine Coon; p.A31P: alanine substituted for a proline at resid...,186,407,Acta_Vet_Scand_2011_Feb_9_53(1)_7.txt
p.Thr328Lys,...ith affected women and men is associated with the p.Thr328Lys mutation in the F12 gene J Allergy Cli...,168,169,Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_15.txt
p.A53T,"...triplications [72] or the SNCA missense mutation, p.A53T [73]. A number of other early-onset familie...",59,313,Alzheimers_Res_Ther_2013_Jul_31_5(Suppl_1)_S7.txt
p.A53T,"...triplications [72] or the SNCA missense mutation, p.A53T [73]. A number of other early-onset familie...",59,313,Alzheimers_Res_Ther_2013_Jul_31_5(Suppl_1)_S7.txt
p.T185S,"... [13,14]. A nonsynonymous SNP numbered rs3173615 (p.T185S) located in exon 6 of the TMEM106B gene sh...",18,956,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"... [13,14]. A nonsynonymous SNP numbered rs3173615 (p.T185S) located in exon 6 of the TMEM106B gene sh...",18,956,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,p.T185S genotypin,65,1,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,The rs3173615 SNP composed of p.T185S (C760G) in exon 6 of the human TMEM106B ge...,66,31,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"...e disequilibrium with the coding rs3173615 SNP of p.T185S, is closely associated with FTLD-TDP in th...",124,115,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.T185S,"... showing the complete linkage disequilibrium with p.T185S on rs3173615 [3,13,15], is reduced in AD c...",130,152,Alzheimers_Res_Ther_2014_Mar_31_6(2)_17.txt
p.G130A,"...with a heterozygous mutation in SOX2 (c.389G > C, p.G130A) [Kelberman et al., 2006] makes this anoth...",22,103,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.A339A,"...Exon 5	Chr9: 125,834,603	n/a	c.1017C > G	1/97 (1)	p.A339A",127,52,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
p.Ala172Phe,...al ReportsThe Fibroblast Growth Factor Receptor 2 p.Ala172Phe Mutation in Pfeiffer Syndrome—History ...,3,204,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...cutive nucleotides (c.514_515delGCinsTT, encoding p.Ala172Phe) and was previously known only from Pf...",16,795,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...regated with a 142 bp allele, suggesting that the p.Ala172Phe mutation had arisen independently in t...",37,675,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...ted British family, has also been implicated. The p.Ala172Phe mutation, involving a double nucleotid...",40,462,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"...ype (mild skull/severe limb) correlation with the p.Ala172Phe mutation, both within and across famil...",42,2474,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ala172Phe,"... conclusion, Pfeiffer syndrome resulting from the p.Ala172Phe mutation is infrequent—only two famili...",75,53,Am_J_Med_Genet_A_2013_May_26_161(5)_1158-1163.txt
p.Ile442Met,"...nsin I complex, subunit G (NCAPG) gene encoding a p.Ile442Met variant is associated with an increase...",1143,89,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
p.Ile442Met,"...nsin I complex, subunit G (NCAPG) gene encoding a p.Ile442Met variant is associated with an increase...",1143,89,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
p.Ile442Met,"...nsin I complex, subunit G (NCAPG) gene encoding a p.Ile442Met variant is associated with an increase...",1143,89,Anim_Sci_J_2016_Feb_11_87(2)_159-167.txt
p.Arg463Trp,"...as was the mutation in the fifth case, c.1387C>T (p.Arg463Trp)17. Clues to the molecular pathology o...",48,781,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg463Trp,"...as was the mutation in the fifth case, c.1387C>T (p.Arg463Trp)17. Clues to the molecular pathology o...",48,781,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Ala349Ser,"...strated the deleterious effects of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 i...",51,1428,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Ala349Ser,"...strated the deleterious effects of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 i...",51,1428,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Arg463Trp,"...s of the mutations (p.Ala349Ser, c.1538-1G>A, and p.Arg463Trp) on α3 integrin structure, processing ...",51,1458,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
p.Y279N,...evealed a homozygous novel mutation c. 835 T > A (p.Y279N) in exon 6,37,129,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
p.Arg438Cys,...that resulted in a change in the protein level of p.Arg438Cys (Fig. 2). Mutation analysis and clinic...,17,547,Ann_Lab_Med_2013_Mar_21_33(2)_150-152.txt
p.Glu255Lys,...e was changed from G to A [NM_005157.4: c.763G>A (p.Glu255Lys)],25,501,Ann_Lab_Med_2015_Jan_8_35(1)_159-161.txt
p.Arg1256X,"...mutations, c.1153dupG (p.Val385fs) and c.3766C>T (p.Arg1256X), in EIF2AK4. Unaffected parents were h...",18,405,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
p.Arg1150X,"... (c.860-1G>A) and a nonsense mutation, c.3438C>T (p.Arg1150X). No mutations were identified in this ...",18,913,Appl_Clin_Genet_2015_Aug_7_8_181-188.txt
p.D630Y,"... GNA11, GNAQ, and SF3B1). The mutation (c.G1888T, p.D630Y) lies in the Y-domain of the highly conser...",41,346,Appl_Clin_Genet_2016_Sep_6_9_147-155.txt
p.Asp411Cys,...n of this codon showed that in-vitro mutagenesis (p.Asp411Cys) resulting i,119,62,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Cys,...n of this codon showed that in-vitro mutagenesis (p.Asp411Cys) resulting i,119,62,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Asp411Cys,...n of this codon showed that in-vitro mutagenesis (p.Asp411Cys) resulting i,119,62,Arq_Bras_Cardiol_2015_Nov_105(5)_536-539.txt
p.Gln4154Lys,"...ve studied the APOB gene polymorphism c.12669G>A, p.Gln4154Lys and its relationship with lipid, apoB...",3,1580,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...ve studied the APOB gene polymorphism c.12669G>A, p.Gln4154Lys and its relationship with lipid, apoB...",3,1580,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...ion in linking APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) with CAD risk in different populatio...",8,1395,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.Gln4154Lys,"...he role of the APOB gene polymorphism (c.12669G>A,p.Gln4154Lys) was studied in native Indian Punjabi...",28,74,Balkan_J_Med_Genet_2011_Dec_8_14(2)_35-40.txt
p.D727E,... of glutamic acid for aspartic acid (p.Asp727Glu; p.D727E) in the intracellular portion of the recep...,8,1225,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,... of glutamic acid for aspartic acid (p.Asp727Glu; p.D727E) in the intracellular portion of the recep...,8,1225,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...type TSHR gene increased cAMP accumulation. Thus, p.D727E could induce growth and function of thyroc...",8,1578,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...s [1]. We have investigated the frequency of this p.D727E polymorphism in Turkish patients with MNG ...,8,1681,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ion in exon 10 of the TSHR gene that contains the p.D727E polymorphism (rs1991517), as previously de...",17,263,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ion in exon 10 of the TSHR gene that contains the p.D727E polymorphism (rs1991517), as previously de...",17,263,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ta did not show a direct relationship between the p.D727E polymorphism and non toxic MNG in our grou...,29,177,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...ta did not show a direct relationship between the p.D727E polymorphism and non toxic MNG in our grou...,29,177,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...al.[13] studied the frequency of the polymorphism p.D727E in a large group of patients with non auto...,33,192,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...sion, taking into consideration the fact that the p.D727E TSHR variant is frequently detected in the...",35,60,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,"...ish patients with MNG. According to our data, the p.D727E variant is frequently detected in the gene...",35,544,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.D727E,...igure 1 The PCR-based restriction analysis of the p.D727E polymorphisms of the TSHR gene shown on 2%...,37,52,Balkan_J_Med_Genet_2012_Dec_2_15(2)_67-72.txt
p.Arg488Ter,"...cal case [chrX:47086497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (http://genetics.emory.edu/egl/emvcla...",91,924,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
p.Arg488Ter,"...cal case [chrX:47086497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (http://genetics.emory.edu/egl/emvcla...",91,924,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
p.R1816X,... mutation in C-terminus at position Arg1827 (also p.R1816X in [15]; Fig. 1a) was found in an 8-year ...,52,57,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.R1816X,... mutation in C-terminus at position Arg1827 (also p.R1816X in [15]; Fig. 1a) was found in an 8-year ...,52,57,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.Leu849Pro,"...utation, where a proline residue replaced Leu860 (p.Leu849Pro in [14,15]). The L860P mutation is loc...",56,73,Biochim_Biophys_Acta_2014_Aug_1838(8)_2053-2065.txt
p.S34N,"...ported that local deficiency in hCAP-18/LL-37 and p.S34N mutation in CAMP gene, which is the gene en...",28,875,Biomed_Res_Int_2014_May_19_2014_420830.txt
p.S34N,"...ported that local deficiency in hCAP-18/LL-37 and p.S34N mutation in CAMP gene, which is the gene en...",28,875,Biomed_Res_Int_2014_May_19_2014_420830.txt
p.V600E, c.1799T>A	p.V600E	56 (29.9),189,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61H, c.183G>T	p.Q61H	1 (0.5),201,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	8 (4.3),203,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	8 (4.3),203,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61H, c.181C>A	p.Q61H	1 (0.5),204,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.180_181TC>AA	p.Q61K	1 (0.5),205,17,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.V600E, c.1799T>A	p.V600E	51,244,12,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	29,250,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	29,250,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61K, c.181C>A	p.Q61K	7,251,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.Q61R, c.182A>G	p.Q61R	2,256,11,Biomed_Res_Int_2015_Jan_12_2015_697068.txt
p.R1441C,... K.  Rademakers R.  Theuns J.    Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene ...,127,63,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
p.R1441C,... K.  Rademakers R.  Theuns J.    Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene ...,127,63,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
p.H178D,25	2	+ (80%)	−	Exon 5/p.H178D,60,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R175H,26	2	+ (70%)	−	Exon 5/p.R175H,61,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.R248E,28	2	+ (79%)	−	Exon 7/p.R248E,63,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.P142R,30	2	+ (53%)	−	Exon 5/p.P142R and exon 6/m.P222 L,66,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.V272M,31	2	+ (91%)	−	Exon 8/p.V272M,67,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.V272M,31	2	+ (91%)	−	Exon 8/p.V272M,67,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.V272M,31	2	+ (91%)	−	Exon 8/p.V272M,67,23,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
p.G12V,...hybridization. A KRAS codon 12 mutation (c.35G>T; p.G12V) was detected in the pyloric gland adenoma ...,7,900,BMC_Cancer_2012_Dec_4_12_570.txt
p.Asp2213Asn,c.6637G>A	p.Asp2213Asn	rs529038,44,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Arg176Cys,c.526C>T	p.Arg176Cys	rs7412,56,11,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Cys130Arg,c.388 T>C	p.Cys130Arg	rs429358,59,12,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Asp432Glu,c.1296 T>G	p.Asp432Glu	rs7041,62,13,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.Ala567Thr,"Our results show that the rs1803274 (1699G>A, p.Ala567Thr) polymorphism of BCHE was also signifi...",265,47,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
p.R605Q,"..., respectively. Two missense mutations (p.M1? and p.R605Q) of unknown functional significance were i...",7,259,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.L398L,Exon 12	c.1194A>G	NA	p.L398L	benign	AA 9/39; AG 12/39; GG 18/39 (AF:A 0...,36,22,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.R605Q,Exon 17	c.1814G>A	NA	p.R605Q	unknown	1/39 (het: Pt-7) (0.013)	0/100	pre...,37,22,BMC_Gastroenterol_2012_Oct_15_12_141.txt
p.D19H,Gallstone disease is associated with p.D19H of ABCG8 as well as alterations of choleste...,4,38,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,...ed from blood leukocytes. Genotype frequencies of p.D19H were established using MALDI-TOF mass spect...,7,494,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"... Moreover, irrespective of phenotype, carriers of p.D19H displayed a significant lower absorption th...",10,620,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,... in gallstone carriers and controls regardless of p.D19H presence,10,1039,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,Both gallstone disease and p.D19H of ABCG8 are associated with diminished cho...,13,28,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"... with diminished cholesterol absorption. However, p.D19H is not responsible for the differences in s...",13,108,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.D19H,"...ividuals and gallstone carriers, with and without p.D19H. Protein content was determined by densitom...",166,733,BMC_Gastroenterol_2013_Feb_13_13_30.txt
p.Trp82Arg,...y. We report here a new large family in which the p.Trp82Arg variant (this nomenclature includes the...,16,1003,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...y. We report here a new large family in which the p.Trp82Arg variant (this nomenclature includes the...,16,1003,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,"...ge of the amino acid from tryptophan to arginine (p.Trp82Arg in the new nomenclature, corresponds to...",25,399,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...new family of hereditary ALys associated with the p.Trp82Arg variant is of particular interest becau...,66,56,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,...new family of hereditary ALys associated with the p.Trp82Arg variant is of particular interest becau...,66,56,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.Trp82Arg,The families with the p.Trp82Arg variant already reported are either fro...,76,23,BMC_Gastroenterol_2014_Sep_13_14_159.txt
p.P18A,p.P18A	c.52 C>G	0	0	0	0	0.08	0	0	0,40,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V38M,p.V38M	c.112 G>A	0	0	0	0	0	0.06	0	0,42,1,BMC_Genet_2008_Apr_10_9_31.txt
p.F45L,p.F45L	c.133 T>C	0	0	0	0	0	0.24	0	0,44,1,BMC_Genet_2008_Apr_10_9_31.txt
p.S47I,p.S47I	c.140 G>T	0	0.43	0	0	0	0	0	0,45,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V60L,p.V60L	c.178 G>T	0.10	0	0	0	10.69	15.75	13.21	0,47,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R67Q,p.R67Q	c.200 G>A	0	0	1.17	0	0	0.06	0	0,48,1,BMC_Genet_2008_Apr_10_9_31.txt
p.L99I,p.L99I	c.295 C>A	0	0.43	0	0	0	0	0	0,55,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A103A,p.A103A	c.309 C>T	0	0.43	0	0	0	0	0	0,56,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I120T,p.I120T	c.359 T>C	0	0	1.75	0	0	0.06	0	0,60,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R142H,p.R142H	c.425 G>A	0.01	0	0	0	0.62	1.31	0.75	0,63,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Y152X,p.Y152X	c.456 C>A	0	0	0	0	0	0.06	0	0,65,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Y152X,p.Y152X	c.456 C>A	0	0	0	0	0	0.06	0	0,65,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I155T,p.I155T	c.464 T>C	0	0	0	0	0.23	0.48	1.51	0,66,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R160W,p.R160W	c.478 C>T	0.04	0	0	0	8.31	1.85	7.17	0,67,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R160Q,p.R160Q	c.479 G>A	0	0	0	0	0	0.06	0	5,68,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R163Q,p.R163Q	c.488 G>A	0.14	0	75.51	4.72	4.62	1.61	4.15...,69,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I168I,p.I168I	c.504 C>T	0	0.43	0	0	0	0	0	0,71,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R213W,p.R213W	c.637 C>T	0	0	0	0	0	0.06	0	0,76,1,BMC_Genet_2008_Apr_10_9_31.txt
p.G220G,p.G220G	c.660 C>T	0	0	0	0	0	0.06	0	0,77,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Q228Q,p.Q228Q	c.684 G>A	0	0	0	0	0	0.12	0	0,78,1,BMC_Genet_2008_Apr_10_9_31.txt
p.Q233Q,p.Q233Q	c.699 G>A	0	0	0	0	0	0.36	0.19	0,81,1,BMC_Genet_2008_Apr_10_9_31.txt
p.A240A,p.A240A	c.720 T>C	0	0	0	0	0	0	0.19	0,82,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T242T,p.T242T	c.726 C>T	0	0	0	0	0	0.12	0	0,83,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T242T,p.T242T	c.726 C>T	0	0	0	0	0	0.12	0	0,83,1,BMC_Genet_2008_Apr_10_9_31.txt
p.I264I,p.I264I	c.792 C>T	0	0	0	0	0.15	0	0	0,86,1,BMC_Genet_2008_Apr_10_9_31.txt
p.V265V,p.V265V	c.795 C>G	0	1.28	0	0	0	0	0	0,87,1,BMC_Genet_2008_Apr_10_9_31.txt
p.N279K,p.N279K	c.837 C>A	0	0	0	0	0	0.06	0	0,90,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T314T,p.T314T	c.942 A>G	0.09	44.44	13.27	13.21	7.69	2.33...,94,1,BMC_Genet_2008_Apr_10_9_31.txt
p.T314T,p.T314T	c.942 A>G	0.09	44.44	13.27	13.21	7.69	2.33...,94,1,BMC_Genet_2008_Apr_10_9_31.txt
p.R124W, 	 	c.370C > T (p.R124W)	18217	32.3	58	39	1.77	58.36	0.48	39.35	0....,57,17,BMC_Genet_2013_Feb_19_14_6.txt
p.M470V,CFTR	NM_000492.3	c.1408 G > A (p.M470V)	9356	30.4	60	38	38.44	0.46	60.04	0.99	0.0...,64,32,BMC_Genet_2013_Feb_19_14_6.txt
p.M470V,CFTR	NM_000492.3	c.1408 G > A (p.M470V)	9356	30.4	60	38	38.44	0.46	60.04	0.99	0.0...,64,32,BMC_Genet_2013_Feb_19_14_6.txt
p.D882G,DMD	NM_004006.2	c.2645A > G (p.D882G)	2974	19.6	5	93	4.98	0.87	92.67	1.48	0	0,67,30,BMC_Genet_2013_Feb_19_14_6.txt
p.R1745H, 	 	c.5234 G > A (p.R1745H)	4289	23.4	4	93	93.38	1.19	4.13	1.31	0	0,68,19,BMC_Genet_2013_Feb_19_14_6.txt
p.S601L, 	 	c.1802C > T (p.S601L)	6027	21.4	59	34	2.17	59.25	4.35	34.23	0.0...,85,18,BMC_Genet_2013_Feb_19_14_6.txt
p.R184C, 	 	c.550C > T (p.R184C)	9215	19.6	39	54	2.59	38.77	4.75	53.88	0	0...,94,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R184C, 	 	c.550C > T (p.R184C)	9215	19.6	39	54	2.59	38.77	4.75	53.88	0	0...,94,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R184C, 	 	c.550C > T (p.R184C)	9215	19.6	39	54	2.59	38.77	4.75	53.88	0	0...,94,17,BMC_Genet_2013_Feb_19_14_6.txt
p.T641A, 	 	c.1921A > G (p.T641A)	20556	23.6	2	97	2.13	0.88	96.5	0.49	0	0.0...,103,18,BMC_Genet_2013_Feb_19_14_6.txt
p.D273H, 	 	c.817 G > C (p.D273H)	27824	32.3	61	38	0.68	37.71	60.85	0.73	0....,114,18,BMC_Genet_2013_Feb_19_14_6.txt
p.D273H, 	 	c.817 G > C (p.D273H)	27824	32.3	61	38	0.68	37.71	60.85	0.73	0....,114,18,BMC_Genet_2013_Feb_19_14_6.txt
p.N409S, 	 	c.1226 A > G (p.N409S)	2864	20.4	62	36	61.91	0.8	36.03	1.26	0	0,116,19,BMC_Genet_2013_Feb_19_14_6.txt
p.L483P, 	 	c.1448 T > C (p.L483P)	3331	26.4	60	38	0.99	38.04	0.9	60.07	0	0,117,19,BMC_Genet_2013_Feb_19_14_6.txt
p.L483P, 	 	c.1448 T > C (p.L483P)	3331	26.4	60	38	0.99	38.04	0.9	60.07	0	0,117,19,BMC_Genet_2013_Feb_19_14_6.txt
p.A495P, 	 	c.1483 G > C (p.A495P)	2569	16.3	53	44	1.01	44.45	53.41	1.05	0	0...,118,19,BMC_Genet_2013_Feb_19_14_6.txt
p.G549R, 	 	c.1645 G > A (p.G549R)	33259	34.6	84	15	15.46	0.47	83.69	0.36	0....,131,19,BMC_Genet_2013_Feb_19_14_6.txt
p.H33Q,IDUA	NM_000203.3	c.99 T > G / p.H33Q	34	10.2	6	91	2.94	0.00	91.18	5.88	0.00	0.00...,132,31,BMC_Genet_2013_Feb_19_14_6.txt
p.A361T, 	 	c.1081 G > A (p.A361T)	9486	26.7	60	38	37.50	1.18	59.99	1.33	0.0...,142,19,BMC_Genet_2013_Feb_19_14_6.txt
p.W402X, 	 	c.1205 G > A (p.W402X)	2679	23.2	62	32	31.88	5.30	61.55	1.27	0.0...,144,19,BMC_Genet_2013_Feb_19_14_6.txt
p.S92P, 	 	c.274 T > C (p.S92P)	2505	11.9	14	75	4.79	74.61	6.43	14.17	0	0,149,18,BMC_Genet_2013_Feb_19_14_6.txt
p.S92P, 	 	c.274 T > C (p.S92P)	2505	11.9	14	75	4.79	74.61	6.43	14.17	0	0,149,18,BMC_Genet_2013_Feb_19_14_6.txt
p.S246S, 	 	c.738C > T (p.S246S)	10356	27.9	76	24	0.3	75.69	0.32	23.68	0	0...,150,17,BMC_Genet_2013_Feb_19_14_6.txt
p.R1005Q, 	 	c.3014 G > A (p.R1005Q)	3027	27	50	48	47.9	1.06	50.21	0.83	0	0,155,19,BMC_Genet_2013_Feb_19_14_6.txt
p.S298P, 	 	c.892 T > C (p.S298P)	12564	31.7	60	38	0.93	37.61	1.13	60.31	0	...,164,18,BMC_Genet_2013_Feb_19_14_6.txt
p.V36A, 	 	c.107 T > C (p.V36A)	 	 	 	 	 	 	 	 	 	 ,167,18,BMC_Genet_2013_Feb_19_14_6.txt
p.L502V,"...les we ran, there is a heterozygous c.1504 C > G (p.L502V) missense mutation in the ACADVL gene. Thi...",310,156,BMC_Genet_2013_Feb_19_14_6.txt
p.P19S,... retardation and a reduced lifespan in mice [17]. p.P19S is therefore a plausible candidate mutation...,103,277,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.P19S,... retardation and a reduced lifespan in mice [17]. p.P19S is therefore a plausible candidate mutation...,103,277,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.V327I,"... in LOC783918 (rs384792959, Chr10: 26,948,606 bp, p.V327I). Thirty-eight (out of 263) sequenced anim...",141,828,BMC_Genomics_2015_Apr_18_16(1)_312.txt
p.Gln27Glu,...valuated the potential relevance of the c.79 C>G (p.Gln27Glu) polymorphism of this receptor gene for...,9,77,BMC_Med_Genet_2006_Mar_30_7_31.txt
p.E34V,Si	F	31	1.2	2.1	539	6.00	1208	+/-	c.101A>T/p.E34V,57,45,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,VI	P	F	16	8.0	18.5	2619	10.12	ND	-/+	c.101A>T/p.E34V,58,47,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,VIII	P	F	40	2.4	4.2	874	5.50	1030	+/+	c.670T>G/p.W224R,67,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.R168H,Si	F	35	ND	ND	ND	3.15	1281	+/-	c.503G>A/p.R168H,113,42,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.H106P,XXVI	P	F	39	4.4	6.2	307	5.33	1214	+/-	c.317A>C/p.H106P,118,48,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,29,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,29,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,VIII	P	16.95	50.98	c.670T>G/p.W224R,201,29,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E34V,...tamic acid residue to a valine residue in exon 3 (p.E34V). The other was a G to C substitution at nu...,209,303,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224G,"...eading to a tryptophan to a glycine substitution (p.W224G) (Proband VIII, Figure 7). These mutations...",209,644,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G332A,"...aryotic PPOXs, revealed that mutations p.E34V and p.G332A affect residues that are conserved in mito...",242,114,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224X,...other two already described mutations causing VP: p.W224X [37] and p.W224R [39]. Recently was also s...,244,359,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,... described mutations causing VP: p.W224X [37] and p.W224R [39]. Recently was also suggested that thi...,244,376,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.W224R,... described mutations causing VP: p.W224X [37] and p.W224R [39]. Recently was also suggested that thi...,244,376,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.G232R,"...ons were also found. One was a missense mutation, p.G232R [34,35]. The other 2 reported mutations we...",250,81,BMC_Med_Genet_2008_Jun_20_9_54.txt
p.E320Q,"...we identified a homozygous mutation (c.958G > C, [p.E320Q]) in exon 3 of SLC19A3 in all patients, wh...",97,93,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.E320Q,"...racterization of a disease mutation (c.958G > C, [p.E320Q]). (A) The sequence analyses showed a G to...",99,82,BMC_Med_Genet_2010_Dec_22_11_171.txt
p.A53T,"...sense mutations: c.145C > T (p.R49W), c.157G > A (p.A53T), c.158C > T (p.A53V) and c.244C > T (p.R82...",54,134,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"... c.2975_2978delAG (p.Q994VfsX6), and c.4819C > T (p.R1607W). The frameshift mutation (c.2975_2978del...",69,132,BMC_Med_Genet_2010_May_26_11_79.txt
p.I515T,"...sponsible heterozygous mutation of the OTOF gene, p.I515T, was first found in two affected children ...",76,378,BMC_Med_Genet_2010_May_26_11_79.txt
p.I515T,"...sponsible heterozygous mutation of the OTOF gene, p.I515T, was first found in two affected children ...",76,378,BMC_Med_Genet_2010_May_26_11_79.txt
p.R1607W,"...ted mutation p.R1607W is a missense mutation, and p.R1607W was the consequence of replacement of an ...",76,1119,BMC_Med_Genet_2010_May_26_11_79.txt
p.G908R,"...ning 2 gene (NOD2, also known as CARD15), namely, p.G908R, p.R702W, and p.L1007fs [12-14]. These thr...",22,200,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"...ning 2 gene (NOD2, also known as CARD15), namely, p.G908R, p.R702W, and p.L1007fs [12-14]. These thr...",22,200,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...ne (NOD2, also known as CARD15), namely, p.G908R, p.R702W, and p.L1007fs [12-14]. These three varian...",22,209,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,"... p.R702W, 3.2 (95% CI: 2.2-4.9; p = 6.4*10-9) for p.G908R, and 5.2 (95% CI: 3.3-8.3; p = 2.0*10-12) ...",41,482,BMC_Med_Genet_2011_May_6_12_63.txt
p.G908R,rs2066845	p.G908R	0.04	0.11	3.23 (2.15-4.85)	6.39*10-9,53,12,BMC_Med_Genet_2011_May_6_12_63.txt
p.R702W,"...in our study conferred a slightly higher risk for p.R702W, p.G908R and p.L1007fs (OR of 1.85 (95% CI...",158,1662,BMC_Med_Genet_2011_May_6_12_63.txt
p.R2146Q,"...el compound heterozygous mutations, IVS11 + 1 and p.R2146Q, of MYO15A in one (SR903 family) of the 1...",10,67,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...el compound heterozygous mutations, IVS11 + 1 and p.R2146Q, of MYO15A in one (SR903 family) of the 1...",10,67,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...). Of these, three variants in MYO15A (IVS11 + 1, p.R2146Q, and p.S3474G) were shared by both siblin...",67,187,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...mpound heterozygous mutations, IVS11 + 1G > A and p.R2146Q, are carried by both affected siblings, S...",69,243,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...mpound heterozygous mutations, IVS11 + 1G > A and p.R2146Q, are carried by both affected siblings, S...",69,243,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...mpound heterozygous mutations, IVS11 + 1G > A and p.R2146Q, are carried by both affected siblings, S...",69,243,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...s genes (p.Q445R in GRHL2, p.T1321S in TECTA, and p.S2161F in MYO15A); only one mutation, p.S2161F i...",71,107,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...ECTA, and p.S2161F in MYO15A); only one mutation, p.S2161F in MYO15A, was shared with an affected si...",71,147,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"...d heterozygous mutations in MYO15A, IVS11 + 1 and p.R2146Q, were found in the SR-903 family, while a...",74,58,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,...placed with a non-polar phenylalanine side-chain (p.S2161F). Both alterations are predicted by SIFT ...,74,887,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,SR-903	Chr17:18049349	c.G6437A	p.R2146Q	Exon 29	MyTH4	0/409	Yes	0	0.99	-0.743,82,32,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,SR-285	Chr17:18049394	c.C6482T	p.S2161F	Exon 29	MyTH4	0/409	Yes	0	1	-0.543,84,32,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...present study, we identified two novel mutations, p.S2161F and p.R2146Q, which are located in the My...",109,1036,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,"..., we identified two novel mutations, p.S2161F and p.R2146Q, which are located in the MyTH4 domain. T...",109,1049,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.R2146Q,...portant roles in the functions of myosin XVA. The p.R2146Q protein contains a prominent exposed hydr...,109,1219,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...fied two novel nonsynomous variants, p.G1220R and p.S2161F, in the MYO15A gene. Both of these varian...",111,71,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.G1220R,"...ted sibling. However, as the heterozygous variant p.G1220R was present in the Korean control exome d...",111,200,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...utation in this family. However, another variant, p.S2161F, was absent in 409 ethnically matched con...",111,395,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,...s-yet-unidentified hearing loss gene. Even though p.S2161F was not the causative mutation in this fa...,111,1236,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.S2161F,"...iblings. (B) In family SR-285, only one mutation, p.S2161F in MYO15A, is shared with the affected si...",134,224,BMC_Med_Genet_2013_Jul_17_14_72.txt
p.Pro240Leu,"..., as well as one novel mutation, p.Asn342Ser. The p.Pro240Leu mutation was found in both families. W...",10,232,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"..., as well as one novel mutation, p.Asn342Ser. The p.Pro240Leu mutation was found in both families. W...",10,232,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...tional file 3: Table S3). Two missense mutations, p.Pro240Leu and p.Glu1595Lys, were identified to b...",57,252,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...tional file 3: Table S3). Two missense mutations, p.Pro240Leu and p.Glu1595Lys, were identified to b...",57,252,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...able S3). Two missense mutations, p.Pro240Leu and p.Glu1595Lys, were identified to be compound heter...",57,268,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...zygous mutations in the proband of SR-106 family. p.Pro240Leu was confirmed in the patient’s father ...,57,369,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...riants were also found in an affected sibling and p.Pro240Leu was confirmed in the father by Sanger ...,57,724,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...wo patients and one patient were heterozygous for p.Pro240Leu (2.15%) and p.Glu1595Lys (1.07%), resp...",57,977,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ent were heterozygous for p.Pro240Leu (2.15%) and p.Glu1595Lys (1.07%), respectively. Direct sequenc...",57,1001,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...ent were heterozygous for p.Pro240Leu (2.15%) and p.Glu1595Lys (1.07%), respectively. Direct sequenc...",57,1001,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...tched negative controls (over 700). The mutations p.Asn342Ser and p.Glu1595Lys were absent in all co...,57,1138,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...tched negative controls (over 700). The mutations p.Asn342Ser and p.Glu1595Lys were absent in all co...,57,1138,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"... compound heterozygous mutations, p.Pro240Leu and p.Asn342Ser, were carried by an affected sibling a...",59,401,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"c.C719T	p.Pro240Leu	8	EC3	ㅡ	DAMAGING/0.02	0.999	−1	SR-106,...",75,9,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,c.A1025G	p.Asn342Ser	11	EC3	DXNDN	DAMAGING/0	0.905	−1	SR-20...,76,10,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"... reported pathological mutations, p.Pro240Leu and p.Glu1595Lys, and one novel mutation, p.Asn342Ser ...",85,113,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...ium binding below the threshold of detection. The p.Glu1595Lys mutation reduces the numbers of oxyge...,85,761,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...e polar and uncharged amino acids themselves, the p.Asn342Ser mutation involves the change from a sm...",85,994,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...is longer and more flexible (Figure 2). Thus, the p.Pro240Leu substitution may affect protein stabil...",85,1631,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,...re wild-type and those of B and D are mutant. The p.Asn342Ser in EC3 and p.Glu1595Lys in EC15 are as...,87,459,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,...of B and D are mutant. The p.Asn342Ser in EC3 and p.Glu1595Lys in EC15 are associated with highly co...,87,482,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,4	Chr10:73405729	12	c.G1282A	p.Asp428Asn	rs188376296	1 (SR-68)	2/128	rs18837629...,102,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gly490Ala,5	Chr10:73434888	14	c.G1469C	p.Gly490Ala	rs1227049	8	14/30	[5],103,30,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Val1335Ala,10	Chr10:73492032	31	c.T4004C	p.Val1335Ala	.	.	1/30	Novel,108,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1437Gln,12	Chr10:73498355	33	c.G4310A	p.Arg1437Gln	rs56181447	5	8/30	[5],110,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg1588Trp,13	Chr10:73501595	36	c.C4762T	p.Arg1588Trp	.	.	1/30	[5],111,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Arg2358Gln,21	Chr10:73558886	49	c.G7073A	p.Arg2358Gln	rs4747194	12	26/30	[5],119,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Met2531Val,23	Chr10:73562763	52	c.A7591G	p.Met2531Val	.	.	1/30	Novel,121,31,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu956Lys,"... the present study, and five others (p.Arg301Gln, p.Glu956Lys, p.Arg1417Trp, p.Gln1716Pro, and p.Arg...",132,446,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Gln1716Pro,"...e others (p.Arg301Gln, p.Glu956Lys, p.Arg1417Trp, p.Gln1716Pro, and p.Arg2029Trp) that occur at rela...",132,473,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"... one patient, respectively, were heterozygous for p.Pro240Leu and p.Glu1595Lys, and no other mutatio...",132,718,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...spectively, were heterozygous for p.Pro240Leu and p.Glu1595Lys, and no other mutation was detected. ...",132,734,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...p.Glu1595Lys, and no other mutation was detected. p.Pro240Leu was reported in Japanese families with...",132,784,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...ant causes of non-syndromic hearing loss and that p.Pro240Leu accounted for nearly 43.3% (45/105) of...,132,1015,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,...ant causes of non-syndromic hearing loss and that p.Pro240Leu accounted for nearly 43.3% (45/105) of...,132,1015,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Pro240Leu,"...with ARNSHL caused by CDH23 mutations carried the p.Pro240Leu mutation and, additionally, two of 93 ...",132,1189,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,... of CDH23-associated ARNSHL in Asian populations. p.Glu1595Lys was present in 1 of 93 patients. Astu...,132,1389,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Glu1595Lys,"...nd in the EC domain. Of the three mutations, two (p.Glu1595Lys and p.Asn342Ser) affected highly cons...",134,677,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...in. Of the three mutations, two (p.Glu1595Lys and p.Asn342Ser) affected highly conserved EC calcium-...",134,694,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asn342Ser,"...in. Of the three mutations, two (p.Glu1595Lys and p.Asn342Ser) affected highly conserved EC calcium-...",134,694,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Asp428Asn,...uld not conclude that it is a causative mutation. p.Asp428Asn in SR-68 was also heterozygous. DNA sa...,136,405,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Phe2801Val,...enicity by segregation analysis. p.Val2283Ile and p.Phe2801Val were identified as compound heterozyg...,136,588,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.Phe2801Val,...enicity by segregation analysis. p.Val2283Ile and p.Phe2801Val were identified as compound heterozyg...,136,588,BMC_Med_Genet_2014_Apr_28_15_46.txt
p.A4704V,"...sequencing. Additionally, rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in...",10,532,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.A4704V,"...sequencing. Additionally, rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in...",10,532,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.H5244Q,"..., rare missense variants (p.A4704V, p.T5004I, and p.H5244Q) were detected in three unrelated Kosovo ...",10,556,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.V121I,"...r was a rare variant. The novel variant (c.G361A, p.V121I) is located in the Contactin 2 gene (CNTN2...",144,121,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.T5004I,"...HMCN1 (c.C14111T, p.A4704V, MAF 0.001; c.C15011T, p.T5004I, MAF 0.008, and c.C15732G, p.H5244Q, MAF ...",144,619,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.H5244Q,"...1; c.C15011T, p.T5004I, MAF 0.008, and c.C15732G, p.H5244Q, MAF 0.005) (Table 2 and Table 3). The ot...",144,655,BMC_Med_Genet_2014_Oct_23_15_115.txt
p.R928C,"...utation in a collagen gene (COL6A3) (c.2782C > T, p.R928C) was identified. Collagen genes encode str...",116,69,BMC_Med_Genet_2015_Jul_16_16_49.txt
p.Gly243Arg,...a score of −3.624. SNPs&GO analysis predicted the p.Gly243Arg change as “disease” with a reliability...,72,398,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...a score of −3.624. SNPs&GO analysis predicted the p.Gly243Arg change as “disease” with a reliability...,72,398,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Gly243Arg,...ral factors pertinent to the identified mutation (p.Gly243Arg) support the suggestion that FBXO32 is...,91,100,BMC_Med_Genet_2016_Jan_14_17_3.txt
p.Arg242Cys,"...74Ser), inherited from the mother and c.724C > T (p.Arg242Cys), inherited from the father, confirmin...",36,494,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,Our case had two mutations in the DHCR7 gene: p.Arg242Cys and p.Phe174Ser. Whilst the p.Arg242Cy...,40,47,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,"...ported in patients affected by SLOS [14, 15], the p.Phe174Ser has only been reported in one Portugue...",40,180,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Arg242Cys,"...he c.521 T > C (p.Phe174Ser), and the c.724C > T (p.Arg242Cys) mutations. b In silico programs showi...",43,76,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,... mutations or with two mutations in loop 8–9. The p.Phe174Ser and the p.Arg242Cys mutations are in t...,48,530,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.Phe174Ser,...able 1 Clinical features of patients carrying the p.Phe174Ser varian,48,1369,BMC_Med_Genet_2016_Mar_11_17_22.txt
p.S110S,rs1780316	c.330 T > C	p.S110S	1.00	0.94	0.95,79,23,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.S110S,rs1780316	c.330 T > C	p.S110S	1.00	0.94	0.95,79,23,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.P292P,rs3200255	c.876A > G	p.P292P	0.20	0.17	0.11,81,22,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.P292P,rs3200255	c.876A > G	p.P292P	0.20	0.17	0.11,81,22,BMC_Musculoskelet_Disord_2016_Aug_9_17_332.txt
p.Arg247Pro,... two SMARCAL1 mutations: a novel missense change (p.Arg247Pro) and a well-known nonsense mutation (p...,7,450,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,"...9], displayed a mild form. The missense mutation (p.Arg247Pro) within the first HARP domain (HARP1),...",35,313,BMC_Nephrol_2014_Mar_3_15_41.txt
p.Arg247Pro,"...9], displayed a mild form. The missense mutation (p.Arg247Pro) within the first HARP domain (HARP1),...",35,313,BMC_Nephrol_2014_Mar_3_15_41.txt
p.G2019S,... the Portuguese population the LRRK2 c.6055G > A; p.G2019S mutation has one of the highest frequenci...,6,204,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...ntly sporadic PD. The LRRK2 mutation c.6055G > A; p.G2019S, accounts for 1–2% of typical sporadic PD...",20,617,BMC_Neurol_2008_Jan_22_8_1.txt
p.E395X,...ed data consistent with a homozygous c.1183G > T; p.E395X mutation and a duplication of exon 9; beca...,45,607,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...amples tested positive for the LRRK2 c.6055G > A; p.G2019S mutation, sample S12 and sample S7. Notab...",67,56,BMC_Neurol_2008_Jan_22_8_1.txt
p.G2019S,"...tients studied here, we did identify c.6055G > A; p.G2019S in 2 of 46 early-onset cases. One of thes...",76,281,BMC_Neurol_2008_Jan_22_8_1.txt
p.E64D,...llnik B Tong L Kruger R Riess O  Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson di...,114,189,BMC_Neurol_2008_Jan_22_8_1.txt
p.Q648X,... the identification of a novel nonsense mutation (p.Q648X) and three previously known mutations,10,233,BMC_Neurol_2011_Oct_1_11_119.txt
p.Q78X,...panel (a). DNA electrophoregram with the c.C232T; p.Q78X mutation in exon 3 of CTNNB1 (b,128,1765,BMC_Neurol_2016_Mar_12_16_35.txt
p.R416W,"...same heterozygous missense mutation, c.1246C > T, p.R416W, despite of no neurological symptoms in he...",8,834,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"...ine, Aarrowhead), leading to amino acid change in p.R416W (arginine > tryptophan",48,769,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"... missense mutation in the GFAP gene, c.1246C > T, p.R416W was identified, which was already shown to...",53,189,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"... missense mutation in the GFAP gene, c.1246C > T, p.R416W was identified, which was already shown to...",53,189,BMC_Neurol_2016_Nov_4_16_211.txt
p.V87G,"...e matter lesion, periventricular rim	c. 274 T > G	p.V87G",81,124,BMC_Neurol_2016_Nov_4_16_211.txt
p.L331P,...ep frontal white matter and caudates	c.1006 T > C	p.L331P,87,111,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"...the cerebellum, medulla, pons changes	c.1260C > T	p.R416W",91,72,BMC_Neurol_2016_Nov_4_16_211.txt
p.R416W,"... missense mutation of the GFAP gene, c.1246C > T, p.R416W, has been reported to be one of the causes...",99,408,BMC_Neurol_2016_Nov_4_16_211.txt
p.Gly12Ser,...ldtype; G12D: p.Gly12Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,59,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Ser,...ldtype; G12D: p.Gly12Asp; G12V: p.Gly12Val; G12S: p.Gly12Ser,84,59,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Gly12Asp,"...ild-type; two labs reported a mutation in exon 12 p.Gly12Asp, and three labs were consistent with th...",92,125,BMC_Res_Notes_2012_Apr_25_5_196.txt
p.Leu1077Pro,"...tation. Although it is typical of Southern Italy, p.Leu1077Pro is not included in the mutation panel...",4,272,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro (L1077P) mutation consists in a trans...,21,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"... 40 patients with this mutation, lead to consider p.Leu1077Pro as a severe CF mutation, associated w...",25,119,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,...tation in the second allele while one carried the p.Asn1303Lys (N1303K) mutation. The group included...,33,585,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,1	M	7 yrs	14.57 (Underweight)	Birth	p.Phe508del/p.Leu1077Pro	112	84/43,40,49,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,4	F	20	16.44 (Underweight)	4 months	p.Asn1303Lys/p.Leu1077Pro	108	NA,43,50,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"...icilian Cystic Fibrosis Centre, the prevalence of p.Leu1077Pro is 3.6% among all mutations",65,67,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The present study provides evidence that the p.Leu1077Pro is a relatively frequent mutation ass...,87,46,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The present study provides evidence that the p.Leu1077Pro is a relatively frequent mutation ass...,87,46,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,The p.Leu1077Pro mutation consists in a transition T t...,89,5,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,"Nevertheless p.Leu1077Pro mutation, although belonging to the c...",93,14,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Leu1077Pro,...irth by sweat test. All of them had a p.Phe508del/p.Leu1077Pro genotype,103,230,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,"...on with a severe mutation such as p.Phe508del and p.Asn1303Lys, it is clear that only a follow-up co...",116,299,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.Asn1303Lys,"...on with a severe mutation such as p.Phe508del and p.Asn1303Lys, it is clear that only a follow-up co...",116,299,BMC_Res_Notes_2013_Nov_13_6_461.txt
p.I852T,"...nd CRB1 mutations in 7.4 % of them, with the same p.I852T mutation (of our patients) in two patients...",72,188,BMC_Res_Notes_2016_Feb_13_9_91.txt
p.Arg528Cys,"...nced, and a novel missense mutation, c.1582C > T (p.Arg528Cys), in CACNA1S was detected. Detection o...",7,977,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...aled a missense mutation in CACNA1S, resulting in p.Arg528Cys. This mutation had not been reported p...",42,644,BMC_Urol_2014_Nov_28_14_96.txt
p.Arg528Cys,"...aled a missense mutation in CACNA1S, resulting in p.Arg528Cys. This mutation had not been reported p...",42,644,BMC_Urol_2014_Nov_28_14_96.txt
p.R206H,"...1 causes an arginine-to-histidine substitution at p.R206H in ALK2 within the GS domain in FOP, makin...",29,1735,Bone_Res_2015_Apr_14_3_15005.txt
p.Q207E,"...in are: p.L196P, p.P198-F199delinsL, p.R202I, and p.Q207E.70–72 Moreover, several mutations noticed ...",29,2684,Bone_Res_2015_Apr_14_3_15005.txt
p.R258S,"...ed in the serine/threonine kinase domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375...",29,2781,Bone_Res_2015_Apr_14_3_15005.txt
p.G356D,"...se domain, such as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figure 2 shows that the ...",29,2812,Bone_Res_2015_Apr_14_3_15005.txt
p.R375P,"...ch as p.R258S, p.G325A, p.G328E/R/W, p.G356D, and p.R375P.73–75Figure 2 shows that the FOP mutations...",29,2825,Bone_Res_2015_Apr_14_3_15005.txt
p.Thr52Pro,"...giectasia type 2 with a novel mutation, c.154A>C (p.Thr52Pro), in the ALK1/ACVRL1 gene Neurol Clin N...",240,149,Bone_Res_2015_Apr_14_3_15005.txt
p.V600E,"...ino acid 600 in the kinase domain of the protein (p.V600E, previously known as p.V599E; Smalley and ...",17,441,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,"...thin the BRAF gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the BRAF gene...",43,394,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,"...thin the BRAF gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the BRAF gene...",43,394,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600D,"...F gene. The assay can detect p.V600E, p.V600K and p.V600D mutations within the BRAF gene, but does n...",43,406,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"... HT29 cell line, known to be heterozygous for the p.V600E mutation. Human genomic DNA (Roche, Basel,...",49,120,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,"...F p.V600K alteration, rather than the more common p.V600E (g.1799T>A). Sequencing detected two sampl...",74,569,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.K601E,...is study: BRAF g.1742A>T (p.N581S) and g.1801A>G (p.K601E). Eighteen mutations were detected by ARMS...,74,766,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,...S. Sequencing had confirmed these mutations to be p.V600E in 42 cases and p.V600K in 3 cases. A furt...,76,158,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,...S. Sequencing had confirmed these mutations to be p.V600E in 42 cases and p.V600K in 3 cases. A furt...,76,158,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600E,...S. Sequencing had confirmed these mutations to be p.V600E in 42 cases and p.V600K in 3 cases. A furt...,76,158,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.V600K,...med these mutations to be p.V600E in 42 cases and p.V600K in 3 cases. A further tumour sample was sh...,76,182,Br_J_Cancer_2009_Nov_17_101(10)_1724-1730.txt
p.Gly12Val,"...used as reference for mutations in KRAS codon 12 (p.Gly12Val, heterozygous) and 13 (p.Gly13Asp, hete...",42,204,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,"...used as reference for mutations in KRAS codon 12 (p.Gly12Val, heterozygous) and 13 (p.Gly13Asp, hete...",42,204,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...ion melting analysis was able to discriminate the p.Gly12Val (H441) and the p.Gly13Asp (HCT116) DNA ...,54,63,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...ion melting analysis was able to discriminate the p.Gly12Val (H441) and the p.Gly13Asp (HCT116) DNA ...,54,63,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,...ble to discriminate the p.Gly12Val (H441) and the p.Gly13Asp (HCT116) DNA from KRAS-WT DNA (PC-9). F...,54,89,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...3%. We were able to detect as little as 3% of MUT p.Gly12Val DNA in a WT background,54,429,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...pond to HRMA mutated samples (from top to bottom: p.Gly13Asp, p.Gly12Val and the p.Gly12Asp). Corres...",87,290,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Asp,"...rom top to bottom: p.Gly13Asp, p.Gly12Val and the p.Gly12Asp). Corresponding WT sequencing electroph...",87,321,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...p to bottom, the first electropherogram shows the p.Gly13Asp HRMA-mutated sample, the second the p.G...",87,476,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...p to bottom, the first electropherogram shows the p.Gly13Asp HRMA-mutated sample, the second the p.G...",87,476,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...p to bottom, the first electropherogram shows the p.Gly13Asp HRMA-mutated sample, the second the p.G...",87,476,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly13Asp,"...p to bottom, the first electropherogram shows the p.Gly13Asp HRMA-mutated sample, the second the p.G...",87,476,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...mutated samples and the third and fourth show two p.Gly12Val HRMA-mutated samples,87,589,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly12Val,...mutated samples and the third and fourth show two p.Gly12Val HRMA-mutated samples,87,589,Br_J_Cancer_2012_Aug_7_107(4)_626-631.txt
p.Gly2891Asp,...in cells of patient A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,327,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...in cells of patient A-T213 is from the c.8672G>A (p.Gly2891Asp) allele,70,327,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,...mutant protein associated with the c.1A>G and the p.Gly2891Asp mutant protein are shown in Figure 6A...,72,257,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...eins in A-T213, there was clear evidence that the p.Gly2891Asp mutant protein was active. Consequent...",74,107,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,"...ng ATM, the presence of two mutant ATM proteins, (p.Gly2891Asp and the c.1A>G derived protein) raise...",89,313,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Val2424Gly,...nt ATM protein; this could also apply to both the p.Val2424Gly and the p.Val2716Ala ATM mutations,89,1150,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.Gly2891Asp,... from c.1A>G in patient A-T213 is obscured by the p.Gly2891Asp (c.8672G>A) mutant protein (lanes 5 a...,112,828,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
p.G13D,HCT15	KRAS	p.G13D	R,135,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G13D,HCT15	KRAS	p.G13D	R,135,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.H1047R, 	PIK3CA	p.H1047R	 ,138,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12A,GEO	KRAS	p.G12A	S,139,10,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12V,SW480	KRAS	p.G12V	S,140,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G13D,HCT116	KRAS	p.G13D	S,141,13,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.G12V,SW620	KRAS	p.G12V	S,143,12,Br_J_Cancer_2012_May_8_106(10)_1648-1659.txt
p.Arg94X,"...carrying a heterozygous RPS19 mutation (c.280C>T, p.Arg94X), and healthy control samples were from o...",77,289,Br_J_Haematol_2015_Nov_25_171(4)_517-529.txt
p.Gln2187X,....50	STGD	c.5882G>A(42)	p.Gly1961Glu	c.6559C>T(48)	p.Gln2187X	Yes,78,72,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-164	21	11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,38,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln234X,...11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,63,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln234X,...11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,63,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln234X,...11	NA	STGD	c.3386G>T(23)	p.Arg1129Leu	c.700C>T(6)	p.Gln234X	Yes,79,63,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-162	50	16	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	Yes,80,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-198	27	19	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	NP,81,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-198	27	19	0.1	0.1	STGD	c.3386G>T(23)	p.Arg1129Leu	ND	ND	NP,81,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gln1315X,...0.1	STGD	c.3056C>T(21)	p.Thr1019Met	c.3943C>T(27)	p.Gln1315X	Yes,87,68,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1108His,ARDM-181	57	16	0.1	0.09	STGD	c.3323G>A (22)	p.Arg1108His	IVS38+5G>A		Yes,89,45,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Trp1724Cys,...4) (false +)	p.Ala1598Asp (false +)	c.5172G>T(36)	p.Trp1724Cys	Yes,90,90,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu2027Phe,ARDM-183	63	55	0.150	0.175	STGD	c.6079C>T(44)	p.Leu2027Phe	c.5929G>A(43) (false –)	p.Gly1977Ser ...,91,47,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg602Trp,ARDM-38	35	6	0.01	0.02	STGD	c.1804C>T(13)	p.Arg602Trp	c.4739delT(33)	p.Leu1580fs	Yes,92,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,ARDM-247	30	12	0.05	0.1	CRD	c.3386G>T(23)	p.Arg1129Leu	c.6410G>A(47)	p.Cys2137Tyr	Yes,99,43,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,RP-773	38	20	0.05	0.05	RP	c.33N86G>T(23)	p.Arg1129Leu	ND	ND	NP,104,42,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Glu433Glu,10	c.1299A>G	p.Glu433Glu	This study,118,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu988Leu,20	c.2964C>T	p.Leu988Leu	18,122,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu988Leu,20	c.2964C>T	p.Leu988Leu	18,122,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Leu988Leu,20	c.2964C>T	p.Leu988Leu	18,122,14,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala762Glu,"...ce (fig 2). Three missense changes were detected (p.Ala762Glu, p.Ile2047Asn and p.Cys2137Tyr) in pat...",130,494,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...nges were detected (p.Ala762Glu, p.Ile2047Asn and p.Cys2137Tyr) in patients but not in the 100 ethni...",130,524,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,"...he time of the screening, and one false negative [p.Gly1977Ser] were detected (1/62; 1.6%)",130,965,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,"...he time of the screening, and one false negative [p.Gly1977Ser] were detected (1/62; 1.6%)",130,965,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,"...he time of the screening, and one false negative [p.Gly1977Ser] were detected (1/62; 1.6%)",130,965,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,"...el ABCA4 variants detected in this screening, the p.Arg1129Leu mutation was found to be the most fre...",138,117,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Ala1598Asp,"...longing to family ARDM-197, the chip detected the p.Ala1598Asp mutation. However, dHPLC and direct s...",147,176,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,"..., the dHPLC technique led to the detection of the p.Gly1977Ser mutation in the patient from the fami...",147,442,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1977Ser,"..., the dHPLC technique led to the detection of the p.Gly1977Ser mutation in the patient from the fami...",147,442,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"...4–25 years. Moreover, both patients presented the p.Gly1961Glu mutation, which is considered an alle...",154,663,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"...4–25 years. Moreover, both patients presented the p.Gly1961Glu mutation, which is considered an alle...",154,663,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,The p.Arg1129Leu mutation was found to be the most fre...,167,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Arg1129Leu,The p.Arg1129Leu mutation was found to be the most fre...,167,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...47), double heterozygous for the p.Arg1129Leu and p.Cys2137Tyr alleles, who presented a CRD phenotyp...",167,641,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,...ssociated with an earlier onset of disease.16 The p.Cys2137Tyr change in combination with the p.Arg1...,167,962,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,...ssociated with an earlier onset of disease.16 The p.Cys2137Tyr change in combination with the p.Arg1...,167,962,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Cys2137Tyr,"...phenotype. Therefore, we speculate that the novel p.Cys2137Tyr variant could be a severe allele whic...",167,1091,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"... prevalent missense disease-associated allele was p.Gly1961Glu (3/62; 4.8%), presenting a lower freq...",169,66,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Gly1961Glu,"... Thus, we could suspect a moderate effect for the p.Gly1961Glu allele, as previously reported.",169,392,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
p.Val374Rfs,...Exome	Exon 6 to 8 duplication; c.836-?_1119+?dup; p.Val374Rfs*8	Exon 6 to 8 duplication; c.836-?_111...,103,70,Brain_2013_Jan_3_136(1)_269-281.txt
p.Val374Rfs,...Rfs*8	Exon 6 to 8 duplication; c.836-?_1119+?dup; p.Val374Rfs*8,103,128,Brain_2013_Jan_3_136(1)_269-281.txt
p.Arg126His,"....chr7:16445843 C>T, which is c.377G>A, leading to p.Arg126His. Interestingly, the second compound he...",116,881,Brain_2013_Jan_3_136(1)_269-281.txt
p.D33V,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,43,Brain_2014_May_18_137(5)_1350-1360.txt
p.R95C,"...	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (P)	2 h	Khayat et al., 2008",51,53,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,(ii)	7	6 y 5 m	c.[347G>A] (M) + c.[347G>A] (P)	p.R116Q (M) + p.R116Q (P)	5 m	Novel,53,48,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,37,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,...7G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,64,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,...74G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,74,Brain_2014_May_18_137(5)_1350-1360.txt
p.R116Q,...74G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min	Novel,60,74,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,...7G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	10 h	Novel,61,64,Brain_2014_May_18_137(5)_1350-1360.txt
p.R225H,...7G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	10 h	Novel,61,64,Brain_2014_May_18_137(5)_1350-1360.txt
p.Leu772*,"...gous frame-shift deletion in CCDC88A (c.2313delT, p.Leu772*ter). Analysis of cDNA extracted from pat...",13,668,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,"... reduced amount of full length mRNA, carrying the p.Leu772X in the lymphocytes of Patient 1 (Fig. 2D...",81,745,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,Having proven the potential pathogenicity of the p.Leu772X mutation in cellular models we asked if ...,84,50,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.Leu772X,Having proven the potential pathogenicity of the p.Leu772X mutation in cellular models we asked if ...,84,50,Brain_2016_Apr_25_139(4)_1036-1044.txt
p.E286Q,TP53	5	(10)	17	GAA>CAA/p.E286Q	X	NA	X	Missense	Transversion	1.00	 	Yes,129,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.M246T, 	 	 	 	ATG>ACG/p.M246T	X	NA	X	Missense	Transition	1.00	 	Yes,130,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.E68K, 	 	 	 	GAG>AAG/p.E68K	NA	NA	X	Missense	Transition	0.09	 	ND,131,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Y234C, 	 	 	 	TAC>TGC/p.Y234C	NA	NA	X	Missense	Transition	0.97	 	ND,132,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.M3430I, 	 	 	 	ATG>ATA/p.M3430I	NA	X	X	Missense	Transition	0.00	 	ND,136,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Q546P, 	 	 	 	CAG>CCG/p.Q546P	NA	NA	X	Missense	Transversion	1.00	 	ND,145,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.Q546P, 	 	 	 	CAG>CCG/p.Q546P	NA	NA	X	Missense	Transversion	1.00	 	ND,145,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.P292S, 	 	 	 	CCT>TCT/p.P292S	NA	NA	X	Missense	Transition	0.34	 	ND,147,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.P292S, 	 	 	 	CCT>TCT/p.P292S	NA	NA	X	Missense	Transition	0.34	 	ND,147,17,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.A659P,FMN2	1	(2)	1	GCT>CCT/p.A659P	X	*	*	Missense	Transversion	0.74	 	No cove...,153,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.T468M,HSP90B1	1	(2)	12	ACG>ATG/p.T468M	X	 	X	Missense	Transition	0.98	 	Yes,154,26,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.N167S,PCF11	1	(2)	11	AAT>AGT/p.N167S	X	X	X	Missense	Transition	0.02	 	Yes,156,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.N167S,PCF11	1	(2)	11	AAT>AGT/p.N167S	X	X	X	Missense	Transition	0.02	 	Yes,156,24,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R864L,PTPN21	1	(2)	14	CGA>CTA/p.R864L	X	X	X	Missense	Transversion	1.00	 	Yes,158,25,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R864L,PTPN21	1	(2)	14	CGA>CTA/p.R864L	X	X	X	Missense	Transversion	1.00	 	Yes,158,25,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.R864L,PTPN21	1	(2)	14	CGA>CTA/p.R864L	X	X	X	Missense	Transversion	1.00	 	Yes,158,25,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.N3400K,UBR4	1	(2)	1	AAC>AAA/p.N3400K	X	X	X	Missense	Transversion	0.98	 	Yes,163,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.N3400K,UBR4	1	(2)	1	AAC>AAA/p.N3400K	X	X	X	Missense	Transversion	0.98	 	Yes,163,22,Breast_Cancer_Res_2014_May_8_16(3)_R46.txt
p.V600E,...drochloride and its enhancer. We could not detect p.V600E mutation in the BRAF gene by quantitative ...,17,999,Case_Rep_Dermatol_2015_Sep_12_7(3)_237-240.txt
p.V600E,...drochloride and its enhancer. We could not detect p.V600E mutation in the BRAF gene by quantitative ...,17,999,Case_Rep_Dermatol_2015_Sep_12_7(3)_237-240.txt
p.Tyr328Ter,"c.984C>A, p.Tyr328Ter",67,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Tyr328Ter,"c.984C>A, p.Tyr328Ter",67,11,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg630X,"c.2455C>T, p.Arg630X",68,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg1488X,"c.4462C>T, p.Arg1488X",70,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Met899Ile,"c.2697G>A, p.Met899Ile",100,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Met932Leu,"c.2796A→C, p.Met932Leu",102,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Arg523Ter,"c.1567C>T, p.Arg523Ter",112,12,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
p.Gly12Ser,"...e nucleotide substitution c.34G > A, resulting in p.Gly12Ser amino acid change representing a mutati...",91,85,Case_Rep_Pediatr_2015_Feb_28_2015_934865.txt
p.Arg112His,"...ation but also within families. In this case, the p.Arg112His genotype could be identified in the in...",77,224,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Glu66Gln,...utation in addition to a functional polymorphism (p.Glu66Gln) frequently seen in the Asian populatio...,77,1144,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.Arg112His,"... a relatively mild phenotype, consistent with the p.Arg112His genotype",82,235,Case_Rep_Transplant_2013_Apr_7_2013_905743.txt
p.T522M,"...y 1 missense mutation (rs138651238; c.1565C>T and p.T522M) was discovered (Fig. 6). In total, 18 het...",87,231,Cell_Adh_Migr_2016_Feb_6_10(1-2)_395-55.txt
p.N306I,"...ent of an asparagine with an isoleucine residue, (p.N306I), has been associated with β-HPV persisten...",62,329,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.N306I,"...ent of an asparagine with an isoleucine residue, (p.N306I), has been associated with β-HPV persisten...",62,329,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.I306N,...We therefore investigated the effect of the EVER2 p.I306N polymorphism on TNF-α-induced apoptosis an...,62,472,Cell_Death_Dis_2013_Feb_21_4(2)_e499.txt
p.R1113X,...in the rod domain of DSP. Two of these mutations (p.R1113X and p.R1934X) affect all three isoforms; ...,70,102,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1775I,"...and p.N1324fsZ23) affect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect ...",70,236,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1775I,"...and p.N1324fsZ23) affect DSPI and DSPIa and four (p.R1775I, p.K1583R, p.L1654P and p.Q1446X) affect ...",70,236,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,"...neous disease (Uzumcu et al. 2006). In this case (p.R1267X/p.R1267X), the cutaneous phenotype is rel...",70,1111,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,...diac phenotype might be considered more severe in p.R1267X/p.R1267X with cardiac failure at age 4 ye...,70,1421,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.R1267X,...otype might be considered more severe in p.R1267X/p.R1267X with cardiac failure at age 4 years compa...,70,1430,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.Q673X,...mpared with cardiac failure at age 9 years in the p.Q673X/p.Q1446X case and therefore we are tempted...,70,1527,Cell_Tissue_Res_2010_Jul_4_341(1)_121-129.txt
p.S358L,P 13 — Deleterious effects of theTMEM43mutation p.S358L found in a German family with arrhythmogen...,1137,49,Cell_Tissue_Res_2012_May_25_348(2)_335-370.txt
p.R649X,...ate founder mutations for RPGRIP1L (c. 1945 C > T p.R649X) and CC2D2A (c. 3540delA p.R1180SfsX6). Tw...,13,288,Cilia_2012_Oct_1_1_18.txt
p.M252T,"...). Two missense mutations in TMEM67 (c. 755 T > C p.M252T, and c. 1392 C > T p.R441C) are also proba...",13,383,Cilia_2012_Oct_1_1_18.txt
p.R441C,"...n TMEM67 (c. 755 T > C p.M252T, and c. 1392 C > T p.R441C) are also probable founder mutations. Thes...",13,410,Cilia_2012_Oct_1_1_18.txt
p.T615P,"...PGRIP1L	RPGRIP1L	JBTS7, NPHP8	[6]	Mixed European -p.T615P	[11]",30,65,Cilia_2012_Oct_1_1_18.txt
p.R441C,347	Pakistani	TMEM67	c. 1392 C > T p.R441C	c. 1392 C > T p.R441C	 	 	 	 	 	 	diagnose...,74,36,Cilia_2012_Oct_1_1_18.txt
p.Q376P,P95	Pakistani	TMEM67	c. 1127A > C p.Q376P	c. 1127A > C p.Q376P	+	+	 	+	 	 	 ,76,35,Cilia_2012_Oct_1_1_18.txt
p.Q376P,P95	Pakistani	TMEM67	c. 1127A > C p.Q376P	c. 1127A > C p.Q376P	+	+	 	+	 	 	 ,76,35,Cilia_2012_Oct_1_1_18.txt
p.R85X,162 + 163	British	TMEM216	c. 253 C > T p.R85X†	c. 253 C > T p.R85X†	+	+	+	+	+	 	facial dy...,96,40,Cilia_2012_Oct_1_1_18.txt
p.P476S,176 + 177	British	TMEM67	c. 1426 C > T p.P476S††	c. 2440–3 C > A	+	+	+	+	 	 	flexion defo...,97,40,Cilia_2012_Oct_1_1_18.txt
p.M252T,83527	Norwegian-Indian	TMEM67	c. 755 T > C p.M252T	c. 2882 C > A p.S961YN	+	+	 	+	 	 	 ,100,44,Cilia_2012_Oct_1_1_18.txt
p.Q662X,"...	CEP290	c. 679_680delGA p.E227SfsX2	c. 1984 C > T p.Q662X	 	+	 	+	 	+	abnormal cerebellum, wide nasa...",102,66,Cilia_2012_Oct_1_1_18.txt
p.H610P,166	British	RPGRIP1L	c. 1829A > C p.H610P	c. 721_724delAATG p.N241fsX25	+	+	+	 	 	+	...,104,35,Cilia_2012_Oct_1_1_18.txt
p.D1264N,"...lycystic kidneys; * in cis with c. 3790 G > A het p.D1264N, ** in cis with c. 3893 T > A p.V1298D; †...",109,190,Cilia_2012_Oct_1_1_18.txt
p.V1298D,"... G > A het p.D1264N, ** in cis with c. 3893 T > A p.V1298D; † p.R85X allele was present in 2/10,266 ...",109,229,Cilia_2012_Oct_1_1_18.txt
p.P476S,"...ls in the Exome Variant Server (EVS) database, †† p.P476S allele present in 6/7,012 European/America...",109,361,Cilia_2012_Oct_1_1_18.txt
p.R208X,"... in 6/7,012 European/American controls (EVS), ††† p.R208X allele present in 8/7,012 European/America...",109,433,Cilia_2012_Oct_1_1_18.txt
p.R441L,"...e mutation affecting the same amino-acid residue, p.R441L, has also been reported previously in an M...",122,65,Cilia_2012_Oct_1_1_18.txt
p.R649X,"...gin. The RPGRIP1L nonsense mutation c. 1945 C > T p.R649X was observed in families 207 and 336, whic...",126,156,Cilia_2012_Oct_1_1_18.txt
p.R649X,"...gin. The RPGRIP1L nonsense mutation c. 1945 C > T p.R649X was observed in families 207 and 336, whic...",126,156,Cilia_2012_Oct_1_1_18.txt
p.M252T,1c). The heterozygous missense mutation p.M252T accounted for 30% of identified alleles in...,130,41,Cilia_2012_Oct_1_1_18.txt
p.M252T,"...nsanguinity, testing the TMEM67 missense mutation p.M252T may be useful, but the most common mutatio...",138,1170,Cilia_2012_Oct_1_1_18.txt
p.R440Q,"...rthermore, some MKS mutations, such as the TMEM67 p.R440Q missense mutation, are allelic for Joubert...",138,1456,Cilia_2012_Oct_1_1_18.txt
p.R440Q,"...rthermore, some MKS mutations, such as the TMEM67 p.R440Q missense mutation, are allelic for Joubert...",138,1456,Cilia_2012_Oct_1_1_18.txt
p.L63R,...third heterozygous putative mutation c. 188 T > G p.L63R in TMEM216. This was the only occurrence of...,143,74,Cilia_2012_Oct_1_1_18.txt
p.C282Y,"...nth month of life. She was carrying the c.845G>A (p.C282Y) mutation in heterozygosis, conferring the...",27,212,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.C282Y,"...nth month of life. She was carrying the c.845G>A (p.C282Y) mutation in heterozygosis, conferring the...",27,212,Clin_Case_Rep_2016_Jun_30_4(8)_752-755.txt
p.Cys1298Phe,"...e replacement of a cysteine with a phenylalanine (p.Cys1298Phe), causing the loose of a cysteine in ...",52,744,Clin_Case_Rep_2016_Sep_28_4(11)_1045-1048.txt
p.Cys1298Phe,"The p.Cys1298Phe mutation was recently reported, but t...",63,5,Clin_Case_Rep_2016_Sep_28_4(11)_1045-1048.txt
p.Cys1298Phe,"The p.Cys1298Phe mutation was recently reported, but t...",63,5,Clin_Case_Rep_2016_Sep_28_4(11)_1045-1048.txt
p.V600E,...-Rodzewicz Z  Von Deimling A    Detection of BRAF p.V600E mutations in melanomas: comparison of four...,212,71,Clin_Cosmet_Investig_Dermatol_2015_Jan_30_8_35-46.txt
p.Leu244Pro,A c.731T>C CAPN5 mutation resulted in a p.Leu244Pro substitution in calpain-5. The eye sho...,10,41,Clin_Ophthalmol_2013_Jul_3_7_1339-1345.txt
p.V587G,... revealed a novel heterozygous missense mutation (p.V587G) i,61,73,Clin_Pediatr_Endocrinol_2015_Oct_24_24(4)_191-193.txt
p.Gly1324Ser,...hy and crystallized. The crystal structure of the p.Gly1324Ser mutant of the A1 domain is deposited ...,5,393,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...i-NTA and Heparin affinity chromatography. VWF A1-p.Gly1324Ser purity and absence of aggregates were...,15,224,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...1 domain containing the loss-of-function mutation p.Gly1324Ser. Furthermore, the data shows quality ...",34,142,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...1 domain containing the loss-of-function mutation p.Gly1324Ser. Furthermore, the data shows quality ...",34,142,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...btained parameters. Finally, the structure of the p.Gly1324Ser A1 domain variant is compared to prev...",34,404,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...btained parameters. Finally, the structure of the p.Gly1324Ser A1 domain variant is compared to prev...",34,404,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...btained parameters. Finally, the structure of the p.Gly1324Ser A1 domain variant is compared to prev...",34,404,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,2.1 Production of p.Gly1324Ser A1 in Escherichia col,37,19,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...1 domain containing the loss-of-function mutation p.Gly1324Ser was expressed in E. coli M15 cells as...,38,74,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...1 domain containing the loss-of-function mutation p.Gly1324Ser was expressed in E. coli M15 cells as...,38,74,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,p.Gly1324Ser A1 was shipped on ice overnight for c...,56,1,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...ear aggregates and then concentrated to 20 mg/mL. p.Gly1324Ser A1 was screened against the Wizard Cl...,56,175,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,4.1 Comparison of p.Gly1324Ser A1 with other crystal structures of t...,59,19,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,"...g. 3, compares the obtained crystal structure for p.Gly1324Ser with the structures mentioned above. ...",60,791,Data_Brief_2016_May_10_7_1700-1706.txt
p.Gly1324Ser,...ructures mentioned above. Fig. 3 illustrates that p.Gly1324Ser is identical to all published structu...,60,865,Data_Brief_2016_May_10_7_1700-1706.txt
p.E66Q,...i M  Yokoseki A  Kuwano R  Narita I   Role of the p.E66Q variant of GLA in the progression of chroni...,138,106,Dement_Geriatr_Cogn_Dis_Extra_2016_Jan_19_6(1)_10-19.txt
p.Gly68Asp,"...R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248L...",34,136,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Gly68Asp,"...R43H and G68D (c.128G>A, p.Arg43His and c.203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248L...",34,136,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Glu248Lys,"....203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R ...",34,177,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Glu248Lys,"....203G>A, p.Gly68Asp), E248 K and I225M (c.742G>A, p.Glu248Lys and c.675C>G, p.Ile225Met), and G261R ...",34,177,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.Gly261Arg,"...C>G, p.Ile225Met), and G261R and D217N (c.781G>A, p.Gly261Arg and c.649G>A, p.Asp217Asn). Of these s...",34,248,Diabetes_Care_2012_Jul_12_35(7)_1482-1484.txt
p.S90W,...[21]. Very recently another heterozygous mutation p.S90W identified in two Korean CMT type 2 disease...,88,925,Diagn_Pathol_2013_May_9_8_78.txt
p.S90W,...[21]. Very recently another heterozygous mutation p.S90W identified in two Korean CMT type 2 disease...,88,925,Diagn_Pathol_2013_May_9_8_78.txt
p.Asn88Ser,"2	c.263A>G	p.Asn88Ser	dHMN	[16,18,28]",99,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Ser90Trp,"2	c.269C>G	p.Ser90Trp	dHMN, CMT2	[22]",101,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Arg138X,3	c.412C>T	p.Arg138X	CGL2	[5],103,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Arg138X,3	c.412C>T	p.Arg138X	CGL2	[5],103,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Arg138X,3	c.412C>T	p.Arg138X	CGL2	[5],103,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Tyr187Cys,4	c.560A>G	p.Tyr187Cys	CGL2	[15],104,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Ala212Pro,"5	c.634G>C	p.Ala212Pro	CGL2	[5,25]",106,12,Diagn_Pathol_2013_May_9_8_78.txt
p.Q223R,"...i EA  Genelhu VA  Cabello PH  Pimentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene var...",142,78,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
p.Q223R,"...i EA  Genelhu VA  Cabello PH  Pimentel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene var...",142,78,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
p.G719S,3	M	exon18 (p.G719S and p.E709A)	PR	First scan	E−	Yes	Yes	Yes	...,79,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.G719S,3	M	exon18 (p.G719S and p.E709A)	PR	First scan	E−	Yes	Yes	Yes	...,79,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.G719S,3	M	exon18 (p.G719S and p.E709A)	PR	First scan	E−	Yes	Yes	Yes	...,79,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.P848L,4	M	exon21 (p.P848L)	–	First scan	E−	Yes	Yes	Yes,82,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.P848L,4	M	exon21 (p.P848L)	–	First scan	E−	Yes	Yes	Yes,82,13,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,6	F	exon19 (p.delE746-A750) and exon20 (p.T790M)	Slow PD	First scan	E+	Yes	Yes	Yes,88,41,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,6	F	exon19 (p.delE746-A750) and exon20 (p.T790M)	Slow PD	First scan	E+	Yes	Yes	Yes,88,41,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,7	M	exon19 (p.E746-S752) and exon20 (p.T790M)	SD	First scan	E−	NA	NA	NA	Aberrant arteri...,91,38,EJNMMI_Res_2016_Feb_9_6_10.txt
p.T790M,7	M	exon19 (p.E746-S752) and exon20 (p.T790M)	SD	First scan	E−	NA	NA	NA	Aberrant arteri...,91,38,EJNMMI_Res_2016_Feb_9_6_10.txt
p.S768I,8	M	exon18 (p.G719S) and exon20 (p.S768I)	SD	First scan	E−	Yes	Yes	Yes,95,34,EJNMMI_Res_2016_Feb_9_6_10.txt
p.L861Q,11	F	exon21 (p.L861Q)	SD	First scan	E−	Yes	Yes	Yes,104,14,EJNMMI_Res_2016_Feb_9_6_10.txt
p.L861Q,11	F	exon21 (p.L861Q)	SD	First scan	E−	Yes	Yes	Yes,104,14,EJNMMI_Res_2016_Feb_9_6_10.txt
p.L858R,13	F	exon21 (p.L858R) and exon20 (p.T790M)	Slow PD	First scan	E...,110,14,EJNMMI_Res_2016_Feb_9_6_10.txt
p.N34S,...eatitis and its association with CTRC and SPINK1 (p.N34S) variants Eur J Gastroenterol Hepatol 2009 ...,242,149,EMBO_Mol_Med_2011_Aug_3(8)_451-464.txt
p.N34S,...eatitis and its association with CTRC and SPINK1 (p.N34S) variants Eur J Gastroenterol Hepatol 2009 ...,242,149,EMBO_Mol_Med_2011_Aug_3(8)_451-464.txt
p.A734E,"...ng-defective, recessive sticky missense mutation (p.A734E) in AARS (alanyl-tRNA synthetase) in a mou...",38,479,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.V368L,"... at two highly conserved amino acids (p.L200V and p.V368L), and an alternative splice-derived deleti...",103,379,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.V368L,"... at two highly conserved amino acids (p.L200V and p.V368L), and an alternative splice-derived deleti...",103,379,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.V368L,"... at two highly conserved amino acids (p.L200V and p.V368L), and an alternative splice-derived deleti...",103,379,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.D390G,"...scle specimens. A pathogenic, recessive mutation (p.D390G) in the enzymatic active site of SARS2 (mi...",106,562,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.L155R,...und heterozygous with a second missense mutation (p.L155R). The mutations in AARS2 cause perinatal o...,109,572,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
p.Ser107Leu,"... We identified three FGFR1 variants (p.Arg448Trp, p.Ser107Leu and p.Pro772Ser) in four unrelated pat...",3,2158,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,...wo males) and two PROKR2 variants (p.Arg85Cys and p.Arg248Glu) in two unrelated female patients. Fiv...,3,2266,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,...wo males) and two PROKR2 variants (p.Arg85Cys and p.Arg248Glu) in two unrelated female patients. Fiv...,3,2266,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...onal studies indicated that the new FGFR1 variant p.Arg448Trp is a loss-of-function variant, while p...",3,2495,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...onal studies indicated that the new FGFR1 variant p.Arg448Trp is a loss-of-function variant, while p...",3,2495,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...a loss-of-function variant, while p.Ser107Leu and p.Pro772Ser present signalling activity similar to...",3,2560,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"Three missense variants, p.Ser107Leu, p.Arg448Trp and p.Pro772Ser, were ide...",47,26,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"Three missense variants, p.Ser107Leu, p.Arg448Trp and p.Pro772Ser, were identified in a ...",47,39,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"Three missense variants, p.Ser107Leu, p.Arg448Trp and p.Pro772Ser, were identified in a ...",47,39,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...e missense variants, p.Ser107Leu, p.Arg448Trp and p.Pro772Ser, were identified in a heterozygous sta...",47,55,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"...tation Taster, SIFT and Polyphen-2 tools, whereas p.Ser107Leu and p.Pro772Ser were predicted to be d...",47,343,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...IFT and Polyphen-2 tools, whereas p.Ser107Leu and p.Pro772Ser were predicted to be disease-causing o...",47,359,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,"Two missense variants, p.Arg85Cys and p.Arg248Glu, were found in a hetero...",50,24,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,"Two missense variants, p.Arg85Cys and p.Arg248Glu, were found in a hetero...",50,24,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,"Two missense variants, p.Arg85Cys and p.Arg248Glu, were found in a hetero...",50,24,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,"Two missense variants, p.Arg85Cys and p.Arg248Glu, were found in a heterozygous state in...",50,39,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"...atients with congenital HH (9, 16, 17). The FGFR1 p.Pro772Ser variant was found in five out of 400 (...",52,107,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ing Project (ESP6500). To date, the FGFR1 variant p.Arg448Trp has not been described in population d...",54,479,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ing Project (ESP6500). To date, the FGFR1 variant p.Arg448Trp has not been described in population d...",54,479,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,The FGFR1 variant p.Ser107Leu was identified in a female patient bor...,60,19,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,The p.Arg448Trp variant was identified in a 4-year-old...,63,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,The p.Arg448Trp variant was identified in a 4-year-old...,63,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,The p.Arg85Cys variant was identified in a 19-year-old...,72,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg85Cys,The p.Arg85Cys variant was identified in a 19-year-old...,72,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,The female patient with p.Arg248Glu variant first presented at 10 years of...,75,25,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,The female patient with p.Arg248Glu variant first presented at 10 years of...,75,25,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,...APK pathway. Cells expressing the p.Ser107Leu and p.Pro772Ser variants elicited dose–response curves...,81,342,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...milar to the WT FGFR1c curve (Fig. 1A and B). The p.Arg448Trp variant, on the other hand, demonstrat...",81,445,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ring three different FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with...",84,541,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...ring three different FGFR1 variants (p.Ser107Leu, p.Arg448Trp and p.Pro772Ser) and two patients with...",84,541,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,...two patients with PROKR2 variants (p.Arg85Cys and p.Arg248Glu),84,624,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Val102Iso,"...n this study, two heterozygous missense variants (p.Val102Iso and p.Ser107Leu) were also found in tw...",88,601,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,...o heterozygous missense variants (p.Val102Iso and p.Ser107Leu) were also found in two unrelated pati...,88,617,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,"... in vitro data, it is unlikely that this variant (p.Ser107Leu) alone is causing the phenotype",88,1460,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Pro772Ser,"Concerning the p.Pro772Ser variant, due to its finding in five of...",90,16,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Thr112Thr,"...tients was examined. Three heterozygous variants (p.Thr112Thr, p.Ser450Phe and p.Pro483Ser) were fou...",94,169,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,The p.Arg248Glu variant is located within the last int...,105,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,The p.Arg248Glu variant is located within the last int...,105,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg248Glu,The p.Arg248Glu variant is located within the last int...,105,5,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,"...B) variants had normal signalling activity, while p.Arg448Trp had reduced maximal signalling activit...",120,275,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,... of total protein and maturation levels of WT and p.Arg448Trp receptors. Plotted are means±s.e.m. of...,120,629,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,...nts. (G) Cell-surface expression levels of WT and p.Arg448Trp receptors assessed in live transiently...,120,756,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Arg448Trp,...nts. (G) Cell-surface expression levels of WT and p.Arg448Trp receptors assessed in live transiently...,120,756,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser107Leu,c.320C>T	p.Ser107Leu	Ig-like C2-type 1 domain	Disease-causi...,140,11,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Thr112Thr,p.Thr112Thr	NS	NS	10,215,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ser450Phe,p.Ser450Phe	⇊	=				0,221,1,Endocr_Connect_2015_Mar_10_4(2)_100-107.txt
p.Ala386Glu,...ping performed in proband's parents revealed that p.Ala386Glu was inherited from the father (carrier...,57,1108,Endocrinol_Diabetes_Metab_Case_Rep_2015_Aug_7_2015_150074.txt
p.N148K,... novo heterozygous mutations (STAR c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R193X)) in the ...,4,902,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R193X,"...R c.444C>A (STAR p.N148K) and STAR c.557C>T (STAR p.R193X)) in the STAR gene, causing lipoid CAH. Ne...",4,935,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...lysis showed that the finger printing of the STAR p.N148K mutant is also different from the WT prote...,5,317,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...lysis showed that the finger printing of the STAR p.N148K mutant is also different from the WT prote...,5,317,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R188C,"...st common mutation causing this phenotype is STAR p.R188C. Thus, the spectrum of clinical presentati...",23,454,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.A218V,"...have reported five Japanese alleles carrying STAR p.A218V (1). However, other STAR mutations appear ...",25,185,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.R182L,"...N1 to screen for the common STAR p.Q258X and STAR p.R182L mutations, as previously described (1). Th...",34,401,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...e (A) (dbSNP – rs775130992), resulted in the STAR p.N148K mutation (Fig. 1), which was observed befo...",44,886,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.M225T,"...ilar to that of the WT protein. For example, STAR p.M225T is folded similarly to WT protein. Thus, w...",54,183,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...l emerge. As shown in Fig. 4, the WT and the STAR p.N148K mutant have different proteolysis patterns...",54,857,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...l emerge. As shown in Fig. 4, the WT and the STAR p.N148K mutant have different proteolysis patterns...",54,857,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...l emerge. As shown in Fig. 4, the WT and the STAR p.N148K mutant have different proteolysis patterns...",54,857,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,"...vector or buffer control. In addition to the STAR p.N148K mutation, a second mutation STAR p.R193X, ...",62,933,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...e altered conformation that results from the STAR p.N148K mutation prevents its interaction with VDA...,67,1111,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.N148K,...e altered conformation that results from the STAR p.N148K mutation prevents its interaction with VDA...,67,1111,Endocrinol_Diabetes_Metab_Case_Rep_2016_Mar_2_2016_150119.txt
p.C194F,...7.1:p.C194* and NM_024022.2:c.581G>T; NP_076927.1:p.C194F) were detected in the region corresponding...,10,1045,Eur_Arch_Otorhinolaryngol_2016_Sep_25_273_1327-1328.txt
p.Ala561Thr,...stitution at position 561 of the encoded protein (p.Ala561Thr) and is located in the pore-forming re...,35,1193,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala561Thr,...stitution at position 561 of the encoded protein (p.Ala561Thr) and is located in the pore-forming re...,35,1193,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala561Thr,...stitution at position 561 of the encoded protein (p.Ala561Thr) and is located in the pore-forming re...,35,1193,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala614Val,"... consistent with recent reports of LQT1 and LQT2 (p.Ala614Val) hiPSC-based modelling.32,38 However, ...",94,207,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Ala561Thr,...t differences between our work with KCNH2 G1681A (p.Ala561Thr) LQT2–hiPSCs when compared with the KC...,94,325,Eur_Heart_J_2011_Apr_2_32(8)_952-962.txt
p.Asn130Asp,...ces. The c.521T>C (p.Val174Ala) SNP and c.388A>G (p.Asn130Asp) SNP were the common mutation in Asian...,148,228,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Val174Ala,"...n more and more studies. Specially, the c.521T>C (p.Val174Ala) SNP has been associated with a marked...",150,123,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
p.Arg307Gln,...s mass extension. We found association of c.946A (p.Arg307Gln) with lower LS-BMD at baseline (P=0.00...,3,2590,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,...s mass extension. We found association of c.946A (p.Arg307Gln) with lower LS-BMD at baseline (P=0.00...,3,2590,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,...s mass extension. We found association of c.946A (p.Arg307Gln) with lower LS-BMD at baseline (P=0.00...,3,2590,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,"...ptor to the cell surface,35 the c.946G>A variant (p.Arg307Gln) abolishes ATP binding to the extracel...",18,618,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Ile568Gln,"... bone, the c.1513C allele and the c.1729A allele (p.Ile568Gln) have been shown to be associated with...",20,228,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lower LS BMD i...,43,17,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,P2RX7 c.946G>A (p.Arg307Gln) SNP is associated with lower LS BMD i...,43,17,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.I568N,"...2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associated with an increased 10-year...",50,899,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.I568N,"...2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associated with an increased 10-year...",50,899,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.I568N,"...2RX7 SNPs, c.1513A>C (p.Glu496Ala) and c.1729T>A (p.I568N), are associated with an increased 10-year...",50,899,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Arg307Gln,"...iation of a major LOF SNP in P2RX7, the c.946G>A (p.Arg307Gln), with low BMD in the LS in post-menop...",52,88,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.H155Y,rs208294	c.489C>T (p.H155Y)	0.43	0.99 (0.01)	1.01 (0.01)	1.00 (0.02)	...,89,20,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.R307Q,rs28360457	c.946G>A (p.R307Q)	0.02	1.00 (0.01)	0.88 (0.03)	*	0.004 (0.0...,90,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.E496A,rs3751143	c.1513A>C (p.E496A)	0.17	0.97 (0.01)	0.97 (0.01)	0.99 (0.06)	...,109,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.E496A,rs3751143	c.1513A>C (p.E496A)	0.17	0.97 (0.01)	0.97 (0.01)	0.99 (0.06)	...,109,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.E496A,rs3751143	c.1513A>C (p.E496A)	0.17	0.97 (0.01)	0.97 (0.01)	0.99 (0.06)	...,109,22,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
p.Gly551Asp, G551D	c.1652G>A	p.Gly551Asp,163,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly551Asp, G551D	c.1652G>A	p.Gly551Asp,163,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly85Glu, G85E	c.254G>A	p.Gly85Glu,169,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly85Glu, G85E	c.254G>A	p.Gly85Glu,169,16,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg347Pro, R347P	c.1040G>C	p.Arg347Pro,172,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp110His, D110H	c.328G>C	p.Asp110His,195,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp110His, D110H	c.328G>C	p.Asp110His,195,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117Cys, R117C	c.349C>T	p.Arg117Cys,196,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly178Arg, G178R	c.532G>A	p.Gly178Arg,201,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly178Arg, G178R	c.532G>A	p.Gly178Arg,201,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Pro205Ser, P205S	c.613C>T	p.Pro205Ser,206,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Leu467Pro, L467P	c.1400 T>C	p.Leu467Pro,227,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Val520Phe, V520F	c.1558G>T	p.Val520Phe,231,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ser549Asn, S549N	c.1646G>A	p.Ser549Asn,235,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg560Lys, R560K	c.1679G>A	p.Arg560Lys,241,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1066His, R1066H	c.3197G>A	p.Arg1066His,273,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly1244Glu, G1244E	c.3731G>A	p.Gly1244Glu,284,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp614Gly, D614G	c.1841 A>G	p.Asp614Gly,302,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Gly1069Arg, G1069R	c.3205G>A	p.Gly1069Arg,305,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1070Gln, R1070Q	c.3209G>A	p.Arg1070Gln,306,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile1234Val, I1234V	c.3700 A>G	p.Ile1234Val,308,20,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Ile148Thr, I148T	c.443 T>C	p.Ile148Thr,315,18,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1070Trp, R1070W	c.3208C>T	p.Arg1070Trp,322,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg1162Leu, R1162L	c.3485G>T	p.Arg1162Leu,323,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp1270Asn, D1270N	c.3808G>A	p.Asp1270Asn,325,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117His,"...ith variable disease penetrance (IVS8-5 T allele, p.Arg117His-7 T …); U, variants of unproven or unc...",396,196,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117His,...in intron 9) (30%) or with the variants R117H-7T (p.Arg117His associated with a 7T allele (c.1210-12...,462,816,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Arg117H,"Thauvin-Robinet C, Munck A, Huet F et al: CFTR p.Arg117H is associated with CBAVD and other CFTR-...",513,48,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.D1270N,"...r-Ports F, Des Georges M: Are p.148 T, p.R74W and p.D1270N CF causing mutations ? BMC Med Genet",529,107,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.L997F,"...is variants in population-based screening panels: p.L997F, further genotype/phenotype correlation da...",575,131,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
p.Asp19His,...orted rs11887534:G>C (NM_022437.2(ABCG8):c.55G>C (p.Asp19His). This amino-acid variant is believed t...,92,780,Eur_J_Hum_Genet_2016_Jan_29_24(1)_106-112.txt
p.A256V,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid ...",314,20,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.A256V,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid ...",314,20,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.K794Q,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid substitutions caus...",314,38,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.V811M,"the effects of the p.A256V, p.L266V, p.K794Q, and p.V811M amino acid substitutions cause",314,51,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.R262X,the OCA2 protein (p.R262X) (Fig. 4Fig. 4. Sequence chromatograms of ...,319,19,Exp_Anim_2015_Jan_22_64(2)_171-179.txt
p.Cys1263Ser,"[14]TET2 (p.Thr1027fs, p.Cys1263Ser) and RUNX1 (p.Asn109Ser) were detecte...",44,24,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.Asn109Ser,"... and the SNV (p.Cys1263Ser) in TET2, and the SNV (p.Asn109Ser) in RUNX1 were confirmed in PB and the...",51,83,Exp_Hematol_Oncol_2014_Jul_11_3_18.txt
p.D420Y,11	c.1258G>T	p.D420Y	1	6.5	10.5	Y	N/Y	3	ND	N	Unknown	[31],157,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.R496C,"11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	[31, 32]",158,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.R496C,"11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	[31, 32]",158,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.R496C,"11	c.1486C>T	p.R496C	1	0.3	3.4	Y	N/N	43	ND	Y	Neutral	[31, 32]",158,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.R496C,"...nst them being deleterious. This is the case for: p.R496C in BRCA1 [31, 32] and p.E462G [29, 33, 34]...",189,458,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
p.Glu54X, 2	F11	1 (37)	Exon 2	g.5446G>T	p.Glu54X	Bil	Yes	Enucl	Epithelial	Bl (52),79,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Glu54X, 2	F11	1 (37)	Exon 2	g.5446G>T	p.Glu54X	Bil	Yes	Enucl	Epithelial	Bl (52),79,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 14a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	Enucl	Melanoma	(23),91,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 14a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	Enucl	Melanoma	(23),91,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 14a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	Enucl	Melanoma	(23),91,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 15a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(37),92,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 17a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(21),94,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg445X, 17a	F8		Exon 14	g.76430C>T	p.Arg445X	Bil	No	RT	Melanoma	(21),94,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg467X, 18a	F23	NA	Exon 15	g.76898C>T	p.Arg467X	Bil	No	RT + CH	Melanoma	(28),95,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg552X, 20a	F9		Exon 17	g.78238C>T	p.Arg552X	Bil	No	RT + CH	Osteosarcoma	(12),97,29,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg579X, 23a	F24	NA	Exon 18	g.150037C>T	p.Arg579X	Bil	No	RT	Osteosarcoma	(10),100,33,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Tyr606X, 24	F25	NA	Exon 19	g.153211T>A	p.Tyr606X	Bil	No	RT	Melanoma	(35),101,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Tyr606X, 24	F25	NA	Exon 19	g.153211T>A	p.Tyr606X	Bil	No	RT	Melanoma	(35),101,32,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg787X, 29a	F27	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT + CH	Sarcoma	LMS (32),108,33,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.Arg787X, 29a	F27	NA	Exon 23	g.162237C>T	p.Arg787X	Bil	No	RT + CH	Sarcoma	LMS (32),108,33,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
p.C121G,"...ents, including the two with the homozygosity for p.C121G (Fig. 4A), consistent with the hypothesis ...",187,613,FEBS_Lett_2016_Jun_27_590(11)_1651-1662.txt
p.C121G,"...ents, including the two with the homozygosity for p.C121G (Fig. 4A), consistent with the hypothesis ...",187,613,FEBS_Lett_2016_Jun_27_590(11)_1651-1662.txt
p.C150R,...arcopenic patient with rigid spine syndrome and a p.C150R mutation in the four-and-half LIM domain p...,33,122,Front_Aging_Neurosci_2015_Aug_13_7_153.txt
p.C150R,...arcopenic patient with rigid spine syndrome and a p.C150R Mutation in FHL1 Gene . Front. Aging Neuro...,142,172,Front_Aging_Neurosci_2015_Aug_13_7_153.txt
p.P158P,"...008). Two of the frameshift mutations, c.474delA (p.P158P fsX22), and c.473delC (p.P158H fsX22), gen...",45,579,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.F160X,"...2). The third non-sense mutation, c.479_480delTT (p.F160X), introduces a premature stop codon that r...",45,793,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.F160X,"...2). The third non-sense mutation, c.479_480delTT (p.F160X), introduces a premature stop codon that r...",45,793,Front_Cell_Dev_Biol_2016_Jun_27_4_68.txt
p.Thr226Arg,...letal deformities are expressed with the mutation p.Thr226Arg and not by p.Thr226Ala and p.Thr226Met...,32,624,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.Thr226Ala,...xpressed with the mutation p.Thr226Arg and not by p.Thr226Ala and p.Thr226Met mutations. Vast differ...,32,647,Front_Cell_Neurosci_2015_Aug_19_9_317.txt
p.R181P,"...ient 3 carried p.T312M in MCM4, patient 4 carried p.R181P in CYP11B1, patient 12 had three variants,...",201,176,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.Q364R,"...d p.V126I and p.I993V in NNT, patient 15 had two, p.Q364R in CYP11A1 and p.L649R in MCM4, and patien...",201,299,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.L649R,"...n NNT, patient 15 had two, p.Q364R in CYP11A1 and p.L649R in MCM4, and patient 17 had two, p.H24_Y25...",201,322,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.S386F,"...atient 17 had two, p.H24_Y25delinsQI in NR5A1 and p.S386F in TXNRD2. The contribution of these varia...",201,394,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.S386F,"...atient 17 had two, p.H24_Y25delinsQI in NR5A1 and p.S386F in TXNRD2. The contribution of these varia...",201,394,Front_Endocrinol_(Lausanne)_2015_Aug_5_6_113.txt
p.L206R,...the synthesis of cortisol and other steroids. The p.L206R and Leu199_Cys200insTrp mutations in the P...,23,638,Front_Endocrinol_(Lausanne)_2015_Jun_9_6_96.txt
p.Pro271Ser,UNC13D	c.811C > T p.Pro271Ser htz	None detected	None detected,51,19,Front_Immunol_2014_Jan_14_4_515.txt
p.Pro271Ser,UNC13D	c.811C > T p.Pro271Ser htz	None detected	None detected,51,19,Front_Immunol_2014_Jan_14_4_515.txt
p.R928C,"...nd homozygous for an uncommon UNC13D c.2782C > T (p.R928C, frequency 0.01 in a Caucasian population ...",83,611,Front_Immunol_2014_Jan_14_4_515.txt
p.L58P,...el autosomal recessive missense STX11 c.173T > C (p.L58P) mutation causative of FHL4 in three childr...,96,68,Front_Immunol_2014_Jan_14_4_515.txt
p.R226X,6	MLH1a	c.676 C > T	p.R226X	8	Causal	ACI	CRC (36),44,21,Front_Oncol_2016_Aug_24_6_189.txt
p.Q97X,"3	MSH2	c.289 C > T	p.Q97X	2	Causal	ACI	CRC (49), SKC (51), UT (52)",54,20,Front_Oncol_2016_Aug_24_6_189.txt
p.Q97X,"3	MSH2	c.289 C > T	p.Q97X	2	Causal	ACI	CRC (49), SKC (51), UT (52)",54,20,Front_Oncol_2016_Aug_24_6_189.txt
p.Q97X,"3	MSH2	c.289 C > T	p.Q97X	2	Causal	ACI	CRC (49), SKC (51), UT (52)",54,20,Front_Oncol_2016_Aug_24_6_189.txt
p.R621X,"N	MSH2	c.1861C > T	p.R621X	11	Causal	ACII	EC (34), CRC (59), SIC (79)...",59,20,Front_Oncol_2016_Aug_24_6_189.txt
p.R621X,"N	MSH2	c.1861C > T	p.R621X	11	Causal	ACII	EC (34), CRC (59), SIC (79)...",59,20,Front_Oncol_2016_Aug_24_6_189.txt
p.V600E,...nventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations . BMC Cance...,240,172,Front_Pediatr_2014_Sep_9_2_96.txt
p.V600E,...nventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations . BMC Cance...,240,172,Front_Pediatr_2014_Sep_9_2_96.txt
p.V600E,...r sequencing for the detection of p.V600E and non-p.V600E BRAF mutations . BMC Cancer  (2014 ) 14 :1...,240,188,Front_Pediatr_2014_Sep_9_2_96.txt
p.V60L,Figure 1 P2RX2 p.V60L attenuates ATP evoked inward current. HEK29...,50,16,Front_Physiol_2016_May_24_7_186.txt
p.G353R,... mutant P2RX2 V60L. Cells expressing mutant P2RX2 p.G353R show a lower inward current peak than thos...,50,405,Front_Physiol_2016_May_24_7_186.txt
p.Arg870His,NM_000257.3(MYH7):c.2609G > A (p.Arg870His) rs36211715	Pathogenic/Likely pathogen...,57,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Met515Thr,NM_000257.3(MYH7):c.1544T > C (p.Met515Thr) rs863224900	Likely pathogenic	Rai et ...,58,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Met515Thr,NM_000257.3(MYH7):c.1544T > C (p.Met515Thr) rs863224900	Likely pathogenic	Rai et ...,58,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Met515Thr,NM_000257.3(MYH7):c.1544T > C (p.Met515Thr) rs863224900	Likely pathogenic	Rai et ...,58,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Val606Met,NM_000257.3(MYH7):c.1816G > A (p.Val606Met) rs121913627	Pathogenic / Likely patho...,59,33,Front_Physiol_2016_Oct_28_7_499.txt
p.Asp770Asn,NM_000256.3 (MYBPC3):c.2308G > A (p.Asp770Asn) rs36211723	Pathogenic/Likely pathogen...,66,36,Front_Physiol_2016_Oct_28_7_499.txt
p.R870H,...i G. R. Gopikrishna M. Narasimhan C.   (2007 ). A p.R870H mutation in the beta-cardiac myosin heavy ...,180,72,Front_Physiol_2016_Oct_28_7_499.txt
p.Val438Met,MCCC1	1	A2	F	Homozygous	c.1315G>A	p.Val438Met	Nonsyn	This study,88,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ala289Val,2	S20	M	Compound Het.	c.866C>T; c.974T>G*	p.Ala289Val,107,43,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Met325Arg,p.Met325Arg	Nonsyn; Nonsyn/splicing	Ref. 15,108,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Asp532His,S5	F	Homozygous	c.1594G>C*	p.Asp532His	Nonsyn/splicing	Ref. 15,111,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln372X,c.1882G>T	p.Gln372X,114,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Glu628X,p.Glu628X	Stop; stop	Ref. 18,115,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A7	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,118,27,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Leu355Phe,A11	F	Homozygous	c.1065A>T	p.Leu355Phe	Nonsyn	This study,119,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser101Phe,A13	F	Compound Het.	c.302C>T; UND	p.Ser101Phe	Nonsyn	This study,120,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ser101Phe,A13	F	Compound Het.	c.302C>T; UND	p.Ser101Phe	Nonsyn	This study,120,35,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg72X,A14	F	Compound Het.	c.214C>T*; UND	p.Arg72X	Nonsyn	This study,121,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg72X,A14	F	Compound Het.	c.214C>T*; UND	p.Arg72X	Nonsyn	This study,121,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg72X,A14	F	Compound Het.	c.214C>T*; UND	p.Arg72X	Nonsyn	This study,121,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg72X,A14	F	Compound Het.	c.214C>T*; UND	p.Arg72X	Nonsyn	This study,121,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ala456Val,A16	F	Homozygous	c.1367C>T	p.Ala456Val	Nonsyn	Ref. 6,122,28,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Gln496His,c.351_353delTGG	p.Gln496His,127,17,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg332X,"p.Arg332X	Frameshift/stop; stop	Refs. 6,13,15",132,1,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg155Gln,c.929C>G*	p.Arg155Gln,134,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Arg155Gln,c.929C>G*	p.Arg155Gln,134,11,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Val339Met,"S9	M	Compound Het.	c.1015G>A*; UND	p.Val339Met	Nonsyn	Refs. 15,17",140,36,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.Ile437Val,"S23	M	Compound Het.	c.1309A>G*; UND	p.Ile437Val	Nonsyn	Refs. 14,15",143,37,Genet_Med_2015_Aug_6_17(8)_660-667.txt
p.E368K,"...NM2 showed the heterozygous mutation c.1102G > A, p.E368K, already known to be pathogenic in dominan...",48,1017,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.E368K,"The mutation found in Patient 2 (p.E368K, in exon 8) is the second most frequent in...",52,34,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.F372C,"...l., 2011). The novel mutation found in Patient 1 (p.F372C, in exon 8) changes phenylalanine to cyste...",52,577,Genet_Mol_Biol_2015_May_1_38(2)_147-151.txt
p.R60Q,... and biochemical assays demonstrated that the MAX p.R60Q and BRAF p.K483E mutations were activating ...,11,438,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... assays demonstrated that the MAX p.R60Q and BRAF p.K483E mutations were activating mutations, where...",11,454,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"... included missense mutations in TP53 (c.743G > A, p.R248Q), MAX (c.179G > A, p.R60Q), BRAF (c.1447A ...",110,493,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"... included missense mutations in TP53 (c.743G > A, p.R248Q), MAX (c.179G > A, p.R60Q), BRAF (c.1447A ...",110,493,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"...tation in ROS1 (c.1176 T > A, p.C392*). The TP53 (p.R248Q) and APC (p.R790*) mutations had allelic f...",110,659,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,The identified TP53 (p.R248Q) mutation is a previously described gain-o...,112,22,Genome_Med_2016_Oct_31_8_116.txt
p.R248Q,"...ggested by the high allelic frequencies for TP53 (p.R248Q) and APC (p.R790*) mutations, we confirmed...",117,414,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...sight into the functional consequence of the MAX (p.R60Q) mutation, we performed in silico modeling ...",128,727,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"... left. e, f Structures of wild-type BRAF and BRAF p.K483E mutant. e Model of the BRAF kinase domain ...",128,3282,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...tant. Overall, our analysis predicts that the MAX p.R60Q mutant could form a stable heterodimer with...",135,361,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...tant. Overall, our analysis predicts that the MAX p.R60Q mutant could form a stable heterodimer with...",135,361,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,... both C-MYC and MXD1. To formally evaluate if MAX p.R60Q could form functional heterodimers with C-M...,135,461,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...f mTOR [47, 48]. Analysis of the identified RPTOR p.A751V mutation by PolyPhen, SIFT, and PROVEAN [4...",138,370,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,"...R or mTOR substrates [52]. In addition, the RPTOR p.A751V mutation has been reported in The 1000 Gen...",138,901,Genome_Med_2016_Oct_31_8_116.txt
p.A751V,...00 Genomes project database indicating that RPTOR p.A751V may represent a genetic variant of RPTOR t...,138,995,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,Functional characterization of BRAF p.K483,140,37,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...nstream MEK/ERK pathway [56]. The identified BRAF p.K483E mutation in the patient’s tumor is localiz...,141,194,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...alogued in the COSMIC database suggests that BRAF p.K483E may paradoxically result in downstream pat...,141,1222,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...functionally evaluate the consequence of the BRAF p.K483E mutation, we transiently expressed wild-ty...",143,54,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...functionally evaluate the consequence of the BRAF p.K483E mutation, we transiently expressed wild-ty...",143,54,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...functionally evaluate the consequence of the BRAF p.K483E mutation, we transiently expressed wild-ty...",143,54,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,... BRAF null cells. These results suggest that BRAF p.K483E mutation activates downstream signaling th...,143,798,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...gation. In the case of the MAX (p.R60Q) and BRAF (p.K483E) mutations, in silico modeling of the muta...",164,462,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...gation. In the case of the MAX (p.R60Q) and BRAF (p.K483E) mutations, in silico modeling of the muta...",164,462,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...gation. In the case of the MAX (p.R60Q) and BRAF (p.K483E) mutations, in silico modeling of the muta...",164,462,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...gation. In the case of the MAX (p.R60Q) and BRAF (p.K483E) mutations, in silico modeling of the muta...",164,462,Genome_Med_2016_Oct_31_8_116.txt
p.R60Q,"...o homodimerize [43], and we further show that MAX p.R60Q retains the ability to efficiently bind C-M...",167,541,Genome_Med_2016_Oct_31_8_116.txt
p.D594A,"...RAF mutants with no kinase activity, such as BRAF p.D594A, are able to promote ERK phosphorylation b...",169,231,Genome_Med_2016_Oct_31_8_116.txt
p.D594A,"...RAF mutants with no kinase activity, such as BRAF p.D594A, are able to promote ERK phosphorylation b...",169,231,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,...sion increased ERK1/2 activation despite the BRAF p.K483E mutant harboring a catalytically dead kina...,169,442,Genome_Med_2016_Oct_31_8_116.txt
p.K483E,"...inhibitors [77]. Therefore, we conclude that BRAF p.K483E is an activating mutation with effects lik...",169,922,Genome_Med_2016_Oct_31_8_116.txt
p.G12V,... Detection of a somatic KRAS mutation (c.35G > T; p.G12V) in DNA extracted from micro-dissected tumo...,26,1573,Gynecol_Oncol_Res_Pract_2016_May_5_3_5.txt
p.Arg265Cys,Perera S Bapat B The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stabili...,107,36,Hered_Cancer_Clin_Pract_2012_Jul_23_10(1)_9.txt
p.Arg265Cys,Perera S Bapat B The MLH1 variants p.Arg265Cys and p.Lys618Ala affect protein stabili...,107,36,Hered_Cancer_Clin_Pract_2012_Jul_23_10(1)_9.txt
p.Leu749Gln,...ys and p.Lys618Ala affect protein stability while p.Leu749Gln affects heterodimer formation Hum Muta...,107,95,Hered_Cancer_Clin_Pract_2012_Jul_23_10(1)_9.txt
p.C634Y,"...ozygous missense mutations; 7 families had MEN2A (p.C634Y [n = 3], p.C634R [n = 2], p.C634F [n = 1],...",45,480,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y, F2	1	1/0	35	p.C634Y	35.0	1/35,67,14,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y, F3	6	2/4	9-44	p.C634Y	30.2	1/36,68,16,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R, F5	3	2/1	19-32	p.C634R	24.7	2/40.5,70,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618R, F7	3	1/2	21-36	p.C618R	27.3	1/40,72,17,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F, p.C634F/Y/R	21	12	9,106,2,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,"...= 3]), 11 (p.C634Y [n = 10], p.C634R [n = 9], and p.C634F [n = 2]), 16 (p.M918T [n = 1]). It was sur...",227,258,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634F,"...= 3]), 11 (p.C634Y [n = 10], p.C634R [n = 9], and p.C634F [n = 2]), 16 (p.M918T [n = 1]). It was sur...",227,258,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634Y,"...amilies, only proband (F2-II1 and F9-II3) had the p.C634Y or p.M918T mutation, while his consanguine...",227,397,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"...ly proband (F2-II1 and F9-II3) had the p.C634Y or p.M918T mutation, while his consanguineous parents...",227,408,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C618Y,"...[for example, F8-III5, F8-IV5 and F8 other 6 with p.C618Y]. This may occur by the accumulation of ge...",232,733,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.C634R,"...e early stages of research, the MEN2A family (F6, p.C634R) was mistaken for the FMTC family; however...",236,66,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.M918T,"... In the current study, in 2 (F2 [p.C634Y] and F9 [p.M918T]) of 9 families (Figure 1), only 2 proband...",238,194,Hered_Cancer_Clin_Pract_2015_Jan_20_13_5.txt
p.R512W,c.1543G>A	p.R512,228,11,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R512Q,JS_D	1	H	c.1535G>A	p.R512Q	Yes,244,21,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R563H,MTI-008	4	H	c.1688G>A	p.R563H	Yes,258,24,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.K580E,MTI-627	3 (1 died)	H	c.1738A>G	p.K580E	Yes,264,33,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.V443D,p.V443,337,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.I641N,p.I641,364,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R48K,A2229	1	H	c.143G>A	p.R48K	Yes,393,21,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,412,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,422,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,422,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G1890*,p.G1890,449,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.S630P,A1371	2	H	c.1888T>C	p.S630P	Yes,468,22,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Q550R,JS_F1	3	H	c.1649A>G	p.Q550R	Yes,486,22,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1019*,p.R1019,502,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1019*,p.R1019,513,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R1019*,p.R1019,513,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.P1122S,p.P1122,523,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.P1122S,p.P1122,523,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.L78Pfs,Fam9	1	H	c.233_234del	p.L78Pfs*2	Yes,566,24,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A966Pfs,p.A966Pfs*8,575,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A966Pfs,p.A966Pfs*8,585,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Q356Pfs,c.1066dupC	p.Q356Pfs*23	Yes,620,13,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Q318Pfs,MTI-131	2	H	c.953_954AGdel	p.Q318Pfs*5	Yes	novel	Emirati	This study,635,29,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.A126T,p.A126,652,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.Y130C,p.Y130,679,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.G2663Afs,p.G2663Afs*4,725,1,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.R479S,c.1437G>C	p.R479S	No	digenic	F (Emirati,741,12,Hum_Genome_Var_2014_Nov_6_1_14020.txt
p.L292P,... impairment. Here we describe a missense variant (p.L292P) within a mutation-rich region of FRMD7 de...,15,192,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,"... structural and functional predictions, we report p.L292P as a variant potentially disrupting FRMD7 ...",15,415,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,"... structural and functional predictions, we report p.L292P as a variant potentially disrupting FRMD7 ...",15,415,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,"...us caballus and Gallus gallus. The FRMD7 variant, p.L292P, is indicated above the aligned sequence, ...",39,940,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.L292P,"...us caballus and Gallus gallus. The FRMD7 variant, p.L292P, is indicated above the aligned sequence, ...",39,940,Hum_Genome_Var_2015_Feb_12_2_15002.txt
p.Arg44Gln,"...ly reported, the two missense mutations c.131G>A (p.Arg44Gln) and c.50A>G (p.Asn17Ser) were found in...",26,938,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Asn17Ser,1	 	Sporadic	Exon5	c.50A>G	Missense	p.Asn17Ser	PD	No	9	F	Total/total	−/−	+/+	−/−	+/+	−...,51,37,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg44Gln,2	 	Sporadic	Exon5	c.131G>A	Missense	p.Arg44Gln	PD	No	21	M	Total/total	−/−	+/+	−/−	+/+	...,52,38,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Arg203X,15	 	Sporadic	Exon8	c.607C>T	Nonsense	p.Arg203X	LNK	Yes	9	F	Partial/partial	−/−	+/+	−/−	...,66,39,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.Gln277X,20	 	Sporadic	Exon10	c.829C>T	Nonsense	p.Gln277X	PST	Yes	13	F	Total/total	−/−	+/+	−/−	+/+...,71,40,Hum_Genome_Var_2016_Feb_11_3_15052.txt
p.N1007S,...an syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene J. Med. Genet. 2007 44...,66,181,Hum_Mol_Genet_2009_Apr_15_18(R1)_R60-R64.txt
p.G608G,"... mutation in exon 11 of the LMNA gene (c.1824C>T, p.G608G). Although this mutation does not result i...",10,332,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
p.G608G,"...ommon progeroid lamin A mutation, LMNA c.1824C>T; p.G608G, to test the hypothesis that neuropatholog...",87,551,Hum_Mol_Genet_2015_Mar_1_24(5)_1305-1321.txt
p.N410H,...A. et al  (2014 ) Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration . Acta. ...,123,191,Hum_Mol_Genet_2015_Nov_1_24(21)_6198-6212.txt
p.A152T,"...generative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia...",178,208,Hum_Mol_Genet_2015_Nov_1_24(21)_6198-6212.txt
p.Ala239Thr,...LD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant . Acta. Neuropathol...,181,210,Hum_Mol_Genet_2015_Nov_1_24(21)_6198-6212.txt
p.R27Lfs,"...t fibroblasts with mutations in AP5Z1 (Patient 3: p.R27Lfs*3), SPG11 or SPG15 were probed with antib...",43,402,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.N2100Efs,...rtuguese origin carries the homozygous c.6296dup (p.N2100Efs*12) mutation (48) and another from Syri...,83,197,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.L1679Rfs,...her from Syria carries the homozygous c.5036delT (p.L1679Rfs*1687) mutation (10). One SPG11 patient ...,83,284,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.L1679Rfs,...her from Syria carries the homozygous c.5036delT (p.L1679Rfs*1687) mutation (10). One SPG11 patient ...,83,284,Hum_Mol_Genet_2015_Sep_1_24(17)_4984-4996.txt
p.G305R,p.G305R	c.913G>A	3.58	4.90	B	1,18,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,p.G305R	c.913G>A	3.58	4.90	B	1,18,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G307S,p.G307S	c.919G>A	0.16	0.50	B	88	ECE: undetectable ...,19,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.N228K,"p.N228K	c.684C>G/A	0.06	0.10	B	4	ECE: aggregates, ...",25,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.N228K,"p.N228K	c.684C>G/A	0.06	0.10	B	4	ECE: aggregates, ...",25,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P49L,p.P49L	c.146C>T	35.01	61.90	S	3,27,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,p.E302K	c.904G>A	15.03	24.50	S	6	ECE: shorter prod...,31,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E302K,p.E302K	c.904G>A	15.03	24.50	S	6	ECE: shorter prod...,31,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,p.R369C	c.1105C>T	4.55	10.90	S	4	SCE: does not aff...,32,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,p.R369C	c.1105C>T	4.55	10.90	S	4	SCE: does not aff...,32,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,p.S466L	c.1397C>T	0.23	0.40	B	1	ECE: ∼310% WT acti...,42,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,p.S466L	c.1397C>T	0.23	0.40	B	1	ECE: ∼310% WT acti...,42,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,p.S466L	c.1397C>T	0.23	0.40	B	1	ECE: ∼310% WT acti...,42,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,p.S466L	c.1397C>T	0.23	0.40	B	1	ECE: ∼310% WT acti...,42,2,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E176K,"...c.341C>T (p.A114V), c.442G>A (p.G148R), c.526G>A (p.E176K), r.1224_1358del; p.W409_G453del, c.1265C>...",58,199,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,"...T (p. P422L), C.1304T>C (p.I435T), and c.1397C>T (p.S466L) were prepared using the previously descri...",58,299,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,"...pe CBS and four mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared the effect...",65,264,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,"...ur mutant enzymes (p.A114V, p.V180A, p.K102N, and p.I278T). We have compared the effects of the foll...",65,277,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,"...or this analysis contained the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p...",78,617,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,"...nalysis contained the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q va...",78,626,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,"...the wild-type CBS, the p.K102N, p.S466L, p.E302K, p.G305R, p.G307S, and p.R125Q variant proteins exp...",78,644,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"... included the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D...",88,387,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,"... the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. Thi...",88,396,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,"... the p.A114V, p.R125Q, p.E144K, p.T191M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. Thi...",88,396,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,"...M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. This set was expanded by additional 18 le...",88,434,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,"...M, p.R266K, p.I278T, p.G307S, p.W409_G453del, and p.D444N. This set was expanded by additional 18 le...",88,434,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,"...e larger than 9% (with the exception of mutations p.C165Y, p.P422L, and p.S466L that belong to burie...",108,1562,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,"...e larger than 9% (with the exception of mutations p.C165Y, p.P422L, and p.S466L that belong to burie...",108,1562,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,... are grouped here (with the exception of mutation p.H65R that belong to solvent exposed mutations). ...,108,1727,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,... are grouped here (with the exception of mutation p.H65R that belong to solvent exposed mutations). ...,108,1727,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,"...details, see Table 2). Only three mutant proteins—p.G305R, p.T262R, and p.N228K—did not exhibit any ...",118,230,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,"...details, see Table 2). Only three mutant proteins—p.G305R, p.T262R, and p.N228K—did not exhibit any ...",118,230,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,B	p.G305R	n.d.	n.d.	n.d.	0.4±0.02	N/A	N/A,128,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.G305R,B	p.G305R	n.d.	n.d.	n.d.	0.4±0.02	N/A	N/A,128,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,Heme binding pocket	S	p.H65R	5.6±1.9	4.4±1.6	1.9±0.7	0.8±0.2	N/A	N/A,130,23,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,B	p.R266K	25.3±4.2	82.3±23.0	29.4±0.03	47.8±24.7	325...,132,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I278T,B	p.I278T	0.4±0.04	0.6±0.1	0.4±0.1	0.9±0.2	N/A	N/A,136,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P49L,S	p.P49L	147.9±38.9	512.8±147.3	170.9±34.1	103.4±43....,137,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,S	p.R369C	2.5±0.4	6.4±0.3	2.4±0.1	13.1±0.4	57.5±8.1	...,142,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,Dimer–dimer interface	S	p.P78R	13.8±5.0	43.4±12.2	13.2±4.9	26.4±9.2	149.7±...,143,25,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,S	p.A114V	109.7±10.5	303.3±36.7	117.0±19.0	13.0±1.2	...,144,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.E176K,S	p.E176K	4.9±0.6	2.7±0.3	4.4±0.6	11.5±8.3	7.9±5.6	N...,145,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,S	p.V180A	13.1±3.5	24.5±5.3	21.7±0.05	127.3±15.2	457...,146,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P422L,Regulatory domain – first CBS domain	B	p.P422L	65.5±12.6	165.8±38.1	67.0±16.6	113.2±77.9	...,148,40,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.I435T,S	p.I435T	196.5±48.2	268.872±.9	186.6±52.8	215.4±72....,149,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R439Q,S	p.R439Q	167.3±28.4	774.0±56.4	179.8±0.04	76.4±14.8...,150,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.D444N,S	p.D444N	233.7±39.9	817.9±101.5	313.6±22.6	117.0±27...,151,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.S466L,B	p.S466L	346.2±69.1	325.2±63.1	353.7±59.9	208.7±98....,152,4,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.C165Y,"... inhibited by AdoHcy, and the p.H65R, p.T191M and p.C165Y appeared to be inhibited by both adenosyl ...",165,473,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"...amers/oligomers of the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p....",168,1066,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R369C,"...gomers of the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. Ho...",168,1075,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"... the wild-type CBS, namely, the p.R266K, p.R369C, p.R125Q, p.P78R, p.V180A, and p.I435T. However, th...",168,1084,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R266K,"...d type at 18°C (see Table 2). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exh...",170,208,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"... 18°C (see Table 2). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited mo...",170,217,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.V180A,"...). The mutant proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited more than approximat...",170,235,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,"... proteins p.R266K, p.R125Q, p.R369C, p.V180A, and p.P78R exhibited more than approximately twofold i...",170,248,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.A114V,"...rroring the increased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V...",175,654,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.H65R,"...he increased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). Ho...",175,663,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.K102N,"...ased amounts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, c...",175,671,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,"...nts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, changes in...",175,680,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.P78R,"...nts of tetramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, changes in...",175,680,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.R125Q,"...etramers (e.g., p.A114V, p.H65R, p.K102N, p.P78R, p.R125Q, and p.V180A). However, changes in amounts...",175,688,Hum_Mutat_2010_Jul_18_31(7)_809-819.txt
p.Ser2Gly,... relevance is the fact that the invariant c.4A>G (p.Ser2Gly) SHOC2 mutation was observed to provoke ...,84,1151,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
p.Ser2Gly,... relevance is the fact that the invariant c.4A>G (p.Ser2Gly) SHOC2 mutation was observed to provoke ...,84,1151,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
p.Ser2Gly,... relevance is the fact that the invariant c.4A>G (p.Ser2Gly) SHOC2 mutation was observed to provoke ...,84,1151,Hum_Mutat_2012_Apr_17_33(4)_703-709.txt
p.Glu6Lys,...aused by an amino acid substitution (HBB c.19G>A; p.Glu6Lys) occurring at the same position. HbAC ca...,27,93,Hum_Mutat_2013_Jul_8_34(7)_937-944.txt
p.Ala1008Pro,"...dues Ala1008 and Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP....",99,589,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,"...dues Ala1008 and Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP....",99,589,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,"...dues Ala1008 and Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP....",99,589,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,"...Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP. H‐NNT residues h...",99,606,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,"...Asn1009, which harbor variations p.Ala1008Pro and p.Asn1009Lys, interact with NADP. H‐NNT residues h...",99,606,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.His365Pro,"...d in orange. B: Residue His365, which harbors the p.His365Pro substitution, is a rim interface resid...",104,371,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"...e opposite domain I. C: Phe215, which harbors the p.Phe215Ser substitution, is a conserved interface...",104,520,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,p.Phe215Ser	9	Phe(100.0%)	0 D	1.00 D	47 Poss D	Lik...,118,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,p.Phe215Ser	9	Phe(100.0%)	0 D	1.00 D	47 Poss D	Lik...,118,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.His365Pro,"p.His365Pro	1	His(61.1%), Val and Lys(11.1%), Tyr,...",121,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Tyr388Ser,"p.Tyr388Ser	7	Tyr(94.4%), Phe(5.6%)	0 D	1.00 D	85 ...",122,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Tyr388Ser,"p.Tyr388Ser	7	Tyr(94.4%), Phe(5.6%)	0 D	1.00 D	85 ...",122,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly664Arg,p.Gly664Arg	8	Gly(100.0%)	0 D	1.00 D	56 D	Likely d...,127,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu977Pro,p.Leu977Pro	9	Leu(100.0%)	0 D	1.00 D	92 D	Likely d...,131,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,"p.Ala1008Pro	9	Ala(94.4%), Ser(5.6%)	0 D	1.00 D	94...",133,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,"p.Ala1008Pro	9	Ala(94.4%), Ser(5.6%)	0 D	1.00 D	94...",133,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"p.Phe215Ser, homozygous in FGD patient [Yamaguchi ...",144,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Met880Ter,"...d heterozygosity in an FGD patient in addition to p.Met880Ter, which is predicted to cause nonsense‐...",150,80,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.His365Pro,"p.His365Pro, homozygous in an FGD patient [Meimari...",153,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala533Val,"p.Ala533Val, homozygous in an FGD patient [Meimari...",162,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly862Asp,p.Gly862Asp Gly862 is an invariant residue located...,171,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,p.Ala1008Pro and p.Asn1009Lys. Both variations wer...,177,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ala1008Pro,p.Ala1008Pro and p.Asn1009Lys. Both variations wer...,177,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,p.Ala1008Pro and p.Asn1009Lys. Both variations were found in patien...,177,18,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Asn1009Lys,"...p.Ala1008Pro was present in homozygosity, whereas p.Asn1009Lys was in compound heterozygosity with p...",177,131,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe	ENST00000264663.5:c.1987C > T	PASS	Mis...,186,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe	ENST00000264663.5:c.1987C > T	PASS	Mis...,186,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe	ENST00000264663.5:c.1987C > T	PASS	Mis...,186,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Thr589Ser,p.Thr589Ser	ENST00000264663.5:c.1765A > T	PASS	Mis...,190,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Arg27His,...anshydrogenases. Position 27 is not conserved and p.Arg27His is predicted benign by most prediction ...,192,264,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Arg27His,...anshydrogenases. Position 27 is not conserved and p.Arg27His is predicted benign by most prediction ...,192,264,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Lys63Arg,"...n site, nor in proximity to NAD binding site. The p.Lys63Arg substitution is likely to be tolerated ...",195,235,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe (rs41271083) Leu663 is in the TM7 alph...,201,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe (rs41271083) Leu663 is in the TM7 alph...,201,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Leu663Phe,p.Leu663Phe (rs41271083) Leu663 is in the TM7 alph...,201,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Ile993Val,p.Ile993Val (rs78818665) Ile993 is located within ...,207,1,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"...ted [David and Sternberg 2015], as in the case of p.Phe215Ser",218,770,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Phe215Ser,"...ted [David and Sternberg 2015], as in the case of p.Phe215Ser",218,770,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.Gly678Arg,"...e for three variations in domain II (p.Gly664Arg, p.Gly678Arg, and p.Gly862Asp). We predicted that t...",220,266,Hum_Mutat_2016_Oct_8_37(10)_1074-1084.txt
p.D806N,... and one deletion mutation. The missense mutation p.D806N was observed in four patients with hypospa...,13,145,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Q1028Q,...o patients showed the presence of silent mutation p.Q1028Q present in exon 14. Another silent mutati...,13,253,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...ients. The pathogenicity of the missense mutation p.D806N was carried out using in-silico approach. ...,13,488,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Q1028Q,...nts (2-4 and 7). The silent mutation (c.3084A > G p.Q1028Q; rs3822625) was also identified in patien...,40,475,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...; whereas the other silent mutation (c. 1284G > A p.T428T; rs832575) was identified in exon 6 [Figur...,40,609,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.T428T,...t) (b) p.Q1028Q mutation in exon 14 of MAP3K1 (c) p.T428T heterozygous mutation in exon 6 of MAP3K1 ...,42,393,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,In-silico analysis of p.D806N missense mutation has been carried out to ...,44,23,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,... sequence alignment and weblogo revealed that the p.D806N was well conserved across species [Figure ...,44,1268,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,... sequence alignment and weblogo revealed that the p.D806N was well conserved across species [Figure ...,44,1268,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...tation site. (a) A multiple sequence alignment of p.D806N mutation showing the conserved aspartate (...,46,175,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...tation site. (a) A multiple sequence alignment of p.D806N mutation showing the conserved aspartate (...,46,175,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...aded box) (b) WebLogo showing the conservation of p.D806N mutation showing the conserved aspartate (...,46,315,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,...aded box) (b) WebLogo showing the conservation of p.D806N mutation showing the conserved aspartate (...,46,315,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.D806N,"In four of our patients, a missense mutation p.D806N was identified in exon 14 which of caused ...",55,46,Indian_J_Hum_Genet_2013_Oct-Dec_19(4)_437-442.txt
p.Val501Gly,"...87186Clinical StudyA Novel, Homozygous c.1502T>G (p.Val501Gly) Mutation in the Thyroid peroxidase Ge...",3,187,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,"... change from valine to glycine at amino acid 501 (p.Val501Gly). In addition, other documented polymo...",42,223,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...n arrow. (b) Ribbon presentation of wild type and p.Val501Gly mutant TPO proteins. The residues Val-...,74,361,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Val501Gly,...eme (Glu-399) and iron (His-494) in wild type and p.Val501Gly mutant. Residues on the top layer are ...,74,982,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
p.Gly1358Lys,"and c.4072G>A (p.Gly1358Lys), and an intronic transversion with w...",133,32,Int_J_Med_Sci_2008_Jul_8_5(4)_197-202.txt
p.A348V,1	IDH3B	chr20:2640199	NM_174855	Exon11	c.1043C>T	p.A348V	Damaging	Het	–	AR	RP46,70,50,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.N1469D,ABCA4	chr1:94495135	NM_000350	Exon30	c.4405A>G	p.N1469D	Tolerated	Het	–	AR	CORD3/STGD1/RP19,72,49,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.N1469D,ABCA4	chr1:94495135	NM_000350	Exon30	c.4405A>G	p.N1469D	Tolerated	Het	–	AR	CORD3/STGD1/RP19,72,49,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.R2210H,CEP290	chr12:88453691	NM_025114	Exon48	c.6629G>A	p.R2210H	Probably damaging	Het	–	AR	BBS14/LCA10,75,51,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.H361R,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,49,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.H361R,NR2E3	chr15:72106440	NM_014249	Exon8	c.1082A>G	p.H361R	Tolerated	Het	0.0023	AD/AR	RP37,79,49,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.E4784K,USH2A	chr1:215822102	NM_206933	Exon66	c.14350G>A	p.E4784K	Probably damaging	Het	–	AR	RP39,82,51,Int_J_Mol_Med_2016_Jun_8_37(6)_1528-1534.txt
p.Arg257X,"c.769 C>T (p.Arg257X)	Finnish, Northern Italian	Nagamine et a...",97,12,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Arg257X,"c.769 C>T (p.Arg257X)	Finnish, Northern Italian	Nagamine et a...",97,12,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Arg139X,c.415C>T (p.Arg139X)	Sardinia	Meloni et al. (2012) [1],105,11,Int_J_Mol_Sci_2016_Jul_12_17(7)_1106.txt
p.Val259Phe,...3 with heterozygous HNF-1α NM 000545.5: c.775G>T (p.Val259Phe) mutation. The patient was initiated o...,16,136,Int_J_Pediatr_Endocrinol_2015_Apr_28_2015(Suppl_1)_P19.txt
p.G202R,"...tion 202 in exon 6 of the ABCA3 gene (c.604G > A; p.G202R). Furthermore, 70 normal individuals have ...",7,306,Iran_J_Pediatr_2016_Mar_5_26(2)_e2493.txt
p.Ser2Gly,"...riant mutation in SHOC2, c.4A > G, predicting the p.Ser2Gly change in the encoded protein, underlies...",12,105,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Ser2Gly,"...esence of the disease-causing mutation (c.4A > G, p.Ser2Gly)",66,174,Ital_J_Pediatr_2012_Sep_20_38_48.txt
p.Val244Leu,...on 23710.1186/s13052-016-0237-8Case ReportA novel p.Val244Leu mutation in MFN2 leads to Charcot-Mari...,3,136,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,...his mutation likely occurred de novo. c.730G > C (p.Val244Leu) in MFN2 is a likely pathogenic mutati...,8,707,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,"...ntified a novel heterozygous mutation c.730G > C (p.Val244Leu) in MFN2, which occurred de novo",21,212,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,"...ntified a novel heterozygous mutation c.730G > C (p.Val244Leu) in MFN2, which occurred de novo",21,212,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Met,"...with specific clinical features [11]. c.730G > A (p.Val244Met), a mutation occurring at the same pos...",53,942,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Met,"...with specific clinical features [11]. c.730G > A (p.Val244Met), a mutation occurring at the same pos...",53,942,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,"... leucine and may affect protein features. Second, p.Val244Leu in MFN2 was predicted to be disease-ca...",55,338,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.Val244Leu,The c.730G > C (p.Val244Leu) mutation in MFN2 is a likely pathogen...,61,17,Ital_J_Pediatr_2016_Mar_8_42_28.txt
p.His586Pro,p.His586Pro	Het	None	None,110,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.His586Pro,p.His586Pro	Het	None	None,110,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Met11Val,DSG1	Desmoglein 1	p.Met11Val	Hom	rs1426310	0.3626,111,19,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Met11Val,DSG1	Desmoglein 1	p.Met11Val	Hom	rs1426310	0.3626,111,19,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Thr912Ala,DSG3	Desmoglein 3	p.Thr912Ala	Hom	rs1380866	0.0008,114,19,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Met659Thr,DSC1	Desmocollin 1	p.Met659Thr	Het	rs28620831	0.0220,116,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Arg142His,JUP	Plakoglobin	p.Arg142His	Het	rs41283425	0.0240,120,17,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Arg142His,JUP	Plakoglobin	p.Arg142His	Het	rs41283425	0.0240,120,17,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Met697Leu,p.Met697Leu	Hom	rs1126821	0.4167,121,3,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gly95Arg,PKP3	Plakophilin 3	p.Gly95Arg	Het	rs11246148	0.3608,124,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gly95Arg,PKP3	Plakophilin 3	p.Gly95Arg	Het	rs11246148	0.3608,124,20,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Gln433Arg,EVPL	Envoplakin	p.Gln433Arg	Het	rs2071192	0.3241,127,17,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Ser4Asn,EVPLL	Envoplakin-like	p.Ser4Asn	Het	rs570145	0.4766,128,23,J_Allergy_Clin_Immunol_2015_Nov_136(5)_1268-1276.txt
p.Asp263His,"...quencing cohort): 4 different missense mutations, p.Asp263His (family 3), p.Arg300Trp (families 2, 4...",60,518,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,"...ic aneurysms (8). The 2 other missense mutations, p.Ile322Thr and p.Leu401Pro, affect highly conserv...",61,380,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,".... The 2 other missense mutations, p.Ile322Thr and p.Leu401Pro, affect highly conserved amino acids l...",61,396,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Leu401Pro,"Missense mutations p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are also predicted to alter TGFB3 func...",67,50,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...rtic wall of a patient carrying a TGFB3 mutation (p.Asp263His), we performed immunohistochemical ana...",75,91,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...rtic wall of a patient carrying a TGFB3 mutation (p.Asp263His), we performed immunohistochemical ana...",75,91,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...es, which cannot be modeled). The point mutations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu40...",129,653,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,"...es, which cannot be modeled). The point mutations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu40...",129,653,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Ile322Thr,"...d). The point mutations p.Asp263His, p.Arg300Trp, p.Ile322Thr, and p.Leu401Pro are shown in red with...",129,679,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.Asp263His,... in a Human Subject With TGFB3 Mutation (3-III:1; p.Asp263His,131,141,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
p.R332W,"...8), who identified a homozygous missense variant (p.R332W) in all affected members of the Turkish co...",72,755,J_Appl_Genet_2014_Oct_27_55(1)_105-115.txt
p.Thr173Met,"...Two novel missense LRP5 HBM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) were identi...",51,735,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...Two novel missense LRP5 HBM mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) were identi...",51,735,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...P5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; p.Gln89Arg]), associated ...",51,883,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"... disruptive structural alterations predicted from p.Arg266Cys, p.Thr173Met, and p.Gln89Arg were asso...",51,1756,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...ied two novel missense LRP5 mutations ([c.518C>T; p.Thr173Met], [c.796C>T; p.Arg266Cys]) as well as ...",81,61,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...usly reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; ...",81,173,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...usly reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; ...",81,173,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,"...usly reported missense LRP5 mutations ([c.593A>G; p.Asn198Ser], [c.724G>A; p.Ala242Thr], [c.266A>G; ...",81,173,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,... Information S5). He has a heterozygous c.593A>G; p.Asn198Ser mutation that is predicted to be funct...,350,64,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,...Mandible enlargement in female aged 49 years with p.Ala242Thr substitution (pedigree 2). (C) Asymmet...,352,229,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,...Mandible enlargement in female aged 49 years with p.Ala242Thr substitution (pedigree 2). (C) Asymmet...,352,229,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,...Mandible enlargement in female aged 49 years with p.Ala242Thr substitution (pedigree 2). (C) Asymmet...,352,229,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"..., C). Interestingly, the novel mutation c.796C>T; p.Arg266Cys, was identified in a 65 year old man w...",355,52,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"..., C). Interestingly, the novel mutation c.796C>T; p.Arg266Cys, was identified in a 65 year old man w...",355,52,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,The p.Asn198Ser mutation directly affects the SOST int...,360,5,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Asn198Ser,The p.Asn198Ser mutation directly affects the SOST int...,360,5,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Arg266Cys,"...with mutations; p.Asn198Ser (B), p.Ala242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), and p.Thr173Met (...",365,107,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"....Asn198Ser (B), p.Ala242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), and p.Thr173Met (F)",365,124,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...a242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), and p.Thr173Met (F)",365,144,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...a242Thr (C), p.Arg266Cys (D), p.Gln89Arg (E), and p.Thr173Met (F)",365,144,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"..., Inc.The mutations, p.Arg266Cys, p.Gln89Arg, and p.Thr173Met, were associated with less severe HBM ...",367,85,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Thr173Met,"...viduals carrying the p.Arg266Cys, p.Gln89Arg, and p.Thr173Met mutations may be due to less disruptiv...",375,181,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,LRP5 mutation p.Gln89Arg was identified in one HBM case (no DNA ...,393,15,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,"...AF 8% in the Japanese population.45 Subsequently, p.Gln89Arg was associated with lower (not higher) ...",393,289,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,...s.48 Importantly functional analyses suggest that p.Gln89Arg does not play a functional role in cano...,393,675,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Gln89Arg,...tional role in canonical Wnt signaling.49 Whether p.Gln89Arg shares a rare haplotype with a function...,393,756,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.Ala242Thr,"...5 protein modeling to date (using p.Asn198Ser and p.Ala242Thr mutations, although without modeling t...",398,192,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
p.L450X,... gene that caused truncation of the Wip1 protein (p.L450,111,56,J_Cell_Biol_2013_May_13_201(4)_511-521.txt
p.F99S,...dysfunctional as well due to a missense mutation (p.F99S) or normal (henceforth designated XPB−/− an...,24,242,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.F99S,...ical differences among XPB patients with the same p.F99S mutation. Primary human diploid fibroblasts...,24,421,J_Cell_Mol_Med_2010_Oct_16_Jan-Feb_14(1-2)_403-416.txt
p.E1099K,"...imethylation. Interestingly, an NSD2p.Glu1099Lys (p.E1099K) variant was also detected in non-translo...",72,345,J_Cell_Mol_Med_2014_Jul_9_18(7)_1239-1246.txt
p.Arg4893Gln,...1 revealed the heterozygous mutation [c.14678G>A (p.Arg4893Gln)] in exon 102 (Fig. 1B). This mutatio...,33,162,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Tyr4864His,"To the best of our knowledge, the p.Tyr4864His mutation identified in case 1 of this...",40,35,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Tyr4864Cys,... missense mutation affecting the same amino acid (p.Tyr4864Cys) has been reported previously in an E...,40,170,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Tyr4864Cys,... missense mutation affecting the same amino acid (p.Tyr4864Cys) has been reported previously in an E...,40,170,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Arg4893Trp,"... different amino acid change of the same residue (p.Arg4893Trp) presented as respiratory impairment,...",40,872,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Arg4893Trp,"... different amino acid change of the same residue (p.Arg4893Trp) presented as respiratory impairment,...",40,872,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.Arg4893Trp,"... different amino acid change of the same residue (p.Arg4893Trp) presented as respiratory impairment,...",40,872,J_Clin_Neurol_2015_Jan_11_11(1)_97-101.txt
p.K659E,"154	55	OC	Endometrioid	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,36,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.K659E,"...Endometrioid	IA	G1	FGFR2 p.K659E, c.1975T>C	FGFR2 p.K659E, c.1975T>C (1)",38,61,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"152	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,30,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.R248Q,"...2	50	OC	Serous	IIC	G3	TP53 p.R248Q, c.743G>A	TP53 p.R248Q, c.743G>A (1)",40,53,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V272E,"149	57	OC	Serous	IIIA	G3	TP53 p.V272E, c.815T>A	TP53 p.V272E, c.815T>A (3)",42,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V272E,"149	57	OC	Serous	IIIA	G3	TP53 p.V272E, c.815T>A	TP53 p.V272E, c.815T>A (3)",42,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.V216M,"148	71	OC	Serous	IIIB	G3	TP53 p.V216M, c.646G>A	TP53 p.V216M, c.646G>A (1)",43,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.L194R,"...	52	OC	Serous	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.L194R,"...	52	OC	Serous	IIIC	G3	TP53 p.C135Y, c.404G>A	TP53 p.L194R, c.581T>G (3)",45,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H193P,"...	70	OC	Serous	IIIC	G3	TP53 p.H193P, c.578A>C	TP53 p.H193P, c.578A>C (1)",49,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12A,"197	73	OC	Serous	IIIC	G3	NA	KRAS p.G12A, c.35G>C (1)",53,34,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H179R,"137	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H179R,"137	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.H179R,"...	61	OC	Serous	IIIC	G3	TP53 p.H179R, c.536A>G	TP53 p.H179R, c.536A>G (1)",54,54,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Q61R,"...C	Malignant mixed Müllerian tumor	IIIC	G3	NA	NRAS p.Q61R, c.182A>G (1)",55,59,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G13D,"..., partly serous	IIIC	G2	KRAS p.G13D, c.38G>A	KRAS p.G13D, c.38G>A (1)",57,73,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12D,"147	60	OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,37,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12D,"...OC	Endometrioid	IIIC	G3	KRAS p.G12D, c.35G>A	KRAS p.G12D, c.35G>A (1)",58,58,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.M1004V,"198	59	OC	Serous	IVB	G3	NA	PIK3CA p.M1004V, c.3010A>G (1)",60,35,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.E17K,"...1	OC LMP	Serous low malignant potential			NA	AKT1 p.E17K, c.49G>A (1)",62,56,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.E17K,"...1	OC LMP	Serous low malignant potential			NA	AKT1 p.E17K, c.49G>A (1)",62,56,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12V,"175	50	B	Ovarian cyst, teratoma			—	KRAS p.G12V, c.35G>T (1)",71,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12C,"177	31	B	Secondary infertility			NA	KRAS p.G12C, c.34G>T (1)",72,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12C,"177	31	B	Secondary infertility			NA	KRAS p.G12C, c.34G>T (1)",72,42,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12C,"178	46	B	Uterus myomatosus, ovarian cyst			—	KRAS p.G12C, c.34G>T (1)",73,51,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12V,"...infertility, polyp of the cervix mucosa			NA	KRAS p.G12V, c.35G>T (1)",74,70,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.G12D,"193	54	B	Inclusion cysts			—	KRAS p.G12D, c.35G>A (1)",77,35,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C242F,"...	39	BC	Breast cancer, uterine leiomyoma			NA	TP53 p.C242F, c.725G>T (1)	Germline mutation",78,55,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.C176Y,"150	51	OC	Serous	IIIC	G3	TP53 p.C176Y, c.527G>A	—",81,31,J_Clin_Oncol_2015_Dec_20_33(36)_4293-4300.txt
p.Arg63Trp,...of an arginine by a tryptophan (p.Arg63Trp). This p.Arg63Trp polymorphism is associated with increas...,9,606,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,...on of an arginine by a tryptophan at position 63 (p.Arg63Trp or R63W). Associated with this substitu...,15,564,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Arg63Trp,...on of an arginine by a tryptophan at position 63 (p.Arg63Trp or R63W). Associated with this substitu...,15,564,J_Exp_Med_2011_Oct_24_208(11)_2183-2191.txt
p.Q336L,CHEK2	c.1007A>T	p.Q336L	54	Damaging	Benign,35,17,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.A9G,DDB1	c.26C>G	p.A9G	86	Damaging	Damaging (possibly),37,14,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,MSH2	c.1618A>G	p.S540G	20	Tolerated	Benign,39,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K543R,MSH6	c.1628A>G	p.K543R	29	Damaging	Benign,41,16,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R335W,"... NER pathways. The “Other” category refers to the p.R335W mutation in the DNTT gene, which encodes f...",50,327,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D293X,"...in CHEK2 included a somatic frameshift insertion (p.D293X), a splice-site mutation (c.319+2T>A), and...",61,469,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D293X,"...in CHEK2 included a somatic frameshift insertion (p.D293X), a splice-site mutation (c.319+2T>A), and...",61,469,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I364T,"...e mutation (c.319+2T>A), and a missense mutation (p.I364T) located in the kinase domain of CHEK2 (Ta...",61,541,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R117G,"...errant splicing of CHEK2 transcripts, whereas the p.R117G and p.D438Y substitutions were shown to ha...",61,881,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R180C,"...ples derived from healthy blood donors, where the p.R180C and p.I157T substitutions, previously iden...",61,1390,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D293X,c.876dupT	p.D293X	Novel	1/171	Somatic	Swedish	0	0	-	-,67,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.Q336L,c.1007A>T	p.Q336L	Novel	1/64	Somatic	Chinese	0	0	Damaging	Da...,68,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.E528K,c.1582G>A	p.E528K	rs138040612	1/64	Germline	Chinese	0	0	Tole...,74,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I157T,c.470T>C	p.I157T	rs17879961	3/171	Germline (1)	Swedish	0.00...,75,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I157T,c.470T>C	p.I157T	rs17879961	3/171	Germline (1)	Swedish	0.00...,75,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R180C,c.538C>T	p.R180C	rs77130927	1/171	ND	Swedish	0.006	0.001	Da...,76,10,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.K633X,...eam of the catalytic domain of the PARP1 protein (p.K633X) and a p.I919T substitution located in the...,81,268,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L1013M,c.3037C>A	p.L1013M	Sanger	rs138906127	ND	Swedish	0.001	Toler...,91,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,c.1619A>G	p.S540G	Selector & Sanger	Novel	Somatic	Chinese	0	...,93,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L833V,c.2498C>G	p.L833V	Selector & Sanger	Novel	Somatic	Chinese	0	...,94,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.L833V,c.2498C>G	p.L833V	Selector & Sanger	Novel	Somatic	Chinese	0	...,94,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I169V,c.505A>G	p.I169V	Sanger	rs63750716	ND	Chinese	0	Tolerated	B...,95,11,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.C40Y,MLH3	c.119G>A	p.C40Y	Selector	Novel	Germline	Chinese	0	Damaging	...,101,15,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S946F,c.2837C>T	p.S946F	Selector	rs201441389	Germline	Chinese	0.00...,104,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.I508V,c.1522A>G	p.I508V	454 amplicon	rs2287558	ND	Swedish	0.003	To...,109,12,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,...encing. In addition to the two somatic mutations (p.S540G and p.L833V) discovered by the latter appr...,112,158,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.S540G,...encing. In addition to the two somatic mutations (p.S540G and p.L833V) discovered by the latter appr...,112,158,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.H371Y,"...rers confirmed all genotypes. For the c.1100delC, p.H371Y and p.D438Y CHEK2 variants control typing ...",174,818,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.H371Y,"...rers confirmed all genotypes. For the c.1100delC, p.H371Y and p.D438Y CHEK2 variants control typing ...",174,818,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.H371Y,"...rers confirmed all genotypes. For the c.1100delC, p.H371Y and p.D438Y CHEK2 variants control typing ...",174,818,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.D438Y,"...ed all genotypes. For the c.1100delC, p.H371Y and p.D438Y CHEK2 variants control typing was performe...",174,830,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
p.R486X,"...iency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C1207T; P4, p>R173W/R173W; P...",96,274,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
p.Pro106Leu,...mbocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene Br J Haematol 2009 144...,127,186,J_Hematol_Oncol_2013_Jan_25_6_11.txt
p.S610X,"...ng detectable. There were two nonsense mutations (p.S610X, p.L727X), three deletion frameshift mutat...",32,251,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S610X,"...ng detectable. There were two nonsense mutations (p.S610X, p.L727X), three deletion frameshift mutat...",32,251,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P76S,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E...",34,35,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P123S,"There were 24 missense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N39...",34,51,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.P297Q,"...ense mutations (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T41...",34,69,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.K369E,"...tions (p.P76S, p.T94I, p.P123S, p.M147V, p.P297Q, p.K369E, p.A372V, p.N392Y, p.G396E, p.T410M, p.A43...",34,78,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S448L,"...72V, p.N392Y, p.G396E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R58...",34,141,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.I529S,"...96E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V65...",34,159,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.I529S,"...96E, p.T410M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V65...",34,159,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S532I,"...10M, p.A434T, p.G439R, p.S448L, p.T527P, p.I529S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S66...",34,168,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.S666F,"...29S, p.S532I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluat...",34,213,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.T721M,"...32I, p.C565Y, p.R581S, p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluate the evo...",34,222,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723Y,"..., p.S657N, p.V659L, p.S666F, p.T721M, p.H723R and p.H723Y). To evaluate the evolutionary conservatio...",34,243,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.H723R,"...are two frequent mutations in east Asians, namely p.H723R and c.919-2A>G. p.H723R is most prevalent ...",56,306,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
p.Arg128His,"...ncing. This study identified a novel heterozygous p.Arg128His mutation in one NPSLE patient, admitte...",80,314,J_Immunol_Res_2015_Dec_21_2015_745647.txt
p.Leu156Arg,... al. 2010). The m.8993T>G point mutation leads to p.Leu156Arg. Leu156 is highly conserved in eukaryo...,95,882,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu156Pro,...006; Debray et al. 2007). The mutation results in p.Leu156Pro. Opposite to the positive charged argi...,97,210,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu183Arg,"...p.Leu183Pro (Kucharczyk et al. 2009a, b, c), atp6-p.Leu183Arg (Rak et al. 2007a, b), atp6-p.Leu247Ar...",99,2204,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu247Arg,"... c), atp6-p.Leu183Arg (Rak et al. 2007a, b), atp6-p.Leu247Arg (Kucharczyk et al. 2009a, b, c), atp6-...",99,2244,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu220Pro,... species (ROS) (Sikorska et al. 2009). m.9185T>C (p.Leu220Pro) results in a phenotype varying from m...,101,482,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Leu220Pro,... species (ROS) (Sikorska et al. 2009). m.9185T>C (p.Leu220Pro) results in a phenotype varying from m...,101,482,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Trp55X,...ature stopcodon in a conserved region of MT-ATP8 (p.Trp55X) (Jonckheere et al. 2008). This resulted ...,108,376,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Trp94Arg,...nserved tryptophan to an arginine at position 94 (p.Trp94Arg) of the nuclear encoded complex V assem...,115,105,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.Tyr12Cys,"Recently, a homozygous missense mutation c.35A>G (p.Tyr12Cys) has been described in exon 2 of the AT...",121,51,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
p.R152W,"....0	0.7	7.6	454 C > T (p.R152W), exon 2	454 C > T (p.R152W), exon 2	Slow	231 (318)	N	Y	N	1	1	Y	N",55,55,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.N301K,"2	F	1.5	1.8	2.1	903 C > G (p.N301K) exon 5, S384N, 1152 G > A, exon 6	903 C >...",56,28,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.N301K,"...01K) exon 5, S384N, 1152 G > A, exon 6	903 C > G (p.N301K) exon 5, S384N, 1152 G > A, exon 6	Rapid	9...",56,82,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G324V,"....6	1.9	2.3	971 G > T (p.G324V), exon 5	971 G > T (p.G324V), exon 5	Rapid	739 (254)	N	Y	N	1	2	N	Y",57,55,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R327X,"...	.8	5.1	5.9	629 A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	207 (145)	Y	N	Y	4	4	N	Y",60,54,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,"M	3.0	5.8	6.2	629 A > G (p.Y210C), exon 3	979C > T (p.R327X)	Slow	158 (145)...",62,27,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.R152W,"...0	10.1	18.3	454 C > T (p.R152W), exon2	454 C > T (p.R152W), exon2	Slow	106 (107)	N	N	N	1	1	Y	Y",65,58,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,... all of Turkish Ancestry). The second group had a p.Y210C mutation combined with either p.P313A or p...,108,206,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.P313A,"...group had a p.Y210C mutation combined with either p.P313A or p.R327X (n = 4, all of Dutch Ancestry)....",108,244,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.Y210C,...t was reported by Swiedler et al. (2005) that the p.Y210C mutation was associated with low GAG excre...,159,430,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G324V,"...ly disrupt splicing; the other was homozygous for p.G324V, which leads to reduced synthesis of aryls...",159,1019,J_Inherit_Metab_Dis_2016_Oct_8_39_285-292.txt
p.G12S,...S mutations. HRAS p.G13R was present in 85 NS and p.G12S was not found (Supplementary Table 2). In p...,21,197,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...lasia found in NS, and the more mildly activating p.G12S mutation causes woolly hair phenotypes",21,818,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...lasia found in NS, and the more mildly activating p.G12S mutation causes woolly hair phenotypes",21,818,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,Figure 2 Somatic HRAS p.G12S mutation causes WHN. (a) In WHN100 and WHN1...,50,23,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.G12S,"...d tissue of WHN100 and WHN101 confirmed this HRAS p.G12S mutation. (c) In WHN100, there is a small m...",50,726,J_Invest_Dermatol_2014_Apr_15_134(4)_1149-1152.txt
p.S200N,"...tin et al., 2001). Note that Variant 1 (c.599G7A; p.S200N) was present in three patients, and, there...",14,1395,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.L156P,...s by the analysis of two mutations (p.E138del and p.L156P) previously identified in patients with fa...,16,624,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S200N,"...se determination (Fig. 1b). Mutations p.R682W and p.S200N were not capable of upregulation of NF-κB,...",16,1180,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S200N,"1a	72/F	47/57	20	2	rs114688446	c.599G>A, p.S200N	A: 0.8	Benign	Tolerated	Neutral	Neutral	Ne...",42,42,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S802R,"4	35/F	32/32	1	1	no data	c.2406C>A, p.S802R	no data	Benign	Damaging	Pathological	Neutr...",47,37,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S802R,"4	35/F	32/32	1	1	no data	c.2406C>A, p.S802R	no data	Benign	Damaging	Pathological	Neutr...",47,37,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.S802R,"4	35/F	32/32	1	1	no data	c.2406C>A, p.S802R	no data	Benign	Damaging	Pathological	Neutr...",47,37,J_Invest_Dermatol_2015_Jul_3_135(7)_1905-1908.txt
p.Ile71Phe,"...a novel heterozygous missense mutation (c.211A/T, p.Ile71Phe). Genetic screening of our patient’s fa...",10,170,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...a novel heterozygous missense mutation (c.211A/T, p.Ile71Phe) in exon 3 (Figure 1a). Mutation was co...",26,964,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,... protein sequences in the region of the mutation (p.Ile71Phe) from different species indicates that ...,28,438,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...11,12]. The novel heterozygous missense mutation (p.Ile71Phe) reported here is located close to the ...",35,641,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...11,12]. The novel heterozygous missense mutation (p.Ile71Phe) reported here is located close to the ...",35,641,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ile71Phe,"...11,12]. The novel heterozygous missense mutation (p.Ile71Phe) reported here is located close to the ...",35,641,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Ala52Ser,"...68Cys and p.Arg72His) [3], and in spasmodic mice (p.Ala52Ser) [13]. The functional analysis performe...",35,963,J_Med_Case_Rep_2014_Jun_26_8_233.txt
p.Val139Leu,...t 10	F	27	30	MYH7	23901935 G>T	NM_000257.2	415G>T	p.Val139Leu	Probably damaging	Probably damaging	32...,129,57,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Gly221Arg,F	–	–	LAMP2	119581776 G>A	NM_002294.2	661G>A	p.Gly221Arg	Probably damaging	Probably damaging	12...,130,47,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.Lys259Glu,...0	M	?	?	?	TPM1	63356265 A>G	NM_001018020.1	775A>G	p.Lys259Glu	Not reliable	Not reliable	56	0.00	C55	...,160,60,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
p.V499M,... identified a novel homozygous missense mutation (p.V499M) in CNNM4 in patient V2.05 who was born to...,176,68,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
p.Cys873Gly,"...of network centrality for phenotype prediction is p.Cys873Gly in MSH2 (UniProt: P43246), which has b...",81,105,J_Mol_Biol_2014_Jul_15_426(14)_2692-2701.txt
p.Cys873Gly,"...of network centrality for phenotype prediction is p.Cys873Gly in MSH2 (UniProt: P43246), which has b...",81,105,J_Mol_Biol_2014_Jul_15_426(14)_2692-2701.txt
p.E197X,"...mozygous for a novel nonsense mutation, c.589G>T; p.E197X, in exon 3 of the UMOD gene (Figure 2). Th...",30,352,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys255Tyr,5	c.764G>A (p.Cys255Tyr)	Pathogeni,106,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys217Gly,7	c.649T>G (p.Cys217Gly)	Pathogeni,110,13,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Gly103Cys,12	c.307G>T (p.Gly103Cys)	Pathogeni,120,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Gly103Cys,12	c.307G>T (p.Gly103Cys)	Pathogeni,120,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.Cys77Tyr,13	c.230G>A (p.Cys77Tyr)	Pathogeni,122,14,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
p.E64D,...Bauer A  Woitalla D  Mietz EM    Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson di...,198,84,J_Mov_Disord_2012_Oct_30_5(2)_33-41.txt
p.A152T,Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for...,132,33,J_Neurol_Neurosurg_Psychiatry_2014_May_5_85(5)_506-508.txt
p.G12C,...our MAP polyps were found to carry canonical KRAS p.G12C mutations resulting from a somatic G:C → T:...,116,2128,J_Pathol_2016_Jan_2_238(1)_98-108.txt
p.Arg59X,c.175C>T; p.Arg59X	0.56	0.04	0.5	49	1	2	0,167,12,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Arg1215X,c.3643C>T p.Arg1215X	0.85	0.31	0.42	73	2	2	1,187,12,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Val62Ile,"...owing SNPs CFH −331C>T (rs3753394), CFH c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His ...",220,140,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Tyr402His,"...H c.184G>A; p.Val62Ile (rs800292), CFH c.1204T>C; p.Tyr402His (rs1061170), CFH c.2016A>G; p.Gln672Gl...",220,178,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.Asp371Gly,The CFB variant p.Asp371Gly (patient 8) has not previously been de...,250,17,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
p.L858R,"...n 21 that changes the leucine 858 in an arginine (p.L858R). Concerning rare alterations, about 3% of...",23,201,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...agnostic are not sensitive enough to detect minor p.T790M subclones (<1%) and this alteration is rar...,32,91,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,...mor. The prognostic significance of baseline EGFR p.T790M has not been reported. In the acquired res...,34,160,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...nce: -i- is EGFR mutation distribution, including p.T790M, heterogeneous within the primary tumor?; ...",39,123,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P20	p.G719A	1	0	4	0	5	5	0	 ,101,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P28	p.L858R	4	0	2	0	6	6	0	 ,109,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P29	p.L858R	1£ + 1£	0	0	0	2	2	0	 ,110,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P30	p.L858R	2	0	0	0	2	2	0	 ,111,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P30	p.L858R	2	0	0	0	2	2	0	 ,111,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	3	3	0	 ,112,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	3	3	0	 ,112,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	3	3	0	 ,112,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	3	3	0	 ,112,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P33	p.L858R	0	3	0	0	3	3	0	 ,114,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P34	p.L858R	1£	1	0	1	3	3	0	 ,115,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P35	p.L858R	4	0	2	0	6	6	0	 ,116,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P36	p.L858R	2	0	1	0	3	3	0	 ,117,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P37	p.L858R	3	0	0	0	3	3	0	 ,118,5,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,P40	p.L861Q/p.T790M	19	0	0	0	19	19	0	 ,121,13,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...EGFR codons 719, 861 and mutated samples for EGFR p.T790M. The 153 fragments generated from mutated ...",130,297,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,"... PCR technology (CAST). Point mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M wer...",132,543,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,"...nt mutations: p.L861Q, p.G719A, p.G719C, p.G719S, p.L858R and p.T790M were analyzed using similar te...",132,570,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...0 insertion (INS20), 2 a p.G719A mutation and 1 a p.L861Q/p.T790M double alteration. For those 40 pa...",143,379,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...ion (INS20), 2 a p.G719A mutation and 1 a p.L861Q/p.T790M double alteration. For those 40 patients, ...",143,387,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...40). Patient was naïve of EGFR-TKI, the tumor was p.L861Q/p.T790M mutated, was divided into 19 parts...",148,149,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,"...40). Patient was naïve of EGFR-TKI, the tumor was p.L861Q/p.T790M mutated, was divided into 19 parts...",148,149,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...ient was naïve of EGFR-TKI, the tumor was p.L861Q/p.T790M mutated, was divided into 19 parts and bot...",148,157,J_Transl_Med_2014_May_16_12_131.txt
p.G719A,P21	p.G719A	5	0	2	0	 	6	1,203,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P28	p.L858R	4	0	2	0	 	6	 ,210,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P30	p.L858R	2	0	0	0	 	2	 ,212,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P30	p.L858R	2	0	0	0	 	2	 ,212,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	 	3	 ,213,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P31	p.L858R	3	0	0	0	 	3	 ,213,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P32	p.L858R	0	3	0	1	2	2	 ,214,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P34	p.L858R	1£	1	0	1	1	 	2,216,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P36	p.L858R	2	0	1	0	 	2	1,218,5,J_Transl_Med_2014_May_16_12_131.txt
p.L858R,P38	p.L858R	3	0	0	0	1	2	 ,220,5,J_Transl_Med_2014_May_16_12_131.txt
p.L861Q,P40	p.L861Q/p.T790M	19	0	0	0	 	18	1,222,5,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,P40	p.L861Q/p.T790M	19	0	0	0	 	18	1,222,13,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,P40	p.L861Q/p.T790M	19	0	0	0	 	18	1,222,13,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,[38]. The p.T790M resistance mutation was studied in all pat...,243,11,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,[38]. The p.T790M resistance mutation was studied in all pat...,243,11,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...was homogeneous suggesting that in this case, the p.T790M alteration is a driver mutation altogether...",244,188,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"...was homogeneous suggesting that in this case, the p.T790M alteration is a driver mutation altogether...",244,188,J_Transl_Med_2014_May_16_12_131.txt
p.T790M,"[15,30,39]. In our series, there was no p.T790M heterogeneity. Considering that our detect...",315,41,J_Transl_Med_2014_May_16_12_131.txt
p.P660L,"...quencing and found a missense variant, c.1979C>T, p.P660L, in exon 20 of TMC1 [NM_138691, (MIM#60097...",66,128,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,138691	c.1979C>T	p.P660L	Hom	SIFT	Polyphen2	MutationTaster,76,19,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,138691	c.1979C>T	p.P660L	Hom	SIFT	Polyphen2	MutationTaster,76,19,J_Transl_Med_2016_Jan_28_14_29.txt
p.P660L,"...vel TMC1 missense mutation in exon 20, c.1979C>T, p.P660L",81,1030,J_Transl_Med_2016_Jan_28_14_29.txt
p.R34X,...Mustapha M  Delmaghani S    High frequency of the p.R34X mutation in the TMC1 gene associated with n...,123,98,J_Transl_Med_2016_Jan_28_14_29.txt
p.Tyr657X,"...latory subunits of PI3K, stood out. The mutation, p.Tyr657X (Y657X) when numbered according to the p...",33,160,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"... (P2–P4) all with the same rare missense variant, p.Arg649Trp (R649W), in the C-terminal SH2 domain ...",39,220,JCI_Insight_1(17)_e88766.txt
p.Asp231Ala,"...n, which we suggest is attributable to the ADIPOQ p.Asp231Ala mutant identified here. Our findings s...",58,977,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...r1-null murine fibroblasts in which WT or mutant (p.Arg649Trp) PIK3R1 was stably overexpressed, a st...",64,541,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...r1-null murine fibroblasts in which WT or mutant (p.Arg649Trp) PIK3R1 was stably overexpressed, a st...",64,541,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...2). However, previous studies have shown that the p.Arg649Trp variant found in the other patients we...",66,377,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...2). However, previous studies have shown that the p.Arg649Trp variant found in the other patients we...",66,377,JCI_Insight_1(17)_e88766.txt
p.Arg649Trp,"...null murine fibroblasts stably overexpressing the p.Arg649Trp mutant PIK3R1 (24); however, recruitme...",66,871,JCI_Insight_1(17)_e88766.txt
p.Asp231Ala,"... of adiponectin, with the approximate site of the p.Asp231Ala (D231A) substitution indicated. SP, si...",149,71,JCI_Insight_1(17)_e88766.txt
p.M40K,48 Bueno AC  et al  A novel ADIPOQ mutation (p.M40K) impairs assembly of high-molecular-weight ...,200,46,JCI_Insight_1(17)_e88766.txt
p.Leu279Arg,...L gene mutations: a missense mutation (c.836T > G p.Leu279Arg) and a large fragment deletion (deleti...,53,1147,Lipids_Health_Dis_2016_May_6_15_88.txt
p.G292R,"...ations and 3 cases were homozygous for the DFNB59 p.G292R variant. Mutations in the WFS1, GJB3, ESRR...",4,851,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G1151R,...edigrees (Figure 2B). Of the 2 missense variants (p.G1151R and p.R1604S) which predictably resulted ...,43,349,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G1151R,...edigrees (Figure 2B). Of the 2 missense variants (p.G1151R and p.R1604S) which predictably resulted ...,43,349,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,...ure 2B). Of the 2 missense variants (p.G1151R and p.R1604S) which predictably resulted in amino acid...,43,362,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,...ure 2B). Of the 2 missense variants (p.G1151R and p.R1604S) which predictably resulted in amino acid...,43,362,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,"...nt alleles by chance. Therefore, we inferred that p.R1604S was causally related to SNHI in family DE...",43,1214,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,"...1582fs, p.P1441_P1443dup, p.G1151R, p.S622fs, and p.R1604S. Sequencing data are shown on either the ...",47,195,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.R1604S,"...1582fs, p.P1441_P1443dup, p.G1151R, p.S622fs, and p.R1604S. Sequencing data are shown on either the ...",47,195,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...mes in the present study, homozygosity for DFNB59 p.G292R has never been found in any of the >70 hea...",49,472,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...mes in the present study, homozygosity for DFNB59 p.G292R has never been found in any of the >70 hea...",49,472,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.V84I,"...somal dominant mutations, WFS1 p.Q485X35 and GJB3 p.V84I,36,37 were detected in 2 matched controls. ...",51,229,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.V84I,"...somal dominant mutations, WFS1 p.Q485X35 and GJB3 p.V84I,36,37 were detected in 2 matched controls. ...",51,229,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...r of 1 patient (DE3039) homozygous for the DFNB59 p.G292R variant, whereas imaging findings were nor...",59,366,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,"...ients. One patient (DE3138) homozygous for DFNB59 p.G292R showed moderate speech perception scores, ...",59,544,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,...15 mutations and 3 were homozygous for the DFNB59 p.G292R variant. The allele frequencies of PCDH15 ...,64,179,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G292R,.... Another possible explanation is that the DFNB59 p.G292R variant is not a causative mutation for de...,68,1094,Medicine_(Baltimore)_2015_Jul_13_94(27)_e1073.txt
p.G3658E,... amino acid change from glycine to glutamic acid (p.G3658E) at a highly conserved residue (Fig. 2) w...,40,676,Meta_Gene_2016_May_18_9_124-127.txt
p.Arg3527Gln,"...them being novel. 13 (8%) individuals carried the p.Arg3527Gln mutation in APOB, and overall the det...",12,122,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln,"...them being novel. 13 (8%) individuals carried the p.Arg3527Gln mutation in APOB, and overall the det...",12,122,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe,"...ould be pathogenic. The mutations p.Cys255Tyr and p.Cys329Phe, would cause loss of cysteine in the l...",48,370,Metabolism_2016_Mar_65(3)_48-53.txt
p.The621Arg,We predict that the novel mutation (p.The621Arg) would cause aberrant recycling of the...,50,37,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ala612Ser,"The other four novel mutations, p.Ala612Ser, p.Asp579Gly, p.Trp483Cys, and p.Val12...",52,33,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asp579Gly,"The other four novel mutations, p.Ala612Ser, p.Asp579Gly, p.Trp483Cys, and p.Val127Asp were als...",52,46,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg3527Gln,...most common APOB mutation in European populations p.Arg3527Gln usually accounts for 5–7% of FH patie...,60,472,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr621Arg,...demonstrated co-segregation of the novel mutation p.Thr621Arg with the FH phenotype. We also describ...,62,152,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe,...henotype. We also described the novel mutation of p.Cys329Phe in a previous report [17]. In our stud...,62,227,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys34Gly, c.100T > G	p.Cys34Gly	3	2	Probably damaging	Not tolerated	Dis...,137,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr62Met, c.185C > T	p.Thr62Met	1	2	Probably damaging	Tolerated	Disease...,138,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ser177Leu, c.530C > T	p.Ser177Leu	1	4	Benign	Not tolerated	Disease causi...,141,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys255Tyr, c.764G > A	p.Cys255Tyr	1	51	Probably damaging	Not tolerated	D...,145,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Cys329Phe, c.986G > T	p.Cys329Phe	4	71	Probably damaging	Not tolerated	D...,147,13,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg574Cys, c.1720C > T	p.Arg574Cys	1	12	Probably damaging	Not tolerated	D...,153,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Gly676Arg, c.2026G > C	p.Gly676Arg	1	14	Probably damaging	Not tolerated	D...,159,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Pro699Leu, c.2096C > T	p.Pro699Leu	2	14	Probably damaging	Not tolerated	D...,162,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Pro699Leu, c.2096C > T	p.Pro699Leu	2	14	Probably damaging	Not tolerated	D...,162,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Ala391Thr, c.1171G > A	p.Ala391Thr	3	8	Benign	Tolerated	Polymorphism	No,177,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Asn515Asn, c.1545C > T	p.Asn515Asn	1	10	n/a	Tolerated	Polymorphism	No,178,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val653Val, c.1959C > T	p.Val653Val	1	131	n/a	n/a	n/a	No,180,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Val653Val, c.1959C > T	p.Val653Val	1	131	n/a	n/a	n/a	No,180,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Gly675Gly, c.2025C > T	p.Gly675Gly	1	141	n/a	n/a	Disease causing	No,181,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Thr726Ile, c.2177C > T	p.Thr726Ile	2	15	Benign	Tolerated	Polymorphism	No,182,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg744Gln, c.2231G > A	p.Arg744Gln	1	15	Benign	Tolerated	Polymorphism	No,183,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.Arg744Gln, c.2231G > A	p.Arg744Gln	1	15	Benign	Tolerated	Polymorphism	No,183,14,Metabolism_2016_Mar_65(3)_48-53.txt
p.C89R,"...nd’s sister presented with the same HJV c.265T>C (p.C89R) homozygote mutation. In addition, we found...",43,446,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"...nd’s sister presented with the same HJV c.265T>C (p.C89R) homozygote mutation. In addition, we found...",43,446,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,...t cases III-9 and III-7 were homozygotes for HJV (p.C89R,180,118,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"for the HJV mutation (p.C89R). Additionally, the mother was a heterozygo...",182,23,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,"for the HJV mutation (p.C89R). Additionally, the mother was a heterozygo...",182,23,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.C89R,The HJV c.265T>C (p.C89R) mutation is a novel mutation and there is ...,336,19,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
p.Arg1715His,...ocal images of HeLa cells expressing wild-type or p.Arg1715His mutant CaV3.1. HeLa cells were transi...,116,85,Mol_Brain_2015_Dec_29_8_89.txt
p.Arg1715His,...ls were transiently transfected with wild-type or p.Arg1715His mutant human CaV3.1 and immunostained...,116,171,Mol_Brain_2015_Dec_29_8_89.txt
p.Ser577Ser,(p.Ser577Ser),84,2,Mol_Cancer_2014_Jan_24_13_11.txt
p.Arg226X,(p.Arg226X),86,2,Mol_Cancer_2014_Jan_24_13_11.txt
p.Gly245Arg,"...d one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heterozygous in...",12,276,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
p.Gly245Arg,"...d one single nucleotide polymorphismus (c.733G>A, p.Gly245Arg) homozygous in two and heterozygous in...",12,276,Mol_Cell_Pediatr_2015_Jul_1_2(Suppl_1)_A7.txt
p.L1291F,"...uencing of 134 known deafness genes. The variant, p.L1291F and p.Y1945X, resided in the myosin motor...",11,790,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Y1945X,"...4 known deafness genes. The variant, p.L1291F and p.Y1945X, resided in the myosin motor and IQ2 doma...",11,803,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,The p.L1291F model was constructed from the wild-type ...,50,5,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,"... region. As phenylalanine is larger than leucine, p.L1291F would push away the actin-binding region ...",50,641,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,.... (C) Sanger sequencing traces for the c.3871C>T (p.L1291F) + c.5835T>G (p.Y1945*) compound heterozy...,79,490,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.L1291F,...hogenicity of the p.L1291F mutation. The mutation p.L1291F would alter the structure of the actin-bi...,85,62,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Thr1253Ile,c.3758C>T	p.Thr1253Ile	Motor	Homozygous	Severe to profound	N...,102,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Lys1557Glu,c.4669A>G	p.Lys1557Glu	Motor	Homozygous	Severe to profound	N...,111,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gly1831Val,c.5492G>T	p.Gly1831Val	Motor	Homozygous	Profound	Kalay et al...,115,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Pro2073Ser,c.6217C>T	p.Pro2073Ser	MyTH4 1	Homozygous	Severe to profound...,120,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Arg2124Gln,c.6371G>A	p.Arg2124Gln	MyTH4 1	Homozygous	Severe to profound...,123,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Thr2205Ile,c.6614C>T	p.Thr2205Ile	MyTH4 1	Hemizygous	*Residual hearing ...,125,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Thr2205Ile,c.6614C>T	p.Thr2205Ile	MyTH4 1	Hemizygous	*Residual hearing ...,125,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Gln2716His,"c.8148G>T	p.Gln2716His		Homozygous	Profound	Liburd et al., 2...",131,11,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
p.Pro221Leu,... separate point mutation within exon 5 (c.662C>T; p.Pro221Leu). Neither mutation has been described ...,10,632,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.Pro221Leu,...ble. It is difficult to predict the effect of the p.Pro221Leu change by itself: the pathogenicity pr...,38,258,Mol_Genet_Genomic_Med_2013_Jul_30_1(2)_113-117.txt
p.G105R,7	c.313G>C	p.G105R	f	Novel	12,36,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.T188Nfs,9	c.557dupT	p.T188Nfs*2	f	Novel	1,38,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.H293Tfs,11	c.877delC	p.H293Tfs*12	f	Novel	15,44,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.L554Kfs,16	c.1660_1678delTTGGCAAGTCTGCTTTTGC	p.L554Kfs*2	i	Novel	14,57,38,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.I522*,"IVS16	c.1730+4_1730+7delAGTA4	p.I522*3	f	Cavé-Riant et al. (2002)	51,17",59,31,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.K654Sfs,18	c.1961_1962delAA	p.K654Sfs*21	f	Novel	43,62,21,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.Q112Ffs,7	c.334_337delCAAA	p.Q112Ffs*13	f	Novel	20,76,20,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
p.W740S,"...his study, with two mutations in MFN2 (c.2219G>C, p.W740S; c.227T>C; p.L76P) comprising 8.7%. Other ...",82,1060,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Ile41Thr,"...C2 (c.2860C>T; p.Arg954* [4.8%]), FIG4 (c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p.Glu102Gl...",82,1192,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Glu102Gly,"...c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p.Glu102Gly [2.5%]) (Table S6). The distribution o...",82,1232,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Glu102Gly,"...c.122T>C; p.Ile41Thr [4.3%]), and GJB1 (c.305A>G; p.Glu102Gly [2.5%]) (Table S6). The distribution o...",82,1232,Mol_Genet_Genomic_Med_2014_Nov_21_2(6)_522-529.txt
p.Asp106Ala,"...given codon (i.e., PTPN11 p.Asp106Gly rather than p.Asp106Ala)",21,1274,Mol_Genet_Genomic_Med_2015_Mar_3_3(2)_99-110.txt
p.A403V,"...nd previously reported p.R243Q, p.Y356X, p.V399V, p.A403V mutations were detected",10,655,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.A403V,...e of a p.Y356X (c.1068 C to A transversion) and a p.A403V (c.1208 C to T transition) in PAH gene. We...,50,809,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.A403V,...e of a p.Y356X (c.1068 C to A transversion) and a p.A403V (c.1208 C to T transition) in PAH gene. We...,50,809,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,"...on database). In this study, a total 4 mutations (p.R243Q, p.Y356X, p.V399V and A403V) from the 2 ca...",55,209,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.V399V,"...his study, a total 4 mutations (p.R243Q, p.Y356X, p.V399V and A403V) from the 2 cases were identifie...",55,227,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.V399V,"...his study, a total 4 mutations (p.R243Q, p.Y356X, p.V399V and A403V) from the 2 cases were identifie...",55,227,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,"...3V) from the 2 cases were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previousl...",55,292,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Y356X,"...the 2 cases were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previously reporte...",55,301,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.V399V,"...es were identified in PAH gene. p.R243Q, p.Y356X, p.V399V mutations were previously reported in Asia...",55,310,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,Phe/Tyr - 22.6	p.R243,73,16,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,Phe/Tyr - 22.6	p.R243,73,16,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.R243Q,Phe/Tyr - 22.6	p.R243,73,16,Mol_Genet_Metab_Rep_2016_Oct_28_9_71-74.txt
p.Val502Asp,"...d mutation (15) was detected (exon 10, c.1505T>A, p.Val502Asp), and a novel unreported missense poin...",31,107,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"...rted missense point mutation (exon 14, c.3279G>A, p.Met1093Ile) (Fig. 1)",31,189,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...ting from F8 compound heterozygous mutations. The p.Val502Asp mutation located in A2 domains was fir...,44,169,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... have often been reported in HA patients (31,32). p.Met1093Ile is a novel missense mutation unreport...",44,1502,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... have often been reported in HA patients (31,32). p.Met1093Ile is a novel missense mutation unreport...",44,1502,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... compound heterozygous mutations (p.Val502Asp and p.Met1093Ile) are causative gene defects, which re...",44,1740,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,"... compound heterozygous mutations (p.Val502Asp and p.Met1093Ile) are causative gene defects, which re...",44,1740,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Val502Asp,...ns 10 and 14. (A) Exon 10: NM_000132.3 c.1505T>A (p.Val502Asp). (B) Exon 14: NM_000132.3 c.3279G>A (...,51,94,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,...p.Val502Asp). (B) Exon 14: NM_000132.3 c.3279G>A (p.Met1093Ile),51,144,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Met1093Ile,...rrow. (B) Simple model of the FVIII B domain. The p.Met1093Ile mutation is located in the B domain a...,53,309,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.Phe2127Ser,"...a A: Identification of a novel missense mutation, p.Phe2127Ser Thromb Haemost 104 718 723 2010 20664...",131,172,Mol_Med_Rep_2014_Feb_4_9(2)_466-470.txt
p.R603I,...from arginine to isoleucine acid at position 603 (p.R603I). No ATP2A2 variants were detected in the ...,24,616,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,"... of the SIFT for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mu...",24,1037,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,"... of the SIFT for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mu...",24,1037,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,"... of the SIFT for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mu...",24,1037,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,"... of the SIFT for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mu...",24,1037,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,"... for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mutations, aff...",24,1049,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,"... for each mutation were 0, therefore, p.R603I and p.G749V were considered deleterious mutations, aff...",24,1049,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,The p.R603I and p.G749V mutations identified in the present study ...,37,17,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.G749V,"...ntified two novel missense mutations, p.R603I and p.G749V, in the ATP2A2 gene in two families contai...",39,87,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R603I,...roband of family B exhibited a missense mutation (p.R603I) in exon 14. Wild-type alleles of (C) exon...,46,219,Mol_Med_Rep_2015_Aug_9_12(2)_1845-1849.txt
p.R541H,... protein function has revealed that the lamin A/C p.R541H mutation causes the highly conserved seque...,51,442,Mol_Med_Rep_2015_Oct_8_12(4)_5065-5071.txt
p.G51D,...t Parkinson’s disease with dementia carrying SNCA p.G51D mutation Parkinsonism Relat Disord 2014 20 ...,307,191,Mol_Neurodegener_2015_Aug_27_10_41.txt
p.H50Q,"...ion M  Sherman H  Yu I  Shah B    Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson’...",322,100,Mol_Neurodegener_2015_Aug_27_10_41.txt
p.F382S,Exon 11	c.1145T>C	p.F382S	Early onset RP		 [19],52,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.E402X,Exon 12	c.1204G>T	p.E402X	LCA	Found in compound heterozygosity with ...,54,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.E402X,Exon 12	c.1204G>T	p.E402X	LCA	Found in compound heterozygosity with ...,54,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R420P,Exon 13	c.1259G>C	p.R420P	Early onset RP	Found in compound heterozyg...,56,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.L461V,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.L461V,Exon 14	c.1381C>G	p.L461V	Juvenile RP		 [16],58,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R420P,...ly onset RP	Found in compound heterozygosity with p.R420P	 [11],59,81,Mol_Vis_2008_Apr_21_14_675-682.txt
p.R482W,Exon 14	c.1444C>T	p.R482W	Early onset RP	Found in compound heterozyg...,60,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.K489R,Exon 14	c.1502G>A	p.K489R	RP		 [18],61,19,Mol_Vis_2008_Apr_21_14_675-682.txt
p.Glu72Lys,c.214G>A	missense	p.Glu72Lys	exon 4	5	5	2	17.86,89,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Glu72Lys,c.214G>A	missense	p.Glu72Lys	exon 4	5	5	2	17.86,89,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Gly140Arg,c.418G>A	missense	p.Gly140Arg	exon 5	4	3	2	12.5%,90,19,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Arg141Cys,...ommonly found mutation (23.21%) was the c.421C>T (p.Arg141Cys) missense mutation (exon 5). Molecular...,121,760,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Arg141Cys,...ommonly found mutation (23.21%) was the c.421C>T (p.Arg141Cys) missense mutation (exon 5). Molecular...,121,760,Mol_Vis_2008_Dec_12_14_2321-2332.txt
p.Glu150Lys,...lacement of a lysine residue for a glutamic acid (p.Glu150Lys) [15]. All affected individuals in thi...,141,178,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,"...r, Zhu et al. [25] have shown that the homozygous p.Glu150Lys change does not affect binding of opsi...",173,330,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.Glu150Lys,...dopsin protein has been shown to be normal in the p.Glu150Lys heterozygotes [25],173,729,Mol_Vis_2009_Dec_3_15_2526-2534.txt
p.S138X,A de novo heterozygous c.413C>G p.S138X stop mutation was identified in a seven-ye...,31,33,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Asn225Ser,c.674A>G	p.Asn225Ser	CPHD	[22],52,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Gln97X,c.289C>T	p.Gln97X	Extreme microphthalmia	[20],59,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Gln97X,c.289C>T	p.Gln97X	Inferior iris coloboma OD/ retinal colobo...,60,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Tyr179X,"c.537T>A	p.Tyr179X	bilateral mild microphthalmia, retinal d...",68,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.Pro133Thr,c.397C>A	p.Pro133Thr	bilateral microphthalmia	[11],71,10,Mol_Vis_2009_Nov_21_15_2442-2447.txt
p.R240X,... c.475delC [p.R159fs47]) and one known (c.718C>T [p.R240X]) PAX6 mutations in the affected members o...,13,430,Mol_Vis_2009_Oct_17_15_2074-2083.txt
p.Glu181Glu,SNX5 (NM_152227)	c.543G>A	p.Glu181Glu	rs2273448	Y (hetero) Score=25	Y (heter...,80,27,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ser15Cys,C20orf72 (NM_018152)	c.43A>T	p.Ser15Cys	rs11551768	Y (hetero) Score=18	N	Y (het...,82,30,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Asp282Asp, 	c.846T>C	p.Asp282Asp	rs28455091	Y (hetero) Score=2*	Y (hete...,84,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Asp282Asp, 	c.846T>C	p.Asp282Asp	rs28455091	Y (hetero) Score=2*	Y (hete...,84,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val116Gly,PTMAP3 (NG_001180)	c.347T>G	p.Val116Gly	-	N*	N*	Y (hetero)	Y (hetero),85,29,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Cys281Cys, 	c.843C>T	p.Cys281Cys	rs3748492	N*	Y (homo) Score=4**	Y (het...,90,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu470Leu, 	c.1410G>C	p.Leu470Leu	rs6075337	Y (homo) Score=26	Y (homo)+ ...,104,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu470Leu, 	c.1410G>C	p.Leu470Leu	rs6075337	Y (homo) Score=26	Y (homo)+ ...,104,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg56Gln, 	c.167G>A	p.Arg56Gln	-	N*	N*	Y (hetero)	N,110,12,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val426Ile, 	c.1276G>A	p.Val426Ile	-	N	N	N	N,113,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val426Ile, 	c.1276G>A	p.Val426Ile	-	N	N	N	N,113,13,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg16Arg,LOC388789 (XM_939954)	c.48A>G	p.Arg16Arg	rs12624935	N*	N*	N	Y (hetero),115,31,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro58Ser,LOC100270804	172C>T	p.Pro58Ser	rs41309831	Y (hetero) Score=13	N	Y (het...,131,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro58Ser,LOC100270804	172C>T	p.Pro58Ser	rs41309831	Y (hetero) Score=13	N	Y (het...,131,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Pro99Ser,c.295C>T	p.Pro99Ser	rs1053839	Y (hetero) Score=20	N	Y (hete...,138,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Val55Ile,c.163G>A	p.Val55Ile	rs1569767	N	Y (hetero) Score=17	N	Y (he...,140,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Leu213Leu,c.639G>A	p.Leu213Leu	rs3790278	Y (homo) Score=30	Y (homo) S...,142,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Ile218Ile,c.654T>C	p.Ile218Ile	rs3790279	Y (homo) Score=26	Y (homo) S...,143,11,Mol_Vis_2010_Dec_18_16_2829-2838.txt
p.Arg514Pro,...ctural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. A...,13,598,Mol_Vis_2010_Feb_15_16_224-230.txt
p.His572Arg,"... Phe515Leu), c. 531C>T (p. Arg124Cys), c.1876A>G (p.His572Arg) in TGFBI were responsible for LCD in ...",16,110,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...ly 1, two novel mutations, c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu), in exon 11 of TGFBI (F...",61,148,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,"...quences of TGFBI displayed a high conservation of p.Arg514Pro and Phe515Leu in the chimpanzee, cow, ...",69,475,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Phe515Leu,...ation of a downstream turn structure; whereas the p.Phe515Leu mutation could predictably elongate th...,74,372,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Phe515Leu,...ation of a downstream turn structure; whereas the p.Phe515Leu mutation could predictably elongate th...,74,372,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Arg514Pro,...indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T (p. Arg12...,77,238,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Gly470X,...d heterozygous mutations p.Arg124Cys coupled with p.Gly470X (a nonsense mutation) have been identifi...,79,978,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Gly470X,...’s daughter who carries the heterozygous mutation p.Gly470X alone was unaffected. This raises the qu...,79,1136,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Pro551Gln,"... compound heterozygous mutations, p.Ala546Asp and p.Pro551Gln, have been reported in two non-consang...",79,1454,Mol_Vis_2010_Feb_15_16_224-230.txt
p.Pro551Gln,"... compound heterozygous mutations, p.Ala546Asp and p.Pro551Gln, have been reported in two non-consang...",79,1454,Mol_Vis_2010_Feb_15_16_224-230.txt
p.L2015L,"...he other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered benign",15,320,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.L1808P,"...8], p.K663N [16], p.A669T [18], p.D984G [21], and p.L1808P [16], have been found to be disease causi...",25,1280,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.D984G,...notypes. We found that RP1 mutations (p.R677X and p.D984G) accounted for about 1.2% of overall RP [2...,27,175,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.A1670T,"...ied (Table 1). Among them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were c...",46,90,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1725Q,"... them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs registere...",46,110,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1725Q,"... them, six (p.R872H, p.N985Y, p.A1670T, p.S1691P, p.Q1725Q, and p.C2033Y) were common SNPs registere...",46,110,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G706R,Exon 4	c.2116G>C *	p.G706R	 [26]	20121	1/190,55,20,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1008Q,Exon 4	c.3024G>A	p.Q1008Q	 [26]	20090	1/190,58,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1008Q,Exon 4	c.3024G>A	p.Q1008Q	 [26]	20090	1/190,58,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,Exon 4	c.4108A>G	p.K1370E	Novel	20090	0/190,59,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,Exon 4	c.4108A>G	p.K1370E	Novel	20090	0/190,59,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.S1691P,Exon 4	c.5071T>C	p.S1691P	rs414352	44/55	106/190,62,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1725Q,Exon 4	c.5175A>G	p.Q1725Q	rs441800	44/55	106/190,63,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.C2033Y,Exon 4	c.6098G>A	p.C2033Y	rs61739567	20149	27/190,65,18,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G706R,"...o identified eight rare variants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both...",69,57,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G706R,"...o identified eight rare variants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both...",69,57,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.Q1008Q,"...ied eight rare variants, three of which (p.G706R, p.Q1008Q, and c.6542C>T) occurred in both the case...",69,66,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ge, while the other three (p.I408L, p.K1370E, and p.R1652L) were missense changes",69,374,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... p.K1370E is potentially disease causing. For the p.R1652L variant, the predictions were “Possibly d...",71,621,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ndex of 7) by PMUT. With a Grantham score of 102, p.R1652L should be moderately radical and highly l...",71,810,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...r around these two residues. However, the variant p.R1652L was predicted to abolish one possible pro...",71,1025,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...Determination of the evolutionary conservation of p.K1370E and p.R1652L by multiple amino acid seque...,71,1190,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"... RP1 wild type protein and the missense variants, p.K1370E and p.R1652L, were analyzed by web-based ...",81,134,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,B. Description	Wild type	p.R1652L,85,26,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"...ntosa 1 (RP1; partially), showing the location of p.K1370E and p.R1652L. The two residues are not co...",92,114,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... partially), showing the location of p.K1370E and p.R1652L. The two residues are not conserved acros...",92,127,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"... partially), showing the location of p.K1370E and p.R1652L. The two residues are not conserved acros...",92,127,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...-be-identified mutation. In contrast, the variant p.R1652L was likely to be a deleterious substituti...",95,1689,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"...PolyPhen, SIFT, PMUT, and Grantham score. Variant p.K1370E was also predicted to be deleterious by t...",95,1823,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...e consistent for pathologic roles of p.R1652L and p.K1370E in RP. The patients with these postulated...,95,2559,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,"... mutation carrier [29]. Notably, the p.R1652L and p.K1370E carriers were classified as sRP because t...",95,2797,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...sentations of the two putative missense mutation (p.K1370E and p.R1652L) carriers. They both appear ...,97,83,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,"...ographs and automated visual field reports of the p.R1652L carrier, showing much milder clinical man...",97,365,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.D984G,"...ies, we identified two RP1 mutations, p.R677X and p.D984G, in two out of 173 Hong Kong Chinese RP pa...",99,71,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.N985Y,"...mited. Recently, Sheng et al. [30] identified the p.N985Y variant as the disease-causing mutation fo...",99,596,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.G79E,"...l., [30] another three missense variants (p.P63I, p.G79E, and p.P903L) were also found to occur at h...",99,1182,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.P903L,"...ther three missense variants (p.P63I, p.G79E, and p.P903L) were also found to occur at high frequenc...",99,1194,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K663N,p.K663N	c.1989G.>T	U.S.A.	ADRP	[16],106,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.D984G,p.D984G	c.2951A>G	Chinese	ADRP	[21],108,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,p.K1370E	c.4108A>G	Chinese	SRP	Present Study,110,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,p.K1370E	c.4108A>G	Chinese	SRP	Present Study,110,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.R1652L,p.R1652L	c.4955G>T	Chinese	SRP	Present Study,111,1,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.K1370E,...tified two novel missense mutations (p.R1652L and p.K1370E). These mutations were predicted to have ...,119,75,Mol_Vis_2010_Jul_15_16_1353-1360.txt
p.V107I,"This study has identified a novel MIP mutation, p.V107I in a Chinese family with congenital catara...",18,49,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"This study has identified a novel MIP mutation, p.V107I in a Chinese family with congenital catara...",18,49,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"This study has identified a novel MIP mutation, p.V107I in a Chinese family with congenital catara...",18,49,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"This study has identified a novel MIP mutation, p.V107I in a Chinese family with congenital catara...",18,49,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,...acement of highly conserved Valine by Isoleucine (p.V107I),46,260,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,...acement of highly conserved Valine by Isoleucine (p.V107I),46,260,Mol_Vis_2010_Mar_25_16_534-539.txt
p.V107I,"...n the substitution of a Valine for an Isoleucine (p.V107I), in loopC of AQP0 (Figure 5). The high co...",75,570,Mol_Vis_2010_Mar_25_16_534-539.txt
p.F9L,EU807741.1	m.8551T>C (p.F9L)	MT-ATP6	Yes	Yes	No	10/15859	1	0.745,49,23,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.L95F,FJ969382.1	m.7868C>T (p.L95F)	MT-CO2	Yes	Yes	No	12/15859	0.15	0.539,50,23,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.L95F,FJ969382.1	m.7868C>T (p.L95F)	MT-CO2	Yes	Yes	No	12/15859	0.15	0.539,50,23,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.V39I,"FJ969383.1	m.3421G>A (p.V39I)	MT-ND1	Yes	Yes	Yes (D4n, HV1a3, W3a1a1, H8...",53,23,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.F9L,"...773G>A, [MT-TC]), EU807741.1 (m.8551T>C [MT-ATP6: p.F9L]), FJ969382.1 (m.7868C>T [MT-CO2: p.L95F]; m...",56,824,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.Y159H,...ed by the TMPRED program. A: Variants m.12811T>C (p.Y159H) and m.14063T>C (p.I576T) changed the stru...,58,205,Mol_Vis_2012_Dec_30_18_3087-3094.txt
p.W157X,"... transcripts of this nonsense mutation (c.471G>A, p.W157X) may escape the NMD pathway and the aberra...",97,457,Mol_Vis_2012_Jul_11_18_1874-1880.txt
p.C637Y,"... family. Two novel mutations of FBN1, p.C271* and p.C637Y, were identified in the MF1 and MF2 famili...",12,551,Mol_Vis_2013_Apr_5_19_751-758.txt
p.C637Y,...a cysteine substitution by tyrosine at codon 637 (p.C637Y). These two allelic variations were cosegr...,93,452,Mol_Vis_2013_Apr_5_19_751-758.txt
p.C637Y,...a cysteine substitution by tyrosine at codon 637 (p.C637Y). These two allelic variations were cosegr...,93,452,Mol_Vis_2013_Apr_5_19_751-758.txt
p.Asp338Gly,p.Asp338Gly	0*	-	0*	-	100	15	29	17	100	16,87,2,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Cys2033Tyr,RP1	p.Cys2033Tyr	0*	-	0*	-	55	33	50	40	41	83,91,5,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Arg310Lys,... 2). The sequences also revealed the polymorphism p.Arg310Lys in exon 3 of PRPH2 [20] in a heterozyg...,97,433,Mol_Vis_2013_Mar_21_19_654-664.txt
p.Arg310Lys,... 2). The sequences also revealed the polymorphism p.Arg310Lys in exon 3 of PRPH2 [20] in a heterozyg...,97,433,Mol_Vis_2013_Mar_21_19_654-664.txt
p.R144W,...he mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are two novel missense mutations,12,338,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,...he mutations of c.313C>A (p. N105H) and c.430G>T (p.R144W) are two novel missense mutations,12,338,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,...n of c.313C>A (p.N105H). C: Mutation of c.430G>T (p.R144W). The upper panel is the chromatogram of t...,55,221,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.N105H,"...—c.672_701dup30 (p.Ala224_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene...",82,92,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.R144W,"...4_Ala234dup10), c.313C>A (p.N105H), and c.430G>T (p.R144W)—in the FOXL2 gene in four Han Chinese fam...",82,116,Mol_Vis_2013_Nov_16_19_2298-2305.txt
p.L5063R,...leucine for an arginine at protein position 5063 (p.L5063R). The comparative amino acid sequence ana...,77,172,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.L5063R,...leucine for an arginine at protein position 5063 (p.L5063R). The comparative amino acid sequence ana...,77,172,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...as found for these mutations. The missense mutant p.F1442S residue, buried in a fibronectin type III...",82,314,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...e variants identified in this pedigree, the USH2A p.F1442S mutation is located in the extracellular ...",87,59,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...e variants identified in this pedigree, the USH2A p.F1442S mutation is located in the extracellular ...",87,59,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...e variants identified in this pedigree, the USH2A p.F1442S mutation is located in the extracellular ...",87,59,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.F1442S,"...ective USH2A membrane anchorage. Furthermore, the p.F1442S change affects long and short isoforms wh...",87,926,Mol_Vis_2013_Nov_7_19_2187-2195.txt
p.Tyr343Asp,"...ico analysis predicted that the missense variant, p.Tyr343Asp, disrupted the CYP4V2 surface electros...",10,724,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Y343D,"...	RE: —10.5	RE:20/200	c.283G>A, p.G95R+ c.1027T>G, p.Y343D﹡",46,64,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,"60	55/M	49	44	RE: —2.75	RE:20/200	c.31C>T, p.Q11X*+ c.31C>T, p.Q11X*",50,44,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Q11X,1	c.31C>T	p.Q11X	1/0	0/200	2/184	novel,66,11,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.L22V,1	c.64C>G	p.L22V	1/4	ND	6/184	Reported,67,11,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.F73L,2	c.219T>A	p.F73L	0/3	0/200	3/184	Reported,69,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.G95R,2	c.283G>A	p.G95R	0/5	ND	5/184	Reported,70,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.W244X,6	c.732G>A	p.W244X	0/1	ND	1/184	Reported,72,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.H331P,8	c.992A>C	p.H331P	0/22	ND	22/184	Reported,76,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.H331P,8	c.992A>C	p.H331P	0/22	ND	22/184	Reported,76,12,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.P396L,9	c.1187C>T	p.P396L	0/2	ND	2/184	Reported,80,13,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Gln11X,"...ermination codon (TAG) at amino acid position 11 (p.Gln11X) in exon 1 was identified (Figure 4C,D), ...",84,661,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Y343D,"...ozygous mutant single base-pair change (c.1027T>G,p.Y343D). B: Control (wild type, WT). C: The homoz...",88,137,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.Gln11X,"...utations, p.Tyr343Asp, c.413+2T>G, c.791delT, and p.Gln11X, segregated with the BCD phenotypes and w...",103,209,Mol_Vis_2014_Dec_31_20_1806-1814.txt
p.V283I,PYROXD2	NM_032709.2	c.847G>A (p.V283I)	Probably damagin,61,31,Mol_Vis_2014_Jun_12_20_790-796.txt
p.R109Q,"...nown significance in three other genes [c.326G>A (p.R109Q) in CAMK1D located on chromosome 10p13, c....",70,95,Mol_Vis_2014_Jun_12_20_790-796.txt
p.E820Gfs,(p.E820Gfs*23)	Exon 18	Frameshift	Homozygous	Saudi ...,89,2,Mol_Vis_2014_Jun_12_20_790-796.txt
p.E820Gfs,(p.E820Gfs*23)	Exon 18	Frameshift	Homozygous	Saudi ...,89,2,Mol_Vis_2014_Jun_12_20_790-796.txt
p.E820Gfs,(p.E820Gfs*23)	Exon 18	Frameshift	Homozygous	Saudi ...,89,2,Mol_Vis_2014_Jun_12_20_790-796.txt
p.Arg116His,...t AM  Nagaoka Y  Jiang M  Bhat SP   HSF4 mutation p.Arg116His found in age-related cataracts and in ...,198,78,Mol_Vis_2015_Aug_28_21_955-973.txt
p.Arg116His,...t AM  Nagaoka Y  Jiang M  Bhat SP   HSF4 mutation p.Arg116His found in age-related cataracts and in ...,198,78,Mol_Vis_2015_Aug_28_21_955-973.txt
p.G3083D,"... elongation of its neighboring β-sheet induced by p.G3083D (c.9248G>A), which could alter the tertia...",12,947,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,...of the wild-type and mutant eys proteins carrying p.G2186E were built based on template 3poy.1A as i...,45,1163,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"ARRP07	RPSP	6: 64,791,763	c.6557G>A	p.G2186E	missense	Hom	E32	DA (0.03)	PD (0.68)	DE (...",68,37,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,"6: 64,940,493	c.6416G>A	p.C2139Y	missense	Het	E31	DA (0)	PD (0.797)	DE (−4...",71,25,Mol_Vis_2016_Jun_16_22_646-657.txt
p.C2139Y,"6: 64,940,493	c.6416G>A	p.C2139Y	missense	Het	E31	DA (0)	PD (0.797)	DE (−4...",71,25,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2410Gfs,"6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	NA	NA	Novel...",73,28,Mol_Vis_2016_Jun_16_22_646-657.txt
p.S1653Kfs,"6: 65,300,802	c.4957dupA	p.S1653Kfs*2	frameshift	Het	E26	NA	NA	NA	Novel",75,26,Mol_Vis_2016_Jun_16_22_646-657.txt
p.I1698T,...ine to the hydrophilic threonine at residue 1698 (p.I1698T),78,1097,Mol_Vis_2016_Jun_16_22_646-657.txt
p.S1653Kfs,...variation that might generate a truncated protein p.S1653Kfs*2 or cause NMD. The two novel variation...,80,626,Mol_Vis_2016_Jun_16_22_646-657.txt
p.S1653Kfs,...variation that might generate a truncated protein p.S1653Kfs*2 or cause NMD. The two novel variation...,80,626,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"...thalmic examinations. The recurrent mutation, EYS p.G2186E, a mutational hotspot among multiple ethn...",116,261,Mol_Vis_2016_Jun_16_22_646-657.txt
p.G2186E,"...studies, the RP age of onset of patients carrying p.G2186E range from 14- to 62 years-old, while one...",116,643,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2410Gfs,...ular splice site and generate a truncated protein p.A2410Gfs*4 or cause NMD. This variant was also f...,116,1410,Mol_Vis_2016_Jun_16_22_646-657.txt
p.A2410Gfs,...ular splice site and generate a truncated protein p.A2410Gfs*4 or cause NMD. This variant was also f...,116,1410,Mol_Vis_2016_Jun_16_22_646-657.txt
p.Arg121Gln,"...Ile48ValfsX55, p.His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, and p.Cys126Arg, including five novel...",10,125,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...His50Asp, p.Ser57*, p.Gly113Asp, p.Arg121Gln, and p.Cys126Arg, including five novel ones), were obse...",10,142,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,...letions (p.Asp23GlufsX9 and p.Ile48ValfsX55). The p.His50Asp mutation was observed in three familial...,68,586,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,... in three sporadic cases (Figure 1). Although the p.His50Asp change segregated with the disease phen...,68,771,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,c.148C>G (p.His50Asp)	Damagin,80,11,Mol_Vis_2016_May_16_22_491-502.txt
p.His50Asp,c.148C>G (p.His50Asp)	Damagin,80,11,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...n at the positions of the novel missense changes (p.H50D, p.G113D, and p.C126R) demonstrates the evo...",96,129,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...n at the positions of the novel missense changes (p.H50D, p.G113D, and p.C126R) demonstrates the evo...",96,129,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...res of the patients with FEVR with novel changes (p.H50D, p.G113D, and p.D23EfsX9) identified in the...",101,110,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...res of the patients with FEVR with novel changes (p.H50D, p.G113D, and p.D23EfsX9) identified in the...",101,110,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,...ovascular traction. B: Patient ID: family 33-I:2 (p.H50D; affected mother of the proband); the left ...,101,394,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,"...cular dragging. C, D: Patient ID: family 72-IV:1 (p.H50D); the right (C) and left (D) eyes show drag...",101,549,Mol_Vis_2016_May_16_22_491-502.txt
p.H50D,...n ectopic macula. E: Patient ID: family 139-II:2 (p.H50D); the right eye of the patient shows an ava...,101,687,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,...ic examination (Figure 1). The p.His4ArgfsX21 and p.Cys126Arg mutations were detected only in the pr...,103,770,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...dy, the three novel missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) were located in the ...",110,69,Mol_Vis_2016_May_16_22_491-502.txt
p.Gly113Asp,"...dy, the three novel missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) were located in the ...",110,69,Mol_Vis_2016_May_16_22_491-502.txt
p.Cys126Arg,"...el missense changes (p.His50Asp, p.Gly113Asp, and p.Cys126Arg) were located in the highly conserved ...",110,86,Mol_Vis_2016_May_16_22_491-502.txt
p.Q36X,"... A heterozygous CTR9 nonsense mutation, c.106C>T; p.Q36X, was present in each half-sister (Fig. 1b)....",19,151,Nat_Commun_2014_Aug_7_5_4398.txt
p.Gly966Ala,c.2897G>C; p.Gly966Ala	rs192522878	Benign	Tolerated	No effect...,186,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Arg985Cys,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect protein fun...,187,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Arg985Cys,c.2953C>T; p.Arg985Cys	 	Possibly damaging	Affect protein fun...,187,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Lys1050Arg,c.3149A>G; p.Lys1050Arg	rs141131642	Benign	Tolerated	No effec...,189,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Cys1052Arg,c.3154T>C; p.Cys1052Arg	rs35696189	Benign	Tolerated	No effect...,190,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Gly1071Ser,c.3211G>A; p.Gly1071Ser	rs35766432	Benign	Tolerated	No effect...,192,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Asp1082Asn,c.3244G>A; p.Asp1082Asn	rs138871050	Benign	Tolerated	No effec...,193,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Asp1171Gly,c.3512A>G; p.Asp1171Gly	 	Benign	Deleterious	No effect	1	 ,198,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.Asp1171Gly,c.3512A>G; p.Asp1171Gly	 	Benign	Deleterious	No effect	1	 ,198,12,Nat_Commun_2014_Aug_7_5_4398.txt
p.V1184A,...umans. Electrophysiological analysis reveals that p.V1184A shifts the voltage dependence of channel ...,3,2636,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ing NaV1.9, was the heterozygous de novo mutation p.L811P, which confers gain-of-function properties...",12,227,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...mperature sensitivity of the patients' phenotype, p.V1184A-dependent nociceptor excitability is less...",14,387,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ividuals, a missense change in SCN11A, c.3551T>C, p.V1184A (chr3:38913144A>G, hg19), was the most li...",20,1199,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ividuals, a missense change in SCN11A, c.3551T>C, p.V1184A (chr3:38913144A>G, hg19), was the most li...",20,1199,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"... for NaV1.9 between −57 and −17 mV; 1.45±0.06 for p.V1184A between −67 and −27 mV), and the closing ...",25,2095,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"At either temperature, mutation p.V1184A did not affect the kinetics of fast chann...",27,33,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"At either temperature, mutation p.V1184A did not affect the kinetics of fast chann...",27,33,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"When overexpressed in DRG neurons, p.V1184A mutant channels depolarized the cell memb...",34,36,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f 1.6±0.1 (P<0.001, two-tailed t-test) for mutant p.V1184A (Fig. 5b,d). Thus, attenuation of DRG neu...",36,837,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,Comparison of mutation p.V1184A with p.L811,38,38,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,The phenotypes associated with mutation p.V1184A in NaV1.9 as well as those with mutations...,39,41,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ned elusive. Therefore, we analysed the impact of p.L811P on excitability of DRG neurons under ident...",39,385,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...ned elusive. Therefore, we analysed the impact of p.L811P on excitability of DRG neurons under ident...",39,385,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...ction potentials were only marginally affected by p.L811P (Supplementary Fig. 1c). Analysis of repet...,39,839,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ng patterns between neurons expressing p.L811P or p.V1184A (Fig. 6). As illustrated in Fig. 6a,b, 76...",39,1293,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...and 81% of repetitively firing neurons expressing p.V1184A maintained stable action potential amplit...,39,1460,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...eurons expressing p.L811P (P<0.01, Z-test). Thus, p.L811P channels increase the probability of cumul...",39,1714,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f KV and NaV channel structures26272829, mutation p.V1184A is located within a conserved sequence at...",44,550,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...e can trigger painful episodes in carriers of the p.V1184A mutation, we analysed the effect of tempe...",46,482,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...nario would be in line with our data showing that p.V1184A does not affect the intrinsic temperature...,48,1083,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,The clinical symptoms caused by mutation p.V1184A in NaV1.9 are reminiscent of primary eryt...,50,42,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,The clinical symptoms caused by mutation p.V1184A in NaV1.9 are reminiscent of primary eryt...,50,42,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,The clinical symptoms caused by mutation p.V1184A in NaV1.9 are reminiscent of primary eryt...,50,42,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...ture sensitivity of pain sensation. Specifically, p.V1184A-related pain is mostly aggravated by cool...",50,372,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1316A,...homologous mutation p.V1316A in NaV1.7 (ref. 10): p.V1316A in NaV1.7 causes warmth-aggravated severe...,50,730,Nat_Commun_2015_Dec_8_6_10049.txt
p.G699R,"...p.A808G. Notably, Han et al.36 described mutation p.G699R, located in the S4/S5 linker in domain II ...",50,1765,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...viously171819, as well as this report on mutation p.V1184A are in marked contrast to the NaV1.9 gain...",52,104,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...d elusive. To infer potential differences between p.V1184A and p.L811P we assessed the functions of ...,52,346,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"...tage dependence of channel inactivation. However, p.L811P shifts the voltage dependence of opening o...",52,1343,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"... of opening of NaV1.9 by −29 mV, whereas mutation p.V1184A shifts the same parameter by only −20 mV,...",52,1430,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,"... only −20 mV, clearly demonstrating that mutation p.L811P facilitates opening of NaV1.9 more strongl...",52,1517,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...f repetitive firing revealed that, in contrast to p.V1184A, mutation p.L811P leads to a substantial ...",54,467,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...ed in a substantial portion of neurons expressing p.L811P mutant channels (Fig. 6). This instability...,54,692,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,... may be caused by increased influx of Na+ through p.L811P as it is predicted by the larger window cu...,54,792,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...(Fig. 7b) and the slower inactivation kinetics of p.L811P compared with p.V1184A or wild-type NaV1.9...,54,898,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...er inactivation kinetics of p.L811P compared with p.V1184A or wild-type NaV1.9 (Fig. 7a). Excessive ...,54,920,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,"...aptic plasticity. In summary, the missense change p.V1184A, which causes cold-aggravated peripheral ...",54,1300,Nat_Commun_2015_Dec_8_6_10049.txt
p.Val1184Ala,...n pcDNA3.1 was used as template15. The c.3551T>C (p.Val1184Ala) mutation was introduced by PCR-based...,67,84,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...of the family with episodic pain. Genotype of the p.V1184A mutation is indicated. V/A=heterozygous m...,130,64,Nat_Commun_2015_Dec_8_6_10049.txt
p.V1184A,...ons p.L811P (blue) causing pain insensitivity and p.V1184A (red) causing cold-aggravated peripheral ...,130,483,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...rent; this window current is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9....,148,681,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...rent; this window current is largest for mutation p.L811P followed by p.V1184A and wild-type NaV1.9....,148,681,Nat_Commun_2015_Dec_8_6_10049.txt
p.L811P,...al insensitivity to pain due to the Na1.9 variant p.L811P . Eur. J. Hum. Genet.,236,76,Nat_Commun_2015_Dec_8_6_10049.txt
p.Leu117Val,...a point mutation causing the predicted amino acid p.Leu117Val substitution. This missense mutation o...,20,521,Nat_Commun_2015_Jun_16_6_7092.txt
p.Leu117Val,...a point mutation causing the predicted amino acid p.Leu117Val substitution. This missense mutation o...,20,521,Nat_Commun_2015_Jun_16_6_7092.txt
p.Glu334Ter,"...onsense mutations in exon 6 (p.Trp124Ter) and 13 (p.Glu334Ter), respectively. Western blot analyses ...",20,1202,Nat_Commun_2015_Jun_16_6_7092.txt
p.Trp124Ter,"... R01-013A (c.993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter; p.Leu117Val), indicating that these m...",20,1375,Nat_Commun_2015_Jun_16_6_7092.txt
p.Leu117Val,"...993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter; p.Leu117Val), indicating that these mutations like...",20,1388,Nat_Commun_2015_Jun_16_6_7092.txt
p.S3G, p.S3G	7A>G	1	1/99 US FTLD-ALS	0/1038 US controls0/...,121,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.S3G, p.S3G	7A>G	1	1/99 US FTLD-ALS	0/1038 US controls0/...,121,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.S195R, p.S195R	585T>G	6	1/30 SP FALS	0/967 AU control exo...,123,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.S621G, p.S621G	1861A>G	16	1/75 AU FALS	0/864 AU Sanger co...,125,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.I772T, p.I772T	2315T>C	17	1/159 UK FALS	0/897 UK controls...,126,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.T181I, p.T181I	542C>T	6	1/283 JA SALS	0/514 JA controls0/...,129,2,Nat_Commun_2016_Apr_15_7_11253.txt
p.R179X,"...predicted protein-truncating variant (rs36095412, p.R179X, genotyped in 11,148 ulcerative colitis pa...",5,1017,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,"...predicted protein-truncating variant (rs36095412, p.R179X, genotyped in 11,148 ulcerative colitis pa...",5,1017,Nat_Commun_2016_Aug_9_7_12342.txt
p.A64T,...ing common non-coding alleles and risk increasing p.A64T is available for further experimentation. F...,42,177,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,"..., the same rare allele of the same variant coding p.R179X has been reported in Iceland to have a gen...",42,343,Nat_Commun_2016_Aug_9_7_12342.txt
p.G149R,"...ariants (p.V362I, MAF=1.27%, OR=0.72 (0.63–0.83); p.G149R, MAF=0.45%, OR=0.60 (0.45–.0.79)) and the ...",42,718,Nat_Commun_2016_Aug_9_7_12342.txt
p.R179X,RNF186 p.R179X was assayed using Sequenom MassARRAY iPLEX...,86,8,Nat_Commun_2016_Aug_9_7_12342.txt
p.Trp977X,"...Table 1) revealed a nonsense mutation, c.2931G>A (p.Trp977X), also in IGSF1 (Fig. 1c). B-III.7 and B...",42,1226,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Trp1173X,c.3518G>A	p.Trp1173X	NL	14.1 yrs	+	+	16.69	19/17 [8-16.5],248,12,Nat_Genet_2012_Dec_11_44(12)_1375-1381.txt
p.Phe91Ser,"...p.Phe91 lines the effector-binding pocket, and so p.Phe91Ser may disrupt effector-binding. Similarly...",28,1333,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Phe91Ser,"...p.Phe91 lines the effector-binding pocket, and so p.Phe91Ser may disrupt effector-binding. Similarly...",28,1333,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Ile123Thr,"...inding by the second EF hand domain. In contrast, p.Ile123Thr is located within the second CIB2 EF-h...",28,1524,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Ile123Thr,"...inding by the second EF hand domain. In contrast, p.Ile123Thr is located within the second CIB2 EF-h...",28,1524,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,"... mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p.Ile123Thr)] co-segrega...",118,632,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,"... mutant alleles [c.272T>C (p.Phe91Ser), c.297C>G (p.Cys99Trp) and c.297C>G (p.Ile123Thr)] co-segrega...",118,632,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Cys99Trp,...iceable changes of CIB2 distribution (not shown). p.Cys99Trp abolished CIB2’s ability to decrease se...,120,885,Nat_Genet_2012_Nov_30_44(11)_1265-1271.txt
p.Asp575Asn,".... Additionally, two SNPs in ERAP1, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, recessively conferred...",7,710,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Asp575Asn,"...ntified rs10050860 and rs17482078, encoding ERAP1 p.Asp575Asn and p.Arg725Gln, which conferred risk ...",17,609,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...hether the recessive model would reveal the ERAP1 p.Arg725Gln association with BD susceptibility in ...,19,162,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...s found significant association of the homozygous p.Arg725Gln genotype with BD susceptibility (p=4.3...,19,362,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...s found significant association of the homozygous p.Arg725Gln genotype with BD susceptibility (p=4.3...,19,362,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...ariant in strong linkage disequilibrium [LD] with p.Arg725Gln) was too low in the Japanese populatio...,19,540,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...ides are altered in ERAP1 deficient mice25. ERAP1 p.Arg725Gln-related alterations might affect the r...,25,443,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,...ides are altered in ERAP1 deficient mice25. ERAP1 p.Arg725Gln-related alterations might affect the r...,25,443,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Ile29Ser,"...in KLRC4, rs1841958 and rs2617170, encoding KLRC4 p.Ile29Ser and Asn104Ser, are found on the BD-prot...",27,231,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Ile29Ser,"...in KLRC4, rs1841958 and rs2617170, encoding KLRC4 p.Ile29Ser and Asn104Ser, are found on the BD-prot...",27,231,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Arg725Gln,ERAP1 rs17482078 (ERAP1 p.Arg725Gln)	Turkish Discovery	TOF-MS	Uveitis BD	4...,121,25,Nat_Genet_2013_Feb_6_45(2)_202-207.txt
p.Gln587Del,"...gs. We also detected a de novo in-frame deletion (p.Gln587Del) in the MYND domain (Gln87), which rep...",36,1603,Nat_Genet_2014_Oct_14_46(10)_1063-1071.txt
p.Q185X,"...sing TRIB3 and HOIL1, and the nonsense c.553 C>T, p.Q185X mutant allele in HOIL1. Pedigree of kindre...",103,189,Nat_Immunol_2012_Dec_28_13(12)_1178-1186.txt
p.A597D,"...tary Methods). Three missense mutations (p.T232P, p.A597D and p.H1204P) could be scored with these a...",17,1545,Nature_2011_Jan_27_469(7331)_539-542.txt
p.H1204P,"...). Three missense mutations (p.T232P, p.A597D and p.H1204P) could be scored with these alignments. T...",17,1557,Nature_2011_Jan_27_469(7331)_539-542.txt
p.H1204P,"...). Three missense mutations (p.T232P, p.A597D and p.H1204P) could be scored with these alignments. T...",17,1557,Nature_2011_Jan_27_469(7331)_539-542.txt
p.R1020K,"...und to have two heterozygous missense mutations - p.R1020K,c.3059G>A and p.L1872P,c.5615T>C. Both ca...",29,198,Nature_2011_Jan_27_469(7331)_539-542.txt
p.S13F,...s: the cardiac phenotype of DES founder mutations p.S13F and p.N342D van Spaendonck-Zwarts K. Y. +31...,3,245,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...gene (DES). We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac pheno...",4,190,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...gene (DES). We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac pheno...",4,190,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,".... We describe new families carrying the p.S13F or p.N342D DES mutations, the cardiac phenotype of al...",4,200,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...the clinical details of all carriers of p.S13F or p.N342D. The founder effects were studied using ge...,7,64,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... p.S13F carriers (eight index patients) and of 21 p.N342D carriers (three index patients). The cardi...,10,221,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...o that of p.S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy ...,10,610,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...o that of p.S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy ...,10,610,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,....S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy and haploty...,10,621,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,....S13F carriers. The founder effects of p.S13F and p.N342D were demonstrated by genealogy and haploty...,10,621,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"In the Netherlands, two DES mutations (p.S13F and p.N342D) have been identified in severa...",28,40,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"In the Netherlands, two DES mutations (p.S13F and p.N342D) have been identified in severa...",28,40,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"In the Netherlands, two DES mutations (p.S13F and p.N342D) have been identified in several index pat...",28,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ms were (1) to describe new families carrying the p.S13F or p.N342D DES mutations, (2) to investigat...",28,394,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...luated known and obligate Dutch carriers (35 with p.S13F and 19 with p.N342D). Some of these data ha...,35,192,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ligate Dutch carriers (35 with p.S13F and 19 with p.N342D). Some of these data have been described p...,35,211,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...so summarised the published cardiological data on p.S13F and p.N342D carriers of other origin,35,669,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...iers (n = 2 and n = 13 respectively) of p.S13F or p.N342D in the Netherlands by collecting the posta...,44,158,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...iers (n = 2 and n = 13 respectively) of p.S13F or p.N342D in the Netherlands by collecting the posta...,44,158,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ng in the following changes at the protein level: p.S13F, p.N342D, p.R454W, p.T442I, and p.T453I (Ta...",48,142,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"p.S13F	6,8	5 families	Dutch	Founder",51,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R454W,p.R454W	7	1 family	Dutch,57,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.R454W,p.R454W	7	1 family	Dutch,57,1,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...ed on the two Dutch founder mutations (p.S13F and p.N342D). Mutation p.S13F (c.38 C > T) is a missen...,65,73,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... index patients. Twelve proven and seven obligate p.N342D carriers were identified by family cascade...,65,611,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...leading to death. In total, 35 known and obligate p.S13F carriers (including eight index patients) h...",68,762,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"D-III-3 8	M	p.S13F	screening (37)	PVCs, IVCD (37)	normal (37)	...",72,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,D-III-4 8	F	p.S13F	screening (32)	IVCD (32)	normal (32)	normal...,73,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,G-III-1	M	p.S13F (index)	Effort-related chest discomfort (37...,76,11,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,H-III-1	F	p.S13F (index)	collapse (36)	cAVB (36)	normal (36)...,77,11,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-I-2 12	F	p.S13F	screening	NA	NA	very mild proximal and dist...,80,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-I-2 12	F	p.S13F	screening	NA	NA	very mild proximal and dist...,80,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-II-2 12	F	p.S13F	screening	NA	NA	very mild proximal and dist...,81,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,P-II-4 12	M	p.S13F	screening	NA	NA	mild proximal and distal li...,83,13,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...CM = dilated cardiomyopathy, E: S13F = carrier of p.S13F mutation, E: - = not a carrier of p.S13F mu...",86,508,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...rrier of p.S13F mutation, E: - = not a carrier of p.S13F mutation, ICD = implantable cardioverter de...",86,549,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,Genealogy and haplotype analysis of families with p.S13,92,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,Cardiac phenotype of p.N342,95,22,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...r these families. In total, 19 known and obligate p.N342D and 10 probable carriers (including three ...",96,315,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ade atrioventricular block (b) from patients with p.S13,96,781,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ade atrioventricular block (b) from patients with p.S13,96,781,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ade atrioventricular block (b) from patients with p.S13,96,781,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,...ade atrioventricular block (b) from patients with p.S13,96,781,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... 3 Clinical characteristics of known and obligate p.N342D carriers and relatives likely to be carrie...,98,56,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,... 3 Clinical characteristics of known and obligate p.N342D carriers and relatives likely to be carrie...,98,56,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,O-III-12	F	p.N342D	MW (37)	Repolarisation abnormality (63)	LV...,106,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,O-IV-2	F	p.N342D (index)	MW (27)	RBBB (45)	normal (45)	bulb...,110,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,O-IV-2	F	p.N342D (index)	MW (27)	RBBB (45)	normal (45)	bulb...,110,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"O-IV-9	F	p.N342D	MW (23)	normal (35)	normal (35)	bulbar, ne...",111,10,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,U-III-15	F	p.N342D	NA	Repolarisation abnormality (45)	NA	scap...,119,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"U-III-17	F	p.N342D	MW (16)	PACs, PVCs, ventricular bigeminy, ...",120,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,A-II-2 7	M	p.N342D	MW (41)	first-degree AVB (46)	LV dysfuncti...,127,12,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"D-I-3 1,14	F	p.N342D (index)	MW (30)	normal	NA	distal, CK 364 (...",128,14,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,Genealogy and haplotype analysis of families with p.N342,136,51,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...ibution of known, obligate and likely carriers of p.S13F (n = 26) or p.N342D (n = 25) in the Netherl...",140,88,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,Fig. 5 Geographical distribution of carriers of p.S13F (A) and p.N342D (B). The geographical distr...,142,49,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...phical distribution of carriers of p.S13F (A) and p.N342D (B). The geographical distribution of know...,142,64,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...ligate and likely carriers of p.S13F (n = 26) and p.N342D (n = 25), respectively, in the Netherlands...",142,169,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...rs of two Dutch DES founder mutations (p.S13F and p.N342D), including three new index patients with ...",147,100,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...p.N342D), including three new index patients with p.S13F and two new large families with p.N342D. Th...",147,150,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...inent in carriers with p.N342D than in those with p.S13F, because all p.N342D carriers presented wit...",151,180,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...eart failure or the exact causes of death of some p.N342D carriers. The type of rhythm and conductio...,151,377,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,"...oblems seem to have been the cause of death. Five p.N342D carriers (5/18, aged between 21-30 years) ...",151,620,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...dependent) penetrance of the cardiac phenotype of p.N342D cannot be excluded,151,867,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...dependent) penetrance of the cardiac phenotype of p.N342D cannot be excluded,151,867,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...r phenotype in carriers of the 2B domain mutation p.N342D is more prominent compared with carriers o...,153,451,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.N342D,...here are many unidentified carriers of p.S13F and p.N342D founder mutations in the Netherlands. Our ...,159,74,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S13F,"...nds. Our estimation of the number of unidentified p.S13F carriers is several hundreds, taking into a...",159,165,Neth_Heart_J_2012_May_4_20(5)_219-228.txt
p.S115S,...ome sequencing analysis [114]. A silent mutation (p.S115S) in the ATP6AP2 gene has been identified i...,289,187,Neurogenetics_2015_May_16_16_245-263.txt
p.L444P,"...297G>T (p.V394L), c.1342G>C (p.D409H), c.1448T>C (p.L444P), c.1504C>T (p.R463C), and c.1604G>A (p.R4...",342,701,Neurol_Genet_2016_Feb_25_2(2)_e55.txt
p.Met694Ile,"...694V (p.Met694Val, c.2080A>G, rs61752717), M694I (p.Met694Ile, c.2082G>A, rs28940578), M680I (p.Met6...",22,607,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Met680Ile,"...694I (p.Met694Ile, c.2082G>A, rs28940578), M680I (p.Met680Ile, c.2040G>C, rs28940580), V726A (p.Val7...",22,651,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Arg761His,"...726A (p.Val726Ala, c.2177T>C, rs28940579), R761H (p.Arg761His, c.2282G>A, rs104895097), and K695R (p...",22,739,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Arg761His,"...726A (p.Val726Ala, c.2177T>C, rs28940579), R761H (p.Arg761His, c.2282G>A, rs104895097), and K695R (p...",22,739,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.Pro369Ser,"...95Arg, c.2084A>G, rs104895094) in exon 10; P369S (p.Pro369Ser, c.1105C>T, rs11466023) in exon 3; and...",22,844,Neuropsychiatr_Dis_Treat_2016_Aug_29_12_2225-2232.txt
p.G12S,...)	Reg Ascending LN & metachr Liver: KRAS c.34G>A (p.G12S)	None,36,107,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,...)	Reg Ascending LN & metachr Liver: KRAS c.34G>A (p.G12S)	None,36,107,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,...)	Reg Ascending LN & metachr Liver: KRAS c.34G>A (p.G12S)	None,36,107,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"L (desc)	2,5 cm	T3	Not tested	KRAS c.35G>A (p.G12D)",37,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"2	74	M	NS	5,8 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Paraaortic LN & metachr Brain & metachr Lu...",38,43,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"5	79	M	L (desc)	3,5 cm	T3	No loss	KRAS c.35G>A (p.G12D)	Synchr lung WT	Prostate Cancer",44,49,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,"8	69	M	L (desc)	5,5 cm	T3	NA	NRAS c.182A>T (p.Q61L)	Reg LN & synchr liver WT	None",50,45,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,"...(p.G12V) in KRAS codon 12, and 1 case of c.34G>A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G...",57,390,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G13D,"...A (p.G12S). A KRAS mutation in codon 13 (c.38G>A [p.G13D]) was observed in 1 patient, and a NRAS mut...",57,437,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12D,"... 1) harbored a mutation in KRAS codon 12 c.35G>A (p.G12D) and c.34G>A (p.G12S), respectively. Of the...",59,430,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.G12S,...N and liver metastases had the same KRAS c.34G>A (p.G12S) mutation. See Table 1 for RAS mutational d...,61,520,Oncoscience_2015_Feb_9_2(2)_125-130.txt
p.Q61L,"...or model. We could confirm a previously described p.Q61L mutation of the NRAS gene in IPC-298 cells,...",100,210,Oncotarget_2015_May_22_6(19)_17178-17191.txt
p.D594G,† 4 p.V600E and 2 p.D594G mutations,65,19,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.D594G,† 4 p.V600E and 2 p.D594G mutations,65,19,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.Y177Ter, 131	p.Y177Ter (c.531T > G)		6,74,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.R233Ter, 133	p.R233Ter (c.697C > T)		7,75,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.A126T, 181	p.A126T (c.376G > A)		5,76,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.T319Ter, 48	p.T319Ter (c.954_957del)	delTACT of (TACT)2	8,78,5,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.L325R, 218	p.L325R (c.974T > G)		8,80,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.I122N, 264	p.I122N (c.365T > A)		5,83,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.I122N, 264	p.I122N (c.365T > A)		5,83,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.R130Q, 264	p.R130Q (c.359G > A),84,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.N323Mfs, 264	p.N323Mfs*21 (c.968delA)	delA of (A)6	8,85,6,Oncotarget_2015_Oct_16_6(39)_42334-42344.txt
p.S241F,...tions identified in TP53 p.R282W in patient 6 and p.S241F in patient 2 in primary sub-sites and meta...,30,96,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"...(Figure 2). Interestingly, another TP53 mutation, p.Y236C separated by 45 bases from p.I251N, was un...",30,444,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...m TP53 fragments spanning the amino acid residues p.I251N and p.Y236C were carried out. We observed ...,30,611,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...in p.Y236C. Tumor B had 59.23% alterations in the p.I251N residue and no alteration in p.Y236C. Thus...,33,393,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,...in p.Y236C. Tumor B had 59.23% alterations in the p.I251N residue and no alteration in p.Y236C. Thus...,33,393,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.I251N,"... and no alteration in p.Y236C. Thus, mutations in p.I251N and p.Y236C residues emerged independently...",33,458,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.Y236C,"...ration in p.Y236C. Thus, mutations in p.I251N and p.Y236C residues emerged independently at differen...",33,470,Oncotarget_2016_Mar_28_7(19)_27185-27198.txt
p.A934P,"...tinguishable from acrocallosal syndrome who has a p.A934P GLI3 mutation [21]. Second, patients with ...",57,949,Orphanet_J_Rare_Dis_2008_Apr_24_3_10.txt
p.R184W,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,11,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.R184W,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,11,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.A176T,c.550C>T (p.R184W)	c.526G>A (p.A176T,167,30,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
p.Ser298Pro,... A Steglich C Muhlhausen C Ullrich K The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is ass...,125,71,Orphanet_J_Rare_Dis_2011_Jun_20_6_43.txt
p.Lys62X,...lly always double heterozygous mutations) and the p.Lys62X/p.Cys84fs mutation is present in two-thir...,260,453,Orphanet_J_Rare_Dis_2011_May_19_6_26.txt
p.V382M,"...igase (Invitrogen Corporation, Carlsbad, CA). The p.V382M mutation was generated by site-directed mu...",60,453,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1295X,"c.3883C > T	18	p.R1295X	+	1	Dreyer et al., 2000",74,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,"c.4474G > T	21	p.E1492X	+	2	Bernal et al., 2005",76,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3587X,"c.10759C > T	55	p.Q3587X	+	2	Baux et al., 2007",86,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3587X,"c.10759C > T	55	p.Q3587X	+	2	Baux et al., 2007",86,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3716X,c.11146C > T	57	p.Q3716X	+	1	Present study,88,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3716X,c.11146C > T	57	p.Q3716X	+	1	Present study,88,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y4031X,c.12093delC	62	p.Y4031X	+	1	Present study,118,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y4031X,c.12093delC	62	p.Y4031X	+	1	Present study,118,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V230M,"c.688G > A	4	p.V230M	-	3	Dreyer et al., 2000",148,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L555V,"c.1663C > G	10	p.L555V	-	2	Bernal et al., 2003",156,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.D644V,"c.1931A > T	11	p.D644V	-	6	Weston et al., 2000",158,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.D644V,"c.1931A > T	11	p.D644V	-	6	Weston et al., 2000",158,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L1572F,"c.4714C > T	22	p.L1572F	-	7	Dreyer et al., 2008",168,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I1665T,"c.4994T > C	25	p.I1665T	-	31	Kaiserman et al., 2007",170,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.I2106T,"c.6317T > C	32	p.I2106T	-	117	Aller et al., 2006",174,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V2562A,"c.7685T > C	41	p.V2562A	-	1	Dreyer et al., 2008",190,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L2886F,"c.8656C > T	43	p.L2886F	-	9	Aller et al., 2006",196,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L2886F,"c.8656C > T	43	p.L2886F	-	9	Aller et al., 2006",196,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.L2886F,"c.8656C > T	43	p.L2886F	-	9	Aller et al., 2006",196,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3099S,"c.9296A > G	47	p.N3099S	-	12	Aller et al., 2006",200,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T3115A,"c.9343A > G	47	p.T3115A	-	9	Dreyer et al., 2008",202,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3199D,"c.9595A > G	49	p.N3199D	-	9	Baux et al., 2007",206,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E3411A,"c.10232A > C	52	p.E3411A	-	94	Aller et al., 2006",212,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,c.10636G > A	54	p.G3546R	+	4	Present Study,214,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R4848Q,"c.14543G > A	66	p.R4848Q	-	1	McGee et al., 2010",232,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R4848Q,"c.14543G > A	66	p.R4848Q	-	1	McGee et al., 2010",232,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R303H,e p.R303H and p.Y1992C were initially described as b...,247,3,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T168T,"c.504A > G	3	p.T168T	-	75	Baux et al., 2008",254,14,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N1315N,c.3945T > C	18	p.N1315N	UV2	3	Present Study,264,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N1315N,c.3945T > C	18	p.N1315N	UV2	3	Present Study,264,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S1457S,"c.4371G > A	20	p.S1457S	-	1	Dreyer et al., 2000",266,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P2502P,"c.7506G > A	40	p.P2502P	-	11	McGee et al., 2010",274,16,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P3969P,"c.11907A > T	61	p.P3969P	-	2	Dreyer et al., 2008",278,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T4204T,"c.12612A > G	63	p.T4204T	-	129	Dreyer et al., 2008",284,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T4222T,"c.12666A > G	63	p.T4222T	-	58	Dreyer et al., 2008",286,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4397E,"c.13191G > A	63	p.E4397E	-	23	Dreyer et al., 2008",288,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4397E,"c.13191G > A	63	p.E4397E	-	23	Dreyer et al., 2008",288,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.A4827A,"c.14481C > T	66	p.A4827A	-	1	McGee et al., 2010",290,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.T4888T,c.14664G > A	67	p.T4888T	UV2	1	Present Study,292,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,RP1274*	p.E1492X/p.E1492X	1969	USH2		Moderate-severe and stable	Nor...,308,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E1492X,RP1633	p.E1492X/p.E1492X	1962	USH2	25	Since infancy	NormalA	25	25	...,310,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,RP1607	p.G3546R/p.G3546R	1925	USH2	33	Mild-moderate	Norma...,312,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G3546R,RP1607	p.G3546R/p.G3546R	1925	USH2	33	Mild-moderate	NormalA	16	25	...,312,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R303H,RP1775	c.2299delG/p.R303H#	1961	USHA	30	Moderate since 7 years and p...,326,19,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3251X,"RP951	c.1214delA/p.C3251X	1969	USH2	25	Congenital, severe and stabl...",340,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3251X,"RP951	c.1214delA/p.C3251X	1969	USH2	25	Congenital, severe and stabl...",340,18,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R1549X,RP1558	p.R1549X/c.1328 + 1G > T	1933	USH2	43	Severe and p...,342,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.W4725X,RP1641*	p.C759F/p.W4725X	1967	USHA		Moderate and progressive	Centr...,348,17,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,RP690M*	p.P4818L/p.Q3368X + c.5278delG	1972	USH2	22	Congen...,352,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y506X,RP532	p.Y506X/p.Q3587X	1968	USH2		Profound	NormalA	15	20...,354,7,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3587X,RP946*	p.Q3587X/p.E2496E	1982	USHNC	17,356,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,RP1613	c.9260delT/p.G44R	1971	USH2	30	Severe	NormalA	20	20	Marked co...,358,19,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S841Y,"...sified as possibly non-pathologic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E...",426,84,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.S841Y,"...sified as possibly non-pathologic (UV2). p.G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E...",426,84,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.K5026E,"....G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been reported in other works...",426,126,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.K5026E,"....G713R, p.S841Y, p.S2196T, p.S2639P, p.G4692R and p.K5026E have already been reported in other works...",426,126,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N2377S,"...umc.nl/LOVD2/Usher_montpellier, [35]]. Meanwhile, p.N2377S, p.N2394K and p.E4921K have not been desc...",426,317,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,"...pellier, [35]]. Meanwhile, p.N2377S, p.N2394K and p.E4921K have not been described previously, so th...",426,340,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,"...pellier, [35]]. Meanwhile, p.N2377S, p.N2394K and p.E4921K have not been described previously, so th...",426,340,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G44R,p.G44R	Affect (Score 0.01)	Probably damaging	Patho...,431,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E4921K,p.E4921K	Tolerated (Score 0.85)	Benign	Neutral (NN...,441,1,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.R303H,...sified as possibly-pathogenic (UV3). The variants p.R303H and p.Y1992C were described previously [ht...,448,83,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Y1992C,...ssibly-pathogenic (UV3). The variants p.R303H and p.Y1992C were described previously [https://grenad...,448,95,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.N3894D,".../LOVD2/Usher_montpellier, [35]]. The novel change p.N3894D was not found in 200 control alleles and ...",448,204,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,Figure 1 In vitro splicing assays for p.E2496E and p.V382M mutations. Gel electrophoresi...,450,39,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,...igure 1 In vitro splicing assays for p.E2496E and p.V382M mutations. Gel electrophoresis shows the d...,450,52,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,"...s compared to the full-length transcript. For the p.E2496E mutation, an evident increase of band b (...",450,371,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,"...s compared to the full-length transcript. For the p.E2496E mutation, an evident increase of band b (...",450,371,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...//grenada.lumc.nl/LOVD2/Usher_montpellier, [35]]. p.C3358Y and p.P4818L were classified by McGee et ...",452,195,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...//grenada.lumc.nl/LOVD2/Usher_montpellier, [35]]. p.C3358Y and p.P4818L were classified by McGee et ...",452,195,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...-pathogenic (UV3). However, in the present study, p.C3358Y was detected in a patient together with a...",452,346,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...-pathogenic (UV3). However, in the present study, p.C3358Y was detected in a patient together with a...",452,346,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3358Y,"...-pathogenic (UV3). However, in the present study, p.C3358Y was detected in a patient together with a...",452,346,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.C3267R,... patient together with another nucleotide change (p.C3267R) and the segregation analysis confirmed t...,452,422,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3368X,...directly or indirectly cause a truncated protein (p.Q3368X and c.5278delG). The segregation analysis...,452,643,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.Q3368X,...directly or indirectly cause a truncated protein (p.Q3368X and c.5278delG). The segregation analysis...,452,643,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,"...lyses support the damaging effect of p.C3358Y and p.P4818L, so we have considered them as pathogenic...",452,913,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.P4818L,"...lyses support the damaging effect of p.C3358Y and p.P4818L, so we have considered them as pathogenic...",452,913,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.E2496E,... three were novel (See Table 3). Only the variant p.E2496E was categorized as pathogenic. It was not...,455,195,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.V382M,"...as pathogenic. On the other hand, the presence of p.V382M revealed a mild increase of the transcript...",465,831,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
p.G162D,I.1	He	c.485 G > A	p.G162D	4	SRCR	Le Quintrec M. et al. 2008 [17],71,20,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.G162D,I.1	He	c.485 G > A	p.G162D	4	SRCR	Le Quintrec M. et al. 2008 [17],71,20,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.A258T,"II.1, II.2, II.3	Ho He	c.772 G > A	p.A258T	5	LDLRA2	Vyse et al. 1996 [18]",73,36,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.V537Vfs,"IV.1, IV.2, IV.4	He	c.1610_1611insAT	p.V537Vfs*2	13	SP	Not described",76,38,Orphanet_J_Rare_Dis_2012_Jun_18_7_42.txt
p.Arg272Gln,...ly162Ser) and exon 6 (rs201231713; g.30099890C>T; p.Arg272Gln) were found in a higher frequency in p...,83,230,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Gly162Ser,p.Gly162Ser	 	 	GA: 12 (10.7%)	GA: 8 (4%),96,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Cys4Ser,"...ne patient had a missense variant (g.35295505G>C; p.Cys4Ser) in exon 1, three patients had the same ...",124,209,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Cys4Ser,"... found in five MA patients. A) The g.35295505G>C (p.Cys4Ser) variant in control and patient 223, B) ...",126,147,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Pro312His,"...in control and patient 223, B) the g.35300142C>A (p.Pro312His) in control and patients 162, 237, and...",126,216,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Cys4Ser,p.Cys4Ser	 	 	GC: 1 (0.9%)	GC: 0 (0%),133,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Pro312His,p.Pro312His	 	 	CA: 3 (2.7%)	CA: 0 (0%),136,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Pro312His,p.Pro312His	 	 	CA: 3 (2.7%)	CA: 0 (0%),136,1,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
p.Arg371Cys,...nt. A missense mutation [NM_006517.4:c.1111C > T; p.Arg371Cys] in exon 4 of the SLC16A2 gene was ide...,62,672,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G833R,...ation t(X;12) (q24;q15)	Deletion	Missense variant p.G833R	Missense variant p.R631S	Missense variant ...,118,74,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.M706T,...p.G833R	Missense variant p.R631S	Missense variant p.M706T	Missense variant p.R450Q	Partial duplicati...,118,124,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.M706T,...p.G833R	Missense variant p.R631S	Missense variant p.M706T	Missense variant p.R450Q	Partial duplicati...,118,124,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.M706T,...p.G833R	Missense variant p.R631S	Missense variant p.M706T	Missense variant p.R450Q	Partial duplicati...,118,124,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G630R,...IA3	Partial duplication of GRIA3	Missense variant p.G630R	Missense variant p.G630R	Missense variant ...,118,232,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.G630R,...IA3	Partial duplication of GRIA3	Missense variant p.G630R	Missense variant p.G630R	Missense variant ...,118,232,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg441Trp,...ution of the amino acid arginine with tryptophan (p.Arg441Trp) and was absent in 100 Finnish anonymo...,219,462,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Gly293Ser,...n exon 6 of the SYP gene [NM_003179.2:c.877G > A; p.Gly293Ser]. This missense variant was found in a...,231,139,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg445Cys,...uld speak some words. Based on the available data p.Arg445Cys mutation seems to be associated with v...,246,333,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg445Cys,...uld speak some words. Based on the available data p.Arg445Cys mutation seems to be associated with v...,246,333,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Met706Thr,"...bled, whereas one patient with a missense change (p.Met706Thr) had mild I",253,553,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg441Trp,The missense mutation c.1321C > T (p.Arg441Trp) (RefSeq NM_201599.2) is the first var...,264,36,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg441Trp,The missense mutation c.1321C > T (p.Arg441Trp) (RefSeq NM_201599.2) is the first var...,264,36,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg441Trp,The missense mutation c.1321C > T (p.Arg441Trp) (RefSeq NM_201599.2) is the first var...,264,36,Orphanet_J_Rare_Dis_2014_Apr_11_9_49.txt
p.Arg2068His,...tions have been found in 3 patients with PCD. The p.Arg2068His and p.Trp3238Arg mutations are theref...,268,1112,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.Trp3238Arg,...ound in 3 patients with PCD. The p.Arg2068His and p.Trp3238Arg mutations are therefore very likely t...,268,1129,Orphanet_J_Rare_Dis_2014_Jan_22_9_11.txt
p.E191K,"...homozygous DHCR24 mutation (NM_014762.3:c.571G>A; p.E191K), a recognized cause of desmosterolosis (A...",26,121,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
p.G205S,"1	CHILD syndrome	NSDHL: c.613G>A, p.G205S (heterozygous)	Yes",34,35,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.R88X,"3	CHILD syndrome	NSDHL: c.262C>T, p.R88X (heterozygous)	Yes",40,35,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.A176D,...recessive congenital ichthyosis	NIPAL4: c.527C>A; p.A176D (homozygous)	No,46,63,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.A176D,"...due to the homozygous NIPAL4 mutation c.527C > A; p.A176D was treated. Ichthyin, the polypeptide enc...",64,690,Orphanet_J_Rare_Dis_2014_Mar_7_9_33.txt
p.Arg401Pro,...e region on chromosome 20: The variant c.1202G>C (p.Arg401Pro) in GTPBP5 affects an evolutionarily n...,117,131,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Thr580Pro,"...h an MAF of 0.04%. A variant in DIDO1 (c.1738A>C; p.Thr580Pro), also affects a non-conserved residue...",117,310,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,"...ls of the family (II:5, III:10, IV:13). Moreover, p.Ser96*SLC17A9 was also present in heterozygous s...",119,445,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,...ndividuals from our DFNA67 family who carried the p.Ser96*SLC17A9 mutation had any skin abnormalitie...,141,568,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,...ndividuals from our DFNA67 family who carried the p.Ser96*SLC17A9 mutation had any skin abnormalitie...,141,568,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,...ndividuals from our DFNA67 family who carried the p.Ser96*SLC17A9 mutation had any skin abnormalitie...,141,568,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Ser96*,...ndividuals from our DFNA67 family who carried the p.Ser96*SLC17A9 mutation had any skin abnormalitie...,141,568,Orphanet_J_Rare_Dis_2015_Feb_10_10_15.txt
p.Gln1432*,"18		37,3	3	1	c.4294C>T heterozygous	p.Gln1432",64,37,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gln1432*,"18		37,3	3	1	c.4294C>T heterozygous	p.Gln1432",64,37,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1526*,"21		18,0			c.4576G>T heterozygous	p.Gly1526",68,35,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Gly1896Arg,"28,9	3	1	c.5686G>A heterozygous paternal	p.Gly1896Arg/Splice	Splice site mutation",78,43,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Glu82Val,...vicinity additional pathogenic missense mutations p.Glu82Val and p.Met102Val have been described pre...,149,585,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Glu82Val,...vicinity additional pathogenic missense mutations p.Glu82Val and p.Met102Val have been described pre...,149,585,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Met102Val,"...onal pathogenic missense mutations p.Glu82Val and p.Met102Val have been described previously [21, 22...",149,600,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Val2572Ile,.... For the other patient with the missense variant p.Val2572Ile no parental samples were available. I...,149,701,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
p.Arg329His,(NM_001605.2)	3	c.986G>A	p.Arg329His,141,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Thr994Ile,(NM_000052.6)	1	c.2981C>T	p.Thr994Ile,144,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn88Ser,(NM_032667.6)	2	c.263 A>G	p.Asn88Ser,147,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn88Ser,(NM_032667.6)	2	c.263 A>G	p.Asn88Ser,147,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn88Ser,(NM_032667.6)	2	c.263 A>G	p.Asn88Ser,147,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu90Ser,(NM_032667.6)	1	c.269 C>T	p.Leu90Ser,150,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asp411Asn,(NM_000399.3)	1	c.1231G>A	p.Asp411Asn,159,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg373Cys,(NM_006329.3)	1	c.1117C>T	p.Arg373Cys,162,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ile71Thr,(NM_000166.5)	1	c.212T>C	p.Ile71Thr,183,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg7Ser,(NM_006308.2)	1	c.21G>T	p.Arg7Ser,195,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Leu128Pro,(NM_022489.3)	1	c.383T>C	p.Leu128Pro,198,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly112Ser,(NM_001136472.1)	1	c.334G>A	p.Gly112Ser,207,30,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Met234Lys,(NM_014874.3)	1	c.701T>A	p.Met234Lys,219,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg280His,(NM_014874.3)	1	c.839G>A	p.Arg280His,222,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn525Ser,(NM_014874.3)	1	c.1574A>G	p.Asn525Ser,234,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Cys42Arg,(NM_153322.1)	1	c.124T>C	p.Cys42Arg,246,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly382Arg,(NM_004863.3)	1	c.1144G>C	p.Gly382Arg,270,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg186Gln,(NM_021625.4)	1	c.557G>A	p.Arg186Gln,273,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Arg598Cys,A mutation p.Arg598Cys (c.1792 C>T) in DYNC1H1 gene was found...,297,12,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Pro168Leu,(NM_001605.2)	c.503 C>T	p.Pro168Leu	SIFT:,320,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Asn73Ser,(NM_001142386.2)	c.218A>G	p.Asn73Ser	SIFT:,366,28,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Ile1942Thr,(NM_015046.5)	c.5825T>C	p.Ile1942Thr	SIFT:,371,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Cys438Leu,(NM_004863.3)	c.1313del	p.Cys438Leu fs*5	frameshift		No,377,26,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
p.Gly694Glu,...r was heterozygous for the p.Thr330 deletion. The p.Gly694Glu variant was not present in the mother;...,33,1125,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly608Glu,...loured according to their atom type. p.Asp608 and p.Gly608Glu are located at the subunit interface a...,37,873,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.Gly694Glu,...to a lesser extent compared to the p.Asp608del or p.Gly694Glu variants. The p.Thr330del variant was ...,43,364,Orphanet_J_Rare_Dis_2016_Sep_29_11_130.txt
p.R150C,...cci syndrome) is not caused by the PTHR1 mutation p.R150C Hum Mutat 2004 24 466 73 15523647,55,141,Orthop_Rev_(Pavia)_2012_May_29_4(2)_e16.txt
p.L227X,...the haplotype inherited from the grandmother. The p.L227X mutation-associated haplotype was found on...,15,702,Pediatr_Rheumatol_Online_J_2013_Nov_8_11(Suppl_1)_A184.txt
p.V1316A,...ort a case of a severe phenotype of IEM caused by p.V1316A mutation in the Nav1.7 channel. Mechanist...,35,671,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...3020) [6–13]. Recently, two sporadic cases of the p.V1316A (located in the DIII/S4–5 linker) mutatio...",46,725,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...3020) [6–13]. Recently, two sporadic cases of the p.V1316A (located in the DIII/S4–5 linker) mutatio...",46,725,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.I848T,"...the S4–S5 linker in each domain, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and ...",48,898,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.L858F,"...n each domain, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations...",48,916,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.L858H,"...main, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Ac...",48,925,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.L858H,"...main, such as p.I234T, p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Ac...",48,925,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...p.I848T, p.G856D, p.L858F, p.L858H, p.P1308L, and p.V1316A mutations [11]. Accordingly, these mutati...",48,948,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...15]. Genetic analysis showed a missense mutation (p.V1316A) of human Nav1.7 (SCN9A) gene. The excruc...,52,203,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,Larger Sustained Na+ Currents in the p.V1316A Mutant than in the WT Channe,66,38,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...hannel. The activation and inactivation curves of p.V1316A mutant channel are negatively and positiv...,67,136,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...he mutation (Fig 4B). These results indicate that p.V1316A mutant channel can be more activated but ...,67,391,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...the open state) or both. Fig 4E shows that in the p.V1316A mutant channel, the decay of transient cu...",67,1228,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...10 mV pulse following the prepulse) curves of the p.V1316A mutant channel in the presence of the Nav...,70,212,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...gle Boltzmann fits to the mean values are for the p.V1316A mutant channel: Vh and k are ~–30.7 mV an...,70,911,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...nnels (n = 15 for the WT channels; n = 12 for the p.V1316A mutant channels). The ratio between the s...,70,1372,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...in the same sweep) is significantly larger in the p.V1316A mutant channel with depolarization potent...,70,1510,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...t currents indeed are significantly larger in the p.V1316A mutant channel than in the WT channel in ...,73,871,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...t currents indeed are significantly larger in the p.V1316A mutant channel than in the WT channel in ...,73,871,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...hese results suggest that DIII/S4–5 linker, where p.V1316A mutation is located, may play a critical ...",73,1007,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e of the Navβ4 peptide. (B) Sample sweeps for the p.V1316A mutant channel in the presence of 0.1 mM ...,76,281,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...om experiments described in part A for the WT and p.V1316A mutant channels (each n = 10). The ratio ...,76,473,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...in the same sweep) is significantly larger in the p.V1316A mutant than WT channels at repolarization...,76,623,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...activation curve of resurgent Na+ currents in the p.V1316A mutant channel is obtained with the same ...,79,1215,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...activation curve of resurgent Na+ currents in the p.V1316A mutant channel is obtained with the same ...,79,1215,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...the activation curve of transient currents in the p.V1316A mutant channels) and 21.70±1.14 (n = 10; ...,79,1831,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...the activation curve of transient currents in the p.V1316A mutant channels), respectively. Single Bo...",79,1947,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...the activation curve of transient currents in the p.V1316A mutant channels), respectively. Single Bo...",79,1947,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... Single Boltzmann fits to the mean values are for p.V1316A mutant channel: Vh = ~59.5 mV and k = ~21...,79,2037,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...n curves of resurgent Na+ currents in both WT and p.V1316A mutant channels are markedly shifted to t...,79,2165,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...the activation curve of resurgent currents in the p.V1316A mutant channel is very similar to or even...,82,1343,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...d Decay Kinetics of the Resurgent Currents in the p.V1316A Mutant Channe,84,83,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the kinetics of resurgent currents caused by the p.V1316A mutation (Fig 7A and 7B). The kinetics of...,85,112,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...resurgent currents is significantly longer in the p.V1316A mutant than in the WT channel (Fig 7B and...,85,360,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ated by membrane hyperpolarization in both WT and p.V1316A mutant channels. Interestingly, the kinet...",85,1042,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...or the resurgent currents remain unchanged by the p.V1316A mutation (see Discussion),85,1733,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...~+160 mV for ~10 ms in 20 mV increment for WT and p.V1316A mutant channels. Note that the inverse de...,88,259,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...time to peak of the resurgent Na+ currents in the p.V1316A mutant channel is always slower than that...,88,538,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...time to peak of the resurgent Na+ currents in the p.V1316A mutant channel is always slower than that...,88,538,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the voltage of the resurgent pulse in the WT and p.V1316A mutant channels (each n = 10). Note trend...,88,933,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the voltage of the resurgent pulse in the WT and p.V1316A mutant channels (each n = 10). Note trend...,88,933,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...for ~20 ms (the deactivation pulse) in the WT and p.V1316A mutant channels. The tail currents show f...,88,2002,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...for ~20 ms (the deactivation pulse) in the WT and p.V1316A mutant channels. The tail currents show f...,88,2002,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...for ~20 ms (the deactivation pulse) in the WT and p.V1316A mutant channels. The tail currents show f...,88,2002,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...nst voltage in semi-logarithmic scales for WT and p.V1316A mutant channels (n = 10). The lines are l...,88,2416,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...nst voltage in semi-logarithmic scales for WT and p.V1316A mutant channels (n = 10). The lines are l...,88,2416,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,... the tail currents are very similar in the WT and p.V1316A mutant channels. Individual data is shown...,88,2796,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...surgent currents are quite the same in the WT and p.V1316A mutant channels, although the absolute sp...",91,993,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...surgent currents are quite the same in the WT and p.V1316A mutant channels, although the absolute sp...",91,993,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...bsolute speed of decay is ~2–3-fold slower in the p.V1316A mutant than in the WT channel (Fig 8C and...,91,1083,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nd 0.31 for +60 mV prepulse, respectively, in the p.V1316A mutant channel (each n = 7). (C) The inve...",94,1083,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nd 0.31 for +60 mV prepulse, respectively, in the p.V1316A mutant channel (each n = 7). (C) The inve...",94,1083,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...l, and 1/tau(V) = 0.07×exp(–0.8V/25) ms–1 for the p.V1316A mutant channel, respectively, where V is ...",94,1384,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...l, and 1/tau(V) = 0.07×exp(–0.8V/25) ms–1 for the p.V1316A mutant channel, respectively, where V is ...",94,1384,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...e is no significant difference between the WT and p.V1316A mutant channels at each voltage (n = 7; N...,94,1712,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...addition of Navβ4 peptide (Fig 2B and 2C). In the p.V1316A mutant channel, the addition of Navβ4 pep...",98,622,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...II and IV) of the homology model of WT Nav1.7 and p.V1316A mutant channels are shown in the ribbon p...,101,3777,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ue distances (from side chain tip to tip) between p.V1316A and L1610, and p.V1316A and R1611 are ~11...",101,4310,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...(tip to tip) distances between residues V1316 (or p.V1316A) and L1610, R1611, V1722, and G1723 in th...",101,4505,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...(tip to tip) distances between residues V1316 (or p.V1316A) and L1610, R1611, V1722, and G1723 in th...",101,4505,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...T channels, the main gating changes caused by the p.V1316A mutation include larger rate constants fo...",104,706,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...T channels, the main gating changes caused by the p.V1316A mutation include larger rate constants fo...",104,706,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nd 0.54 for +60 mV prepulse, respectively, in the p.V1316A mutant channel. (E) The inverses of time ...",104,1605,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"..., and 1/tau(V) = 0.17×exp(–1.03V/25) ms–1 for the p.V1316A mutant channel, respectively, where V is ...",104,1894,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...thout Navβ4 peptide	WT channel with Navβ4 peptide	p.V1316A mutant channel with Navβ4 peptide,107,65,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,The p.V1316A mutant Nav1.7 channel is characterized by...,129,5,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...n effective promotion of repetitive discharges by p.V1316A mutation in different firing patterns (e....,129,457,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...omology modeling of Nav1.7 channel shows that the p.V1316A mutation may increase the inter-residue d...,129,2334,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...omology modeling of Nav1.7 channel shows that the p.V1316A mutation may increase the inter-residue d...,129,2334,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...y that the conformational changes associated with p.V1316A mutation may well involve the pivotal poi...,129,2748,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... [40–42]. In this study, we demonstrated that the p.V1316A mutation, which causes very prominent and...",132,671,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... [40–42]. In this study, we demonstrated that the p.V1316A mutation, which causes very prominent and...",132,671,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...r fluorescent microscope (Nikon, Inc. Japan). The p.V1316A mutation was made using Quikchange site-d...",139,263,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...r fluorescent microscope (Nikon, Inc. Japan). The p.V1316A mutation was made using Quikchange site-d...",139,263,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"... in presence or absence of the Navβ4 peptide, and p.V1316A mutant channels in presence of Navβ4 pept...",154,285,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...gs, simulated sustained currents are increased in p.V1316A mutant channels. (B) The kinetics of the ...",166,239,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nnel, and 1/tau(V) = 0.003×exp(–2.0V/25) ms-1 for p.V1316A mutant channel, respectively, where V is ...",166,548,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...nnel, and 1/tau(V) = 0.003×exp(–2.0V/25) ms-1 for p.V1316A mutant channel, respectively, where V is ...",166,548,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...(D) The activation and inactivation curves in the p.V1316A mutant channels are simulated with the sa...,166,1617,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,S2 Fig The homology modeling for the WT and p.V1316A mutant Nav1.7 channels based on the X-ray...,172,46,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,S2 Fig The homology modeling for the WT and p.V1316A mutant Nav1.7 channels based on the X-ray...,172,46,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,...II and IV) of the homology model of WT Nav1.7 and p.V1316A mutant channels are in the ribbon present...,173,87,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...ue distances (from side chain tip to tip) between p.V1316A and V1722, and p.V1316A and G1723 are ~6....",173,609,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.V1316A,"...G1723 are ~6.4 Å, and ~6.9 Å, respectively in the p.V1316A mutant channel. Individual data is shown ...",173,696,PLoS_Biol_2016_Sep_21_14(9)_e1002561.txt
p.Arg760*,"...s the G2/M checkpoint defect in CV1720 cells, and p.Arg760*ATRIP impairs ATR–ATRIP protein interacti...",175,155,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Met1159Ile,"...). This change causes an amino acid substitution, p.Met1159Ile, which lies within a conserved UME (N...",184,916,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Met1159Ile,"...both patients causing an amino acid substitution, p.Met1159Ile, which lies within a conserved UME (N...",275,261,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Met1159Ile,"...both patients causing an amino acid substitution, p.Met1159Ile, which lies within a conserved UME (N...",275,261,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
p.Gly1890Glu,"...es unavailable) harbored variant (T2587c.5669G>A, p.Gly1890Glu) a rare missense variant. Both mutati...",131,511,PLoS_Genet_2015_Mar_12_11(3)_e1005022.txt
p.Gly204Ser,... syndrome [32]. Two affected individuals with the p.Gly204Ser amino acid substitution in CRD of COLE...,27,920,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,The non-synonymous COLEC11 variant rs7567833G/A (p.R216H) in exon8 was observed more frequently amo...,65,50,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,The non-synonymous COLEC11 variant rs7567833G/A (p.R216H) in exon8 was observed more frequently amo...,65,50,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"..., 95%CI = 1.15–2.70, Pcorr = 0.007). COLEC11*TCCA-p.R216H, was observed more frequently among SELN c...",99,508,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...s (median values) with investigated rs7567833G/A (p.R216H) variant,142,123,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...s (median values) with investigated rs7567833G/A (p.R216H) variant,142,123,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...tic models for the contribution of the respective p.R216H genotypes. It has been hypothesized that t...,154,603,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,...tic models for the contribution of the respective p.R216H genotypes. It has been hypothesized that t...,154,603,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...n addition, this particular variant rs7567833G/A (p.R216H) was reported to be under selective pressu...",154,1015,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.R216H,"...n addition, this particular variant rs7567833G/A (p.R216H) was reported to be under selective pressu...",154,1015,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
p.Phe31Ile,...sense substitutions in STK15 and MMP3 (rs2273535 (p.Phe31Ile) and rs679620 (p.K45E) respectively) we...,15,1777,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,...sense substitutions in STK15 and MMP3 (rs2273535 (p.Phe31Ile) and rs679620 (p.K45E) respectively) we...,15,1777,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,"... not detect a significant association between the p.Phe31Ile variant and RCC, the patient and contro...",95,1387,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.Phe31Ile,"... not detect a significant association between the p.Phe31Ile variant and RCC, the patient and contro...",95,1387,PLoS_ONE_2009_Jun_24_4(6)_e6037.txt
p.S135L,"MVK (N = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G ...",110,47,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S135L,"MVK (N = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G ...",110,47,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S135L,"MVK (N = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G ...",110,47,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.S135S,"... = 19)	p.S52N(1)(2),c.371+8C>T(1)(2), p.S135L(1), p.S135S(1), p.D170D(1)(2),c.632−18A>G (1)(2), c.76...",110,59,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.G309S,"... (1)(2), c.769-7_769-6dupT(1)*,c.885+24G>A(1)(2), p.G309S(1), p.S329N(1), p.V377I(1)(2), p.R388X(1),...",110,146,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Y141Y,"NLRP3 (N = 23)	c.278−45T>C(1), p.Y141Y(1)*, p.R168Q(3), p.V198M(1), p.T219T(1), p...",111,34,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Q703K,"....L344L(1)(3), p.A439P(1), p.H463H(1), p.T587I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M...",111,165,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...7I(1), p.Q703K(1)(2), p.Y859C(1),c.3005+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)	...",111,208,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T436P,"...+25C>T(1), p.T348M(1), p.L411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = 1)	p.T348M artificial delet...",111,247,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = 1)	p.T348M artificial deletion (allele specific prime...",111,273,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = 1)	p.T348M artificial deletion (allele specific prime...",111,273,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...411L(3), p.S434S(1)(2), p.T436P(3)		NLRP3 (N = 1)	p.T348M artificial deletion (allele specific prime...",111,273,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C30R,"TNFRSF1A (N = 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54...",112,20,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C30R,"TNFRSF1A (N = 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54...",112,20,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.C30R,"TNFRSF1A (N = 7)	p.C30R(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54...",112,20,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.P46L,"...(1), p.C30F(1), p.C73W(1), p.H69fs(1), p.E54E(1), p.P46L(1), p.R92Q(1)		ITGB5 (N = 1)	Chr3q21.2dup		...",112,76,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,...ng for mental retardation); 2) One patient with a p.T348M (c.1043C>T) mutation in NLRP3 in whom we p...,146,335,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.T348M,"...I]+[G226S], and p.[T237S]+[T237S]; one with CAPS, p.T348M; and two with TRAPS, p.C70R and p.R92Q. Re...",152,414,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.R92Q,"...ith CAPS, p.T348M; and two with TRAPS, p.C70R and p.R92Q. Representative HRM difference plots are sh...",152,454,PLoS_One_2010_Nov_23_5(11)_e14096.txt
p.Arg274Trp,...ather (P1) [6]. The same STAT1 variant (c.820C>T; p.Arg274Trp) was detected in all three individuals...,20,221,PLoS_One_2011_Dec_14_6(12)_e29248.txt
p.G1069R,A. Mutation c.3293A>G (p.G1069R) in homozygous state in our proband and i...,24,24,PLoS_One_2011_Jun_9_6(6)_e20854.txt
p.Q1069R,"...bols, unaffected individuals; Mut/Mut, homozygous p.Q1069R mutation; Mut/WT, heterozygous Q1069R mut...",24,387,PLoS_One_2011_Jun_9_6(6)_e20854.txt
p.R2065S,"... of the protein containing the missense mutation, p.R2065S, was identified as highly conserved in va...",56,505,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.R2065S,"...he region containing the novel missense mutation, p.R2065S (indicated as an asterisk), is highly con...",164,263,PLoS_One_2011_Sep_13_6(9)_e24511.txt
p.Ile283Val,...Ser86Asn in NADH dehydrogenase 4) and m.13183A>G (p.Ile283Val in NADH dehydrogenase 5) confer resist...,147,1340,PLoS_One_2012_Aug_28_7(8)_e44128.txt
p.Pro253Arg,"...755C>G encoding p.Ser252Trp and c.758C>G encoding p.Pro253Arg, both causing Apert syndrome) and a mu...",26,450,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.Met918Thr,"...drome) and a mutation in RET (c.2943T>C, encoding p.Met918Thr and causing multiple endocrine neoplas...",26,535,PLoS_One_2012_Aug_6_7(8)_e42382.txt
p.E542K,(a) The heterozygous p.E542K (c.G1624A) PIK3CA hotspot mutation was det...,109,22,PLoS_One_2012_Feb_17_7(2)_e31255.txt
p.L1341P,...or our experimental design: DYSF p.G299R and DYSF p.L1341P. The consequences of these mutations at t...,18,100,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...or our experimental design: DYSF p.G299R and DYSF p.L1341P. The consequences of these mutations at t...,18,100,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...using an anti-dysferlin ab. (C) merge. (D–F) DYSF p.G299R-GFP tagged. Experiment performed 14×. (D) ...,21,415,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...r but not expressed at the sarcolemma. (G–I) DYSF p.L1341P-GFP tagged. Experiment performed 12×. (G)...,21,786,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...ed. (H) Peptide B2 (10-mer) corresponding to DYSF p.L1341P supports reallocation of dysferlin to the...,21,902,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...y human myotubes obtained from patients with DYSF p.G299R and DYSF p.L1341P. Missense mutated dysfer...,39,144,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...obtained from patients with DYSF p.G299R and DYSF p.L1341P. Missense mutated dysferlin accumulates w...,39,161,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ect. (A–C) Primary human myotubes expressing DYSF p.G299R. Experiment performed 9x. (A) No peptides ...,42,506,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...) Peptide A2 (10-mer) added corresponding to DYSF p.G299R. (C) Nonsense peptide added (control). (D–...,42,615,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... influx (FM1-43) in human myotubes harboring DYSF p.G299R or in normal human myotubes is shown at th...,48,66,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,"...µm boundary area of the plasma membrane. (A) DYSF p.G299R, no peptide. (B) DYSF p.G299R, nonsense pe...",48,289,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptide FM1-43 dye rapidly spreads within the DYSF p.G299R human myotubes. After treatment with speci...,48,551,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... normal and dysferlin-mutant human myotubes. DYSF p.L1341P myotubes, untreated and treated with TAT-...",50,209,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"...otubes. Peptide B2, which corresponds to the DYSF p.L1341P mutation, was fluorescently labeled with ...",56,174,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"...otubes. Peptide B2, which corresponds to the DYSF p.L1341P mutation, was fluorescently labeled with ...",56,174,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"...otubes. Peptide B2, which corresponds to the DYSF p.L1341P mutation, was fluorescently labeled with ...",56,174,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...t C2E domain of dysferlin that contained the DYSF p.L1341P mutation and the corresponding wildtype o...,56,845,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,Peptide B2 corresponding to DYSF p.L1341P was labeled with ATTO-495-ME fluorescent ...,59,34,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...TO-495-ME fluorescent dye (red) and added to DYSF p.L1341P human myotubes. (A) DYSF p.L1341P human m...,59,112,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,"... after addition of ATTO-495-ME-peptide B2 to DYSF p.L1341P human myotubes, (B) after 8 minutes and (...",59,230,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,ER Stress is Reduced by Treating DYSF p.G299R Expressing myotubes with TAT-Labeled Mutan...,61,39,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,(A) In DYSF p.G299R human myotubes HSPA5 gene expression is si...,65,13,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...ients with LGMD2B: DYSF c.855+1delG and c.895G>A; p.G299R; homozygosity for DYSF c.4022T>C; p.L1341P...,91,464,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...o wildtype dysferlin and dysferlin mutations DYSF p.G299R and DYSF p.L1341P 10 and 15mer peptides we...,94,66,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1431P,...o DYSF p.G299R and DYSF c.4022T>C leading to DYSF p.L1431P were cloned into the vector by site-direc...,97,261,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... with either missense-mutated dysferlin cDNA DYSF p.G299R (upper lane) or p.L1341P (lower lane). Tra...,131,183,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...bes carrying the dysferlin missense mutation DYSF p.G299R in (A) and immortalized human myotubes car...,137,128,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,...eptides. (A) In human myotubes harboring the DYSF p.G299R mutation specific peptides reduce the rela...,149,109,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... FM1-43 uptake after laser induced damage in DYSF p.G299R primary human myotubes. Corresponding pept...,173,60,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.G299R,... FM1-43 uptake after laser induced damage in DYSF p.G299R primary human myotubes. Corresponding pept...,173,60,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.L1341P,...d and TAT conjugated dysferlin-peptide B2 in DYSF p.L1341P primary human myotubes. Time lapse is ind...,203,98,PLoS_One_2012_Nov_20_7(11)_e49603.txt
p.A350V,"...enhanced Mg2+-efflux conducted by SLC41A1 variant p.A350V might result, in the long-term, in chronic...",7,1447,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...ve mainly examined the effect of the substitution p.A350V potentially related to PD on the performan...,23,71,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...3-(HA-strep-SLC41A1) and HEK293-(HA-strep-SLC41A1-p.A350V) were constructed in co-operation with Dua...,27,79,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,HEK293 cells inducibly over-expressing wt or the p.A350V variant were grown to approximately 80% co...,34,50,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...eins from HEK293 cell lines over-expressing wt or p.A350V according to the manufacturer's protocol. ...,43,167,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...rmination of the phosphorylation status of wt and p.A350V varian,48,55,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...and Western blot analysis of SLC41A1- and SLC41A1 p.A350V-protein complexe,51,79,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...and Western blot analysis of SLC41A1- and SLC41A1 p.A350V-protein complexe,51,79,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...and Western blot analysis of SLC41A1- and SLC41A1 p.A350V-protein complexe,51,79,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... goat serum. For detection of strep-tagged wt and p.A350V, we used a primary anti-strep antibody (di...",55,224,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...dent Mg2+ extrusion from induced SLC41A1 (wt) and p.A350V cells was determined from the [Mg2+]i chan...,60,401,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...dent Mg2+ extrusion from induced SLC41A1 (wt) and p.A350V cells was determined from the [Mg2+]i chan...,60,401,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"..., or dB-cAMP. Subsequently, per well, 5×105 wt or p.A350V cells were plated in a final volume of 100...",67,220,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in soluble and membrane-protein-enriched f...,75,1064,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...mbinant HA-strep-SLC41A1(wt) and HA-strep-SLC41A1-p.A350V in soluble and membrane-protein-enriched f...,75,1064,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...fractions isolated from +tet (24 h) cells. Wt and p.A350V were predominantly detected in membrane (M...,75,1704,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ith equal amounts of protein isolates from wt and p.A350V cells, we calculated that the density of p...",78,892,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,SLC41A1 p.A350V localizes within the cytoplasmic membran,80,9,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...tionation with HEK293 cells over-expressing wt or p.A350V (Fig. 1E). Probing of the electroseparated...,81,936,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...exa-488- and Alexa-647-specific signals in wt and p.A350V variants revealed a 94.5±1.8% (N = 6) and ...,81,1945,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...18%) and Western blot analysis of SLC41A1(wt) and p.A350V (M) complexes. Both wt and p.A350V variant...,92,54,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...18%) and Western blot analysis of SLC41A1(wt) and p.A350V (M) complexes. Both wt and p.A350V variant...,92,54,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...g2+ efflux [20]. The results for +tet wt and +tet p.A350V cells are summarized in figure 4 showing a...,104,150,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...g2+ efflux [20]. The results for +tet wt and +tet p.A350V cells are summarized in figure 4 showing a...,104,150,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...]i changes after resuspension of Mg2+-loaded +tet p.A350V cells and wt cells in completely Mg2+-free...,115,464,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...on; **P = 0.01. C: Original growth curves of +tet p.A350V cells and wt cells under control condition...,115,801,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ates of induced +tet flag-wt, strep-wt, and strep-p.A350V. Figure 6 demonstrates that the ∼56 kDa ba...",117,385,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,The 48-h growth curves of +tet p.A350V cells and wt cells obtained under control ...,125,32,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,The 48-h growth curves of +tet p.A350V cells and wt cells obtained under control ...,125,32,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...th +tet wt cells, the normalized CI (nCI) of +tet p.A350V cells was reduced (2.03±0.03 vs. 2.26±0.08...",125,235,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"...ylation status, or complex-forming ability of the p.A350V variant when compared with the wt protein....",132,396,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... protein. However, we have demonstrated that +tet p.A350V cells are able to perform Mg2+-efflux more...",132,487,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... with wt cells. The inability further to increase p.A350V-related NME function via cAMP also suggest...,137,841,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... block SLC41A1-related Mg2+ efflux in both wt and p.A350V cells. Increasing the extracellular Mg2+ c...,140,139,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,"... PD-associated coding variant of the NME SLC41A1, p.A350V. We have demonstrated that p.A350V is able...",145,423,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... indicate that the rare conservative substitution p.A350V is a gain-of-function mutation leading to ...,145,720,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,... indicate that the rare conservative substitution p.A350V is a gain-of-function mutation leading to ...,145,720,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.A350V,...p.A350V in -tet (24 h) cells. Strep-tagged wt and p.A350V were immunolabeled with primary mouse anti...,148,135,PLoS_One_2013_Aug_15_8(8)_e71096.txt
p.Tyr1957Ter,"...to identify a novel nonsense mutation of CACNA1A (p.Tyr1957Ter, NP_001120693.1) resulting in truncat...",7,849,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"... technology, we identified a nonsense mutation of p.Tyr1957Ter in CACNA1A. Sanger sequence confirmed...",62,590,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"...in is caused by “dominant negative effect” of the p.Tyr1957Ter. However, abdominal pain and episodic...",66,1403,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Tyr1957Ter,"In summary, a novel nonsense mutation of p.Tyr1957Ter in CACNA1A was identified in a four-g...",68,42,PLoS_One_2013_Feb_18_8(2)_e56362.txt
p.Lys2950Asn,... (DSS1) or pGEX-4T1 (BRCA2). The BRCA2 c.8850G>T (p.Lys2950Asn) variant was inserted by direct mutag...,38,272,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Cys64X,...form	r.[191_212del]	mono-allelic	stop at codon 64	p.Cys64X	5,92,98,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Gly1366Asp,...ne	r.[4097g>a]	bi-allelic	aa change at codon 1366	p.Gly1366Asp	2,96,73,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Asp1778Gly,...ne	r.[5333a>g]	bi-allelic	aa change at codon 1778	p.Asp1778Gly	2,99,74,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Pro3039Leu,...ne	r.[9116c>u]	bi-allelic	aa change at codon 3039	p.Pro3039Leu	2,103,75,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Lys2950Asn,...2 DBD wild-type and BRCA2 DBD carrying a variant (p.Lys2950Asn) classified as clinically neutral [7]...,144,505,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Asp1778Gly,...d 3 introduced missense changes (p.Gly1366Asp and p.Asp1778Gly in BRCA1 and p.Pro3039Leu in BRCA2). ...,183,105,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Pro3039Leu,...anges (p.Gly1366Asp and p.Asp1778Gly in BRCA1 and p.Pro3039Leu in BRCA2). For all the latter substit...,183,131,PLoS_One_2013_Feb_22_8(2)_e57173.txt
p.Thr498Ser,"...ing four novel mutations (p.Val145Phe, p.Glu388X, p.Thr498Ser and p.Gly837X) in the ATP7B gene were ...",7,1350,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"...revealed that founder effects for four mutations (p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala12...",7,1497,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Phe763Phe,"...polymorphisms: c.411C>A (p.Ser137Ser), c.2289C>T (p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (...",73,117,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Leu1325Leu,"...p.Phe763Phe), c.2502C>G (p.Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu), IVS8+26A>...",73,167,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Leu1333Leu,"....Val834Val), c.3973C>T (p.Leu1325Leu), c.3999G>T (p.Leu1333Leu), IVS8+26A>G, and IVS8+27G>A), in the...",73,193,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ser105X,"...Twenty mutations, including 3 nonsense mutations (p.Ser105X, p.Gln388X and p.Gly837X), one deletion ...",73,400,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ser105X,"...Twenty mutations, including 3 nonsense mutations (p.Ser105X, p.Gln388X and p.Gly837X), one deletion ...",73,400,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...ng 3 nonsense mutations (p.Ser105X, p.Gln388X and p.Gly837X), one deletion mutation (c.2659delG), on...",73,425,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr498Ser,"...708-1G>C) and 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu...",73,547,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Asp765Gly,"... 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg...",73,560,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Asp765Gly,"... 15 missense mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg...",73,560,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Arg778Leu,"...mutations (p.Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro...",73,573,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro840Leu,"...Val145Phe, p.Thr498Ser, p.Asp765Gly, p.Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro...",73,586,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr888Pro,"...Arg778Leu, p.Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Va...",73,625,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr935Met,"...Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148T...",73,638,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr935Met,"...Pro840Leu, p.Gly869Arg, p.Ala874Pro, p.Thr888Pro, p.Thr935Met, p.Pro992Leu, p.Asp1047Val, p.Ile1148T...",73,638,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...992Leu, p.Asp1047Val, p.Ile1148Thr, p.Glu1173Lys, p.Ala1295Val and p.Arg1320Ser) were identified by ...",73,706,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gln388X,"... S2–4). Among these mutations, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X) of them are ...",73,955,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gln388X,"... S2–4). Among these mutations, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X) of them are ...",73,955,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Gly837X,"...ns, Four (p.Val145Phe, p.Gln388X, p.Thr498Ser and p.Gly837X) of them are novel ATP7B gene mutations ...",73,982,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ile1148Thr,"...38, M1623, M1841, M1856, M4061, M4062 and M4174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1...",76,248,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1295Val (Families M41 and M1407) mutations ex...",76,292,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1295Val (Families M41 and M1407) mutations ex...",76,292,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...174), p.Ile1148Thr (Families M1807 and M1856) and p.Ala1295Val (Families M41 and M1407) mutations ex...",76,292,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val145Phe,"...ong the novel mutations identified in this study, p.Val145Phe was present in two compound heterozygo...",101,1591,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val145Phe,"...ong the novel mutations identified in this study, p.Val145Phe was present in two compound heterozygo...",101,1591,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Val145Phe,"...ong the novel mutations identified in this study, p.Val145Phe was present in two compound heterozygo...",101,1591,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Thr498Ser,"...1038, II:1) with compound heterozygous mutations (p.Thr498Ser and p.Pro992Leu), and the age at the o...",101,1828,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,... Compound heterozygous ATP7B mutations (p.Gly837X/p.Pro992Leu) were found in an 18-year WD female (M...,101,1977,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Ala1295Val,"...may be inherited from a same ancestor. Homozygous p.Ala1295Val mutation, located in the conserved ad...",101,3509,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.Pro992Leu,"...edigrees existed founder effects for p.Arg778Leu, p.Pro992Leu, p.Ile1148Thr and p.Ala1295Val mutatio...",101,4110,PLoS_One_2013_Jul_2_8(7)_e66526.txt
p.G1481E,"...V linker (Figure 6), leading to either LQTS (e.g. p.G1481E, p.M1498T, p.1500delK, p.L1501V, p.1505–1...",158,864,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.Y1494N,"... current [33] or to BrS (e.g. p.Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W...",158,1064,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.G1502S,"...Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W, p.I1521K) [23], [44], [45], [4...",158,1096,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.G1502S,"...Q1476X, p.K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W, p.I1521K) [23], [44], [45], [4...",158,1096,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.R1512W,"...K1493X, p.Y1494N, p.1500delK, p.L1501V, p.G1502S, p.R1512W, p.I1521K) [23], [44], [45], [46], [47] a...",158,1106,PLoS_One_2013_Jun_28_8(6)_e67963.txt
p.D359N,T113	Clear cell	Stable	c.G1075A	p.D359N	Missense	Low	Tolerated	Benign,96,34,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.S532L,T77	Clear cell	Unstable	c.C1595T	p.S532L	Missense	Low	Tolerated	Probably damaging,97,35,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.R854W,T88	Endometrioid	Unstable	c.C2560T	p.R854W	Missense	Medium	Tolerated	Possibly damagin...,100,37,PLoS_One_2013_Jun_3_8(6)_e63313.txt
p.H731D,rs4934281	10	88692330	MMRN2	NM_024756	c.C2191G	p.H731D	0.62	neutral	NA	NA,122,48,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.H731D,rs4934281	10	88692330	MMRN2	NM_024756	c.C2191G	p.H731D	0.62	neutral	NA	NA,122,48,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.E110V,rs9864	10	88712378	SNCG	NM_003087	c.A329T	p.E110V	0.15	borderline	0.36	neutral,124,43,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.I82V,rs2641563	10	88758233	AGAP11	NM_133447	c.A244G	p.I82V	1.00	neutral	NA	NA,125,48,PLoS_One_2013_Mar_21_8(3)_e55037.txt
p.W151C,...tion of a highly conserved Tryptophan to Cystine (p.W151C). The mutation was confirmed by restrictio...,9,1176,PLoS_One_2013_Nov_28_8(11)_e81290.txt
p.W151C,...tion of a highly conserved Tryptophan to Cystine (p.W151C). The mutation was confirmed by restrictio...,9,1176,PLoS_One_2013_Nov_28_8(11)_e81290.txt
p.D107D,"...ients a sysnonimous variant of ATP6AP2, c.321C>T (p.D107D) and a resultant markedly increased exon 4...",119,152,PLoS_One_2013_Nov_4_8(11)_e78603.txt
p.D107D,"...ients a sysnonimous variant of ATP6AP2, c.321C>T (p.D107D) and a resultant markedly increased exon 4...",119,152,PLoS_One_2013_Nov_4_8(11)_e78603.txt
p.S3588P,...99. SIFT prediction output denotes that bfb Fras1 p.S3588P amino acid change is ‘not tolerated’. A t...,69,484,PLoS_One_2013_Oct_15_8(10)_e76342.txt
p.Ala461Val,"...st, variants in RGS6 predicting missense changes (p.Ala461Val, p.Ala270Ser and p.Leu73Phe) did not s...",104,789,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala270Ser,"...in RGS6 predicting missense changes (p.Ala461Val, p.Ala270Ser and p.Leu73Phe) did not significantly ...",104,802,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala270Ser,"...nsistent with the clinical data, the p.Ala461Val, p.Ala270Ser and p.Leu73Phe variants did not affect...",106,487,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Ala270Ser,"...nsistent with the clinical data, the p.Ala461Val, p.Ala270Ser and p.Leu73Phe variants did not affect...",106,487,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Leu73Phe,"...e clinical data, the p.Ala461Val, p.Ala270Ser and p.Leu73Phe variants did not affect the ability of ...",106,503,PLoS_One_2013_Oct_29_8(10)_e76973.txt
p.Cys356Gly,p.Cys356Gly mutant	57±9	52±10,97,1,PLoS_One_2014_Apr_10_9(4)_e94697.txt
p.Gly57Glu,"...g52Cys, MBL2*D), 54 (p.Dly54Asp, MBL2*B), and 57 (p.Gly57Glu, MBL2*C), interfere with the formation ...",30,214,PLoS_One_2014_Apr_21_9(4)_e95519.txt
p.Ala681Thr,MLH1/Exon 18	c.2041G>A	p.Ala681Thr	Chinese	1	1	Pathogenic	Dis causing	Yes...,85,24,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gln170X,"MSH2/Exon 3	c.508C>T	p.Gln170X	Chinese	1	1	Pathogenic	Dis causing	Yes, ...",87,22,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Arg265Cys,"32	MLH1/Exon 10, c.793C>T, p.Arg265Cys	Pathogenic	Lost	Normal	Normal	Lost	Yes...",110,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Arg265Cys,"32	MLH1/Exon 10, c.793C>T, p.Arg265Cys	Pathogenic	Lost	Normal	Normal	Lost	Yes...",110,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gln681X,"52	MSH2/Exon 13, c.2041C>T, p.Gln681X	Novel Pathogenic	Normal	Lost	Lost	Normal...",117,29,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gln681X,"52	MSH2/Exon 13, c.2041C>T, p.Gln681X	Novel Pathogenic	Normal	Lost	Lost	Normal...",117,29,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ala681Val,"81	MLH1/Exon 18, c.2042 C>T, p.Ala681Val	Discrepancy by InSiGHT † and HGMD ‡ cl...",127,30,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Leu390Phe,"68	MSH2/Exon 7, c.1168C>T, p.Leu390Phe	Probably dis causing by HGMD criteria ...",131,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Gly749Ala,"8	MSH6/Exon 4, c.2246G>C, p.Gly749Ala	Novel VUS	Normal	Normal	Normal	Normal	...",132,27,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.Ile240Phe,"409	PMS2/Exon 7, C.718 A>T, p.Ile240Phe	Novel VUS	Normal	Normal	Normal	Normal	...",133,29,PLoS_One_2014_Apr_7_9(4)_e94170.txt
p.R93H,"...und in these patients, and one amino acid change (p.R93H) was identified in one subject with early-o...",94,1127,PLoS_One_2014_Aug_11_9(8)_e104326.txt
p.R93H,"...to change the amino acid sequence of the protein (p.R93H) and transmitted from his father, who had a...",102,1180,PLoS_One_2014_Aug_11_9(8)_e104326.txt
p.R268Q,"...e identified a novel missense mutation (c.803G>A, p.R268Q) in the plasma membrane calcium ATPase (PM...",7,589,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,"... identified a novel causative mutation, c.803G>A, p.R268Q in the PMCA4 gene",15,222,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.R268Q,...m 1% to 3%. All the other variants were rare. The p.R268Q variant that was identified in the symptom...,84,743,PLoS_One_2014_Aug_13_9(8)_e104790.txt
p.P297S,"...ransactivation in in vitro reporter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P...",11,513,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,exon 3	c.280G>C	p.A94P	28	M	—	—	—	rs201350646,53,18,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,c.565A>T	p.I189F	40	P	—	—	—	—,54,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,c.565A>T	p.I189F	40	P	—	—	—	—,54,12,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,c.1331A>G	p.Q444R	34	—	0.2	0.14	—	rs147258453,63,13,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.T233T,GATA4	exon 2	c.699G>A	p.T233T	323	—	—	0.3	0.1	rs55788387,70,23,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.T233T,GATA4	exon 2	c.699G>A	p.T233T	323	—	—	0.3	0.1	rs55788387,70,23,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.G27G,TBX20	exon 1	c.81C>T	p.G27G	325	M	—	0.01	—	rs113390069,89,22,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,exon 2	c.364A>G	p.I122V	31	M	0.2	—	—	—,90,18,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,"...orter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPRYDPCAAAAPGAPGP....",101,154,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.S113T,"...orter assays: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPRYDPCAAAAPGAPGP....",101,154,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I189F,"...Six variants (HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and FOXC1 p.G378_G380delGGG a...",101,255,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...missense changes, in silico tools predicted FOXA2 p.A94P, p.I189F and p.Y445C to be damaging (with P...",101,478,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...missense changes, in silico tools predicted FOXA2 p.A94P, p.I189F and p.Y445C to be damaging (with P...",101,478,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"... silico tools predicted FOXA2 p.A94P, p.I189F and p.Y445C to be damaging (with PolyPhen scores of 0....",101,498,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.A94P,"...ptional activities of HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and the compound FOXC...",101,653,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"...f HAND2 p.A25_A26insAA, FOXA2 p.A94P, p.I189F and p.Y445C, and the compound FOXC1 p.G378_G380delGGG ...",101,673,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Y445C,"...FOXA2 variants investigated (p.A94P, p.I189F, and p.Y445C) affected transcriptional activity as meas...",110,194,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,"...nd found to alter transactivation capacity: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P...",124,388,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.Q444R,"...er transactivation capacity: FOXC1 p.P297S, FOXC2 p.Q444R, FOXH1 p.S113T and TBX1 p.P43_G61del PPPPR...",124,403,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P11R,... [28]. This study detected one missense mutation (p.P11R) in two TOF patients that was not present i...,127,1219,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.P297S,...in Axenfeld Rieger syndrome (ARS) patients. FOXC1 p.P297S has been reported in two patients with thi...,137,392,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.I122V,"...e readout of the functional assays, nor for TBX20 p.I122V. More detailed phenotypic information for ...",139,909,PLoS_One_2014_Aug_5_9(8)_e95453.txt
p.G149V,"...main and its high conservation through evolution, p.G149V mutation could be a potential pathogenic c...",7,1663,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,"...main and its high conservation through evolution, p.G149V mutation could be a potential pathogenic c...",7,1663,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,...utation at the nucleotide position 446 (c.446G>T; p.G149V) in a Chinese family with CADASIL,15,111,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,...e reported a novel NOTCH3 gene missense mutation (p.G149V) in a Chinese CADASIL family. The clinical...,89,67,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149V,...e reported a novel NOTCH3 gene missense mutation (p.G149V) in a Chinese CADASIL family. The clinical...,89,67,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.G149C,"...ype of CADASIL. Similarly, the mutation c.445G>T (p.G149C) was reported in 5 individuals with CADASI...",91,1506,PLoS_One_2014_Aug_6_9(8)_e104533.txt
p.V44A,"...fied a novel heterozygous mutation, the c.131T>C (p.V44A) mutation, in exon2 of GJA8 in a Chinese fa...",28,75,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...fied a novel heterozygous mutation, the c.131T>C (p.V44A) mutation, in exon2 of GJA8 in a Chinese fa...",28,75,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...ary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chinese or...",116,58,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...ary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chinese or...",116,58,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...ary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chinese or...",116,58,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.V44A,"...ary, we identified a novel heterozygous c.131T>C (p.V44A) mutation in GJA8 in a family of Chinese or...",116,58,PLoS_One_2014_Dec_17_9(12)_e115406.txt
p.Arg355Gln,...heterozygote of c.615+5G>A and a novel c.1064G>A (p.Arg355Gln) mutation. An aberrant transcript with...,11,158,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.R355Q,...AAAACTCAAATGCAGAACC	Site-directed mutagenesis for p.R355Q,54,62,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,"...lix of citrin protein (Fig. 4B), and the mutation p.Arg355Gln shortened the distance of the H-bond b...",109,291,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,"...lix of citrin protein (Fig. 4B), and the mutation p.Arg355Gln shortened the distance of the H-bond b...",109,291,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,"...Furthermore, functional prediction of the variant p.Arg355Gln by Polyphen-2 produced a value of 1.00...",109,701,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Arg355Gln,...ompound heterozygote of c.615+5G>A and c.1064G>A (p.Arg355Gln). The former was a common SLC25A13 mut...,130,794,PLoS_One_2014_Feb_21_9(2)_e89267.txt
p.Pro15Ser,...829	G	G/A	0.093**	0.089	0.85	0.113	0.48	C	c.43C>T	p.Pro15Ser	missense	1	NH2-terminal region,92,70,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Pro15Ser,...829	G	G/A	0.093**	0.089	0.85	0.113	0.48	C	c.43C>T	p.Pro15Ser	missense	1	NH2-terminal region,92,70,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Thr296Thr,...s144891994	C	C/T	0 ∧	0.005	NA	0.008	NA	G	c.888G>A	p.Thr296Thr	synonymous	2	CCD,95,65,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Asn561Asn,...4	A	A/G	0.250**	0.292	0.20	0.347	0.02	T	c.1683T>C	p.Asn561Asn	synonymous	6	linker region between TMD...,98,73,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Asn561Asn,...4	A	A/G	0.250**	0.292	0.20	0.347	0.02	T	c.1683T>C	p.Asn561Asn	synonymous	6	linker region between TMD...,98,73,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Tyr705Tyr,...044	G	G/A	0.020	0.020	1.00	0.024	0.75	C	c.2115C>T	p.Tyr705Tyr	synonymous	8	linker region between TMD...,99,71,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Thr714Thr,...4891994	C	C/A	0.008	0.005	0.66	0	0.32	G	c.2142G>T	p.Thr714Thr	synonymous	8	TMD 6,100,68,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.Gln904Gln,...8	C	C/T	0.140**	0.158	0.49	0.153	0.69	G	c.2712G>A	p.Gln904Gln	synonymous	13,103,73,PLoS_One_2014_Jul_14_9(7)_e102065.txt
p.I148M,"Genotyping of PNPLA3 variant p.I148M (rs738409, allele C/G) was performed accor...",61,30,PLoS_One_2014_Mar_17_9(3)_e91987.txt
p.I148M,"Genotyping of PNPLA3 variant p.I148M (rs738409, allele C/G) was performed accor...",61,30,PLoS_One_2014_Mar_17_9(3)_e91987.txt
p.I148M,"...and J , et al (2012 ) A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic ...",275,109,PLoS_One_2014_Mar_17_9(3)_e91987.txt
p.S45F,"...dic desmoids, with p.T41A (threonine to alanine), p.S45F (serine to phenylalanine), and p.S45P (seri...",14,830,PLoS_One_2014_May_1_9(5)_e96391.txt
p.S196G,"...tial disease-causing mutations, p.P140S, p.S183L, p.S196G, p.Ser161delAGC and p. Ser192_Gly193delAGC...",7,802,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S196G,"...ction of VP16-P300 and the four mutants (p.S183L, p.S196G, p.Ser161delAGC, p.Ser192_Gly193delAGCGGC)...",122,530,PLoS_One_2014_May_21_9(5)_e98157.txt
p.P140S,"...ein interactions between p300 and CITED2, but the p.P140S mutant didn't alter the interactions",122,803,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S183L,"...th wt. (p.P140S vs. wt-type 80% (t test, p<0.01), p.S183L vs. wt-type 85% (t test, p<0.01), p.Ser192...",132,540,PLoS_One_2014_May_21_9(5)_e98157.txt
p.S183L,"...th wt. (p.P140S vs. wt-type 80% (t test, p<0.01), p.S183L vs. wt-type 85% (t test, p<0.01), p.Ser192...",132,540,PLoS_One_2014_May_21_9(5)_e98157.txt
p.I94X,"...ation of four novel cytochrome P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary ...",152,110,PLoS_One_2014_Oct_16_9(10)_e110473.txt
p.H279D,"... four novel cytochrome P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary congenit...",152,118,PLoS_One_2014_Oct_16_9(10)_e110473.txt
p.L160H,"...with other CYP2A6 SNPs, e.g., rs1801272 (c.479T>A/p.L160H), with effect size of 0.68 CPD (N = 66,380...",176,516,PLoS_One_2015_Jul_1_10(7)_e0126113.txt
p.Ser163Arg,...responsible for X-linked retinitis pigmentosa and p.Ser163Arg in C1QTNF5 associated with Late-Onset ...,7,1304,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Asp186Asn,... a missense change in PRPH2 (NM_000322.4:c556G>A; p.Asp186Asn) [30] and the complete segregation in ...,97,74,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Asp186Asn,... a missense change in PRPH2 (NM_000322.4:c556G>A; p.Asp186Asn) [30] and the complete segregation in ...,97,74,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.Asp186Asn,RP-0107	adRP	adCRD	PRPH2 c556G>A; p.Asp186Asn (NM_000322.4)	Kohl et al. 2012 [33],103,35,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
p.R132H,"6	39	F	+++	p.R132H	WT	3,5",130,12,PLoS_One_2015_Jul_9_10(7)_e0130596.txt
p.D150H,...structure and function of AQP0. The wild type and p.D150H mutant AQP0 were expressed in HeLa cells s...,7,1505,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"...ndividually. Taken together, our data suggest the p.D150H mutation is a novel disease-causing mutati...",7,2046,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...served aspartic acid with histidine at codon 150 (p.D150H) (Fig 3). This change was cosegregated wit...,60,203,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...on was damaging. These results together indicated p.D150H mutation is likely to be deleterious to th...,82,535,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...ids individually. These data demonstrate that the p.D150H mutation would damage the trafficking mech...,91,852,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...ace the conserved aspartic acid with a histidine (p.D150H) in AQP0. This mutation was cosegregated w...,97,382,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"...esult, we identified this novel mutation of AQP0 (p.D150H) as the genetic defect of this congenital ...",97,915,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.M1T,"...autosomal dominant congenital cataract in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16...",97,1235,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.M1T,"...autosomal dominant congenital cataract in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16...",97,1235,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.R33C,"...minant congenital cataract in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [...",97,1247,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.E134G,"...in humans (p.M1T [14], p.R33C [15], p.R113X [13], p.E134G [16], p.T138R [16], p.G165D [12], p.Y177C ...",97,1274,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.T138R,"...ations in transmembrane domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water p...",99,800,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G165D,"... transmembrane domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water permeabili...",99,809,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G215D,"...ne domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water permeability due to im...",99,821,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.G215D,"...ne domains, such as p.E134G, p.T138R, p.G165D and p.G215D, show loss of water permeability due to im...",99,821,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,"...s in AQP0 function, we first tested the impact of p.D150H on protein location in HeLa cells. Intrigu...",101,134,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...gressive cortical punctate cataract caused by the p.D150H mutation of MIP. It is a new missense muta...,105,99,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.D150H,...dies focusing on the biological changes caused by p.D150H are needed,105,570,PLoS_One_2015_May_6_10(5)_e0126679.txt
p.P2328S,"...ter called as exon 3 deletion) or point mutations p.P2328S (c.6982C>T), p.T2538R (c.7613C>G), p.L411...",31,346,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.Q4201R,"...>T), p.T2538R (c.7613C>G), p.L4115F (c.12343C>T), p.Q4201R (c.12602A>G) or p.V4653F (c.13957G>T). Mu...",31,413,PLoS_One_2015_May_8_10(5)_e0125366.txt
p.His305Leu,"... Carrier frequencies of the minor alleles of TLR1 p.His305Leu (OR = 4.79, 95% CI = 2.35–9.75, P = 0....",7,1521,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"... Carrier frequencies of the minor alleles of TLR1 p.His305Leu (OR = 4.79, 95% CI = 2.35–9.75, P = 0....",7,1521,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"...rphisms (SNPs) such as p.Asp299Gly allele A/G and p.Thr399Ile allele C/T, recipients were less likel...",13,1636,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,"... testing, TLR3 p.Leu412Phe (P = 0.046) and SIGIRR p.Gln312Arg (P < 0.0001) appeared in Hardy-Weinber...",33,634,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln312Arg,"... testing, TLR3 p.Leu412Phe (P = 0.046) and SIGIRR p.Gln312Arg (P < 0.0001) appeared in Hardy-Weinber...",33,634,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	4	p.Asn248Ser (rs4833095)	LOF [25–27]	C/t	53.7	36.6	...,72,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"TLR4	9	p.Asp299Gly (rs4986790)	LOF [34,35]	A/g	89.3	10.1	...",75,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	1	p.Arg392Ter (rs5744168)	LOF [36–38]	G/a	88.1	11.7	...,77,8,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...(OR = 4.79, 95% CI = 2.35–9.75, P = 0.0002), TLR1 p.Asn248Ser (OR = 1.26, 95% CI = 1.07–1.47, P = 0....",86,428,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,...lying disease entities. The minor allele for TLR1 p.His305Leu showed the strongest association with ...,86,877,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...(OR = 4.37, 95% CI = 1.83–10.43, P = 0.003). TLR1 p.Asn248Ser and TLR8 p.Met1Val showed some specifi...",86,1280,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...1.83–10.43, P = 0.003). TLR1 p.Asn248Ser and TLR8 p.Met1Val showed some specificity for immunecomple...",86,1301,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	9.5	2.6	4.79	2.35–9.75	0.0002	0%,90,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	8.2	7.1	2.93	1.03–8.33	0.4,95,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	44.6	42.6	0.92	0.82–1.04	1,96,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	38.6	41.0	0.92	0.81–1.04	1,97,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	27.9	22.6	1.37	1.14–1.64	0.008	1%,99,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	Congenital	216	10.4	2.6	4.94	2.26–10.8...,108,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	C/t	1.28	0.85–1.90	1	0.85	0.56–1.28	1,140,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	C/t	1.28	0.85–1.90	1	0.85	0.56–1.28	1,140,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	G/a	1.35	0.94–1.93	1	1.08	0.75–1.54	1,142,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Gln11Leu,TLR7	p.Gln11Leu	A/t	0.88	0.63–1.23	1	0.83	0.57–1.19	1,148,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	A/g	0.96	0.68–1.34	1	1.09	0.77–1.55	1,150,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	T/a	0.68	0.39–1.18	1	1.60	1.20–2.12	0....,164,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,TLR2	p.Arg753Gln	G/a	0.84	0.59–1.20	1	1.32	1.04–1.68	0....,168,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,TLR4	p.Asp299Gly	A/g	0.85	0.60–1.20	1	0.90	0.65–1.25	1,170,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,TLR5	p.Arg392Ter	G/a	1.00	0.75–1.34	0.3	0.80	0.59–1.09	...,174,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	0.89	0.72–1.12	1	0.73	0.59–0.92	0....,178,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	0.89	0.72–1.12	1	0.73	0.59–0.92	0....,178,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	0.89	0.72–1.12	1	0.73	0.59–0.92	0....,178,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	0.89	0.72–1.12	1	0.73	0.59–0.92	0....,178,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	C/t	1.13	0.84–1.52	1	1.11	0.82–1.50	1,198,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,TLR1	p.Asn248Ser	C/t	1.13	0.84–1.52	1	1.11	0.82–1.50	1,198,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,TLR4	p.Thr399Ile	C/t	1.17	0.76–1.81	1	0.74	0.45–1.20	1,204,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Phe616Leu,TLR5	p.Phe616Leu	A/g	1.03	0.75–1.43	1	1.20	0.87–1.64	1,208,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	G/a	1.19	0.87–1.64	1	0.85	0.62–1.17	1,210,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"...l transplant recipients, we observed that 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val s...",223,495,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...ients, we observed that 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val significantly assoc...",223,513,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asn248Ser,"...ients, we observed that 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val significantly assoc...",223,513,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...at 1) TLR1 p.His305Leu, TLR1 p.Asn248Ser and TLR8 p.Met1Val significantly associated with the preval...",223,534,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"... in our cohort. Unfortunately, in this study TLR1 p.His305Leu, the variant that showed a robust and ...",225,741,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,"... in our cohort. Unfortunately, in this study TLR1 p.His305Leu, the variant that showed a robust and ...",225,741,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...disease in our cohort, was not investigated. TLR4 p.Asp299Gly and p.Thr399Ile are by far the most st...",225,888,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...disease in our cohort, was not investigated. TLR4 p.Asp299Gly and p.Thr399Ile are by far the most st...",225,888,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"...n line with our study and because p.Asp299Gly and p.Thr399Ile are in high linkage disequilibrium, on...",225,1293,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"...n line with our study and because p.Asp299Gly and p.Thr399Ile are in high linkage disequilibrium, on...",225,1293,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,...n association of the minor allele of TLR5 variant p.Arg392Ter with native kidney diseases [57]. The ...,225,1797,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,"...]. The residual TLR variants, which includes TLR8 p.Met1Val that showed an association with end-stag...",225,1890,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.His305Leu,TLR1	p.His305Leu	-	-	-	-	-	-	-,229,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,"TLR2	p.Arg753Gln	Mutlubas, 2009	[58]	Turkey	Native	CKD	...",232,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Thr399Ile,"TLR4	p.Thr399Ile	Nogueira, 2007	[12]	Brazil	Native	CKD	...",258,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Ser249Pro,TLR6	p.Ser249Pro	-	-	-	-	-	-	-,277,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Met1Val,TLR8	p.Met1Val	-	-	-	-	-	-	-,279,6,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg753Gln,... al. [58] did not identify an association of TLR2 p.Arg753Gln with renal transplant outcomes. In the...,286,519,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Asp299Gly,"...es. In the context of renal transplantation, TLR4 p.Asp299Gly and p.Thr399Ile are also among the mos...",286,609,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,"...th our study, did not find an association of TLR5 p.Arg392Ter with renal transplant outcomes. Even t...",286,2198,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.Arg392Ter,"...th our study, did not find an association of TLR5 p.Arg392Ter with renal transplant outcomes. Even t...",286,2198,PLoS_One_2015_Oct_7_10(10)_e0139769.txt
p.A1066V,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,9,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
p.A1066V,"M1040I, p.A1066V	3120G>A, 3197C>T	1	0.1",79,9,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
p.Gly1752Arg,Variant c.5254G>A (p.Gly1752Arg) in the RAI1 gen,78,20,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...153841.g001Fig 1 Identification of the c.5254G>A (p.Gly1752Arg) mutation in the RAI1 gene in Altaian...,81,73,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly371Arg,...153841.g002Fig 2 Identification of the c.1111C>G (p.Gly371Arg) mutation in the OTOF gene and the c.2...,95,73,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.His723Arg,Homozygous mutation c.2168A>G (p.His723Arg) in gene SLC26A4 was found in the only...,101,32,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...hanging nonpolar glycine to basic polar arginine (p.Gly1752Arg) at amino acid position 1752 in the C...,114,389,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Q1562R,...tes in RAI1 amino acid sequence between mutations p.Q1562R (c.4685A>G) and p.S1808N (c.5423G>A) stud...,116,2169,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Gly1752Arg,...ation prediction tools used in this study defined p.Gly1752Arg as possibly damaging or deleterious. ...,118,576,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.D398E,"....G368AfsX2), c.1180dupG (p.E394GfsX6), c.1194T>A (p.D398E), and c.1236delC (p.E413NfsX90) located in...",124,358,PLoS_One_2016_Apr_15_11(4)_e0153841.txt
p.Asn98Ser,...estive of a possible underlying CPVT phenotype. A p.Asn98Ser mutation in CALM2 was detected in both ...,17,252,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,... pathogenic variant found in probands A and B was p.Asn98Ser in CALM2 (protein code: NP_001734.1:p.A...,37,1845,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,... pathogenic variant found in probands A and B was p.Asn98Ser in CALM2. p.Asn98Ser is not listed in p...,54,98,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,... pathogenic variant found in probands A and B was p.Asn98Ser in CALM2. p.Asn98Ser is not listed in p...,54,98,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.Asn98Ser,"...ow frequency, that pAsn98Ser is a mutation. CALM2 p.Asn98Ser has been described recently by Makita e...",54,415,PLoS_One_2016_Apr_21_11(4)_e0153851.txt
p.G110Efs,"...YP21A2 deletion, large gene conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M23...",57,364,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.I236N,"... conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p...",57,391,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.V237E,"...on, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p...",57,400,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.V237E,"...on, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237E, p.M239K), p.Leu307fs, p.R356W, p.Q318X, p...",57,400,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
p.A467T,...resis (SANDO) in a sibling pair with a homozygous p.A467T POLG mutation . Muscle Nerve . 2010 ;41 (2...,239,103,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.A467T,...resis (SANDO) in a sibling pair with a homozygous p.A467T POLG mutation . Muscle Nerve . 2010 ;41 (2...,239,103,PLoS_One_2016_Jan_6_11(1)_e0145500.txt
p.Trp152Arg,"...XC1 gene, a novel heterozygous variant (c.454T>C; p.Trp152Arg) segregated with the disease in a Mexi...",14,396,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.Trp152Arg,"... ARS: a heterozygous missense mutation (c.454T>C; p.Trp152Arg), and a homozygous in-frame deletion (...",73,142,PLoS_One_2016_Jul_27_11(7)_e0160016.txt
p.D61N,2 p.D61N,222,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.A99T,2 p.A99T,262,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.A99T,2 p.A99T,262,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.T115A,1 p.T115A,310,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.T115A,1 p.T115A,310,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.T115A,1 p.T115A,310,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.T115A,1 p.T115A,310,3,PLoS_One_2016_Jul_28_11(7)_e0159992.txt
p.Gly316Ser,... severe diseases of infancy. The patient’s ATP1A3 p.Gly316Ser mutation was validated in the laborato...,7,802,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"ATP1A3	19	NM_152296.3	[c.946G>A, p.Gly316Ser]	A/G	G/G	G/G	G/G	G/G",60,34,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"ATP1A3	19	NM_152296.3	[c.946G>A, p.Gly316Ser]	A/G	G/G	G/G	G/G	G/G",60,34,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...in binding pockets in the middle of the membrane. p.Gly316Ser mutation is novel, and is in the highl...",67,216,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...e crystal structure in the K+-bound conformation, p.Gly316Ser is directly apposed to a residue in th...",67,367,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...e crystal structure in the K+-bound conformation, p.Gly316Ser is directly apposed to a residue in th...",67,367,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...ession studies were performed to test whether the p.Gly316Ser ATP1A3 mutation impairs the activity o...,73,64,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,...le those with pGly316Ser were more rounded. Other p.Gly316Ser-transfected wells were trypsinized at ...,73,1125,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...aces were flattened (white arrowheads). In C, the p.Gly316Ser mutation was transfected. Many cells s...",76,462,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...aces were flattened (white arrowheads). In C, the p.Gly316Ser mutation was transfected. Many cells s...",76,462,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Gly316Ser,"...her lanes show transient expression of WT ATP1A3, p.Gly316Ser, and p.Glu815Lys, an inactive mutation...",76,1284,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.Thr467Ile,"...quilins, is a homozygous UBQLN2 missense variant, p.Thr467Ile, found in a female FTD patient [41]. I...",87,1227,PLoS_One_2016_Mar_18_11(3)_e0151429.txt
p.N120Lfs,"...Fig 4). These results identified LMNA c.357-2A>G (p.N120Lfs*5) (NM_170707.3), a novel heterozygous s...",119,610,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Arg690Cys,...anger sequencing. Two examples are provided: TMPO p.Arg690Cys variant (C>T) for a confirmed variant ...,122,113,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Lys219Thr,...unaffected) found a known LMNA missense mutation (p.Lys219Thr) in an Italian family [17]. WES of fiv...,142,520,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Lys219Thr,...unaffected) found a known LMNA missense mutation (p.Lys219Thr) in an Italian family [17]. WES of fiv...,142,520,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Met1113Val,"...690Cys [22], MYBPC3 p.Val895Met [23,24], and HCN4 p.Met1113Val [25] as highly penetrant, primary mut...",148,133,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Met1113Val,"...690Cys [22], MYBPC3 p.Val895Met [23,24], and HCN4 p.Met1113Val [25] as highly penetrant, primary mut...",148,133,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Val895Met,"...iomyopathy (HCM); however, the role of the MYBPC3 p.Val895Met variant is not clear. As evidence for ...",150,219,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,...th preliminary evidence for an association of HCN p.M1113V and post-partum sinus bradycardia [25]. A...,152,180,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,"...lished HCN4 mutation and two subjects had the HCN p.M1113V variant [25]. In our family, we found the...",152,336,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,"...lished HCN4 mutation and two subjects had the HCN p.M1113V variant [25]. In our family, we found the...",152,336,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.M1113V,"...ily, we found the lack of segregation for the HCN p.M1113V and heart disease; only one affected sibl...",152,419,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.Thr6018Ser,"... further analysis (Table 2) including a novel TTN p.Thr6018Ser variant, the rare variants reported a...",174,118,PLoS_One_2016_May_16_11(5)_e0155421.txt
p.R222S,"...CN11A p.R222H (Family 1, 2, 4, 5 and 6) or SCN11A p.R222S (Family 3) for each individual is illustra...",35,528,PLoS_One_2016_May_25_11(5)_e0154827.txt
p.Y81N,Comp. Het.	Comp. Het		p.Y81N* in POAG			0 for both	5for Y81N; 0 for fs	J...,93,23,PLoS_One_2016_May_31_11(5)_e0156252.txt
p.Arg23Lys,c.68G>A (p.Arg23Lys)	rs6190		2.98% (ss1317539290)	2.85%	2.4...,130,10,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
p.Asn363Ser,N363S	c.1088A>G (p.Asn363Ser)	rs56149945 (former rs6195 or rs356601...,131,18,PLoS_One_2016_Sep_20_11(9)_e0162437.txt
p.Arg101His,"...la, mature protein), PI*M2 (rs709932; c.374G > A; p.Arg101His) and PI*M3 (rs1303; c.1200A > C; p.Glu...",28,451,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Glu342Lys,"... p. Glu264Val) and PI*Z (rs28929474; c.1096G > A; p.Glu342Lys), with a PI*S prevalence in Caucasians...",28,923,Respir_Res_2014_Oct_7_15(1)_125.txt
p.Leu79Arg,"...on 79, resulting in a missense amino acid variant p.Leu79Arg. This p.Leu79Arg variant is listed in t...",44,464,SAGE_Open_Med_Case_Rep_2014_Oct_6_2_2050313X14553520.txt
p.Leu79Arg,... at the Leiden Open Variation Database. Since the p.Leu79Arg variant had been identified in only one...,44,1341,SAGE_Open_Med_Case_Rep_2014_Oct_6_2_2050313X14553520.txt
p.R161Q,... for a mutation in the GCDH-coding gene (c.482G>A;p.R161Q). This case alerts pediatricians to consid...,26,390,Saudi_Med_J_2015_Nov_36(11)_1269.txt
p.R161Q,... for a mutation in the GCDH-coding gene (c.482G>A;p.R161Q). This case alerts pediatricians to consid...,26,390,Saudi_Med_J_2015_Nov_36(11)_1269.txt
p.Q734X,...etected a homozygous nonsense mutation (c.2200C>T;p.Q734X) in the patient and heterozygous in both h...,25,69,Saudi_Med_J_2015_Sep_36(9)_1110-1114.txt
p.E376G,"MAP3K9	c.1127T > C, p.E376G (MeWo)",190,21,Sci_Rep_2013_Dec_13_3_3494.txt
p.V734M,...nd identified a novel homozygous missense change (p.V734M) in the CDH3 gene. The p.V734M change was ...,27,675,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,"...s missense change (p.V734M) in the CDH3 gene. The p.V734M change was absent in WES databases, fully ...",27,706,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,"...s missense change (p.V734M) in the CDH3 gene. The p.V734M change was absent in WES databases, fully ...",27,706,Sci_Rep_2015_Aug_26_5_13187.txt
p.C363S,ADAM9	c.1087T>A	p.C363S	0	arRP	Iraqi Jew	MOL0827 MOL0838	—	Homozyg...,85,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.R160Q,BBS1	c.479G>A	p.R160Q	4*10−5	arRP	Arab Muslim	MOL0745	—	Homozygo...,87,15,Sci_Rep_2015_Aug_26_5_13187.txt
p.R762C,CNGB1	c.2284C>T	p.R762C	0	arRP	Buchara Jew	MOL0990	4	Homozygous	 ,91,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.D498E,CNNM4	c.1494C>A	p.D498E	0	ar Jalili syndrome	Druze	MOL0367	—	Homoz...,93,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.H241L,RPE65	c.722A>T	p.H241L	0	arRP	Ashkenazi Jew	MOL0942	—	Homozygous	...,107,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.H241L,RPE65	c.722A>T	p.H241L	0	arRP	Ashkenazi Jew	MOL0942	—	Homozygous	...,107,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.G2313C,USH2A	c.6937G>T	p.G2313C	1*10−4	arRP	Arab Muslim	MOL1234	—	Heteroz...,113,17,Sci_Rep_2015_Aug_26_5_13187.txt
p.M1L,CDHR1	c.1T>G	p.M1L	0	arRP	Druze	MOL1275	—	Homozygous	 ,123,14,Sci_Rep_2015_Aug_26_5_13187.txt
p.V734M,CDH3	c.2200G>A	p.V734M	Disease causing	1	0.06 Tolerated	0	0	3*10−...,132,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.H76P,RPE65	c.227A>C	p.H76P	Disease causing	0.059	0.11 Tolerated	0	0	0,135,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.H76P,RPE65	c.227A>C	p.H76P	Disease causing	0.059	0.11 Tolerated	0	0	0,135,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.D110G,RPE65	c.329A>G	p.D110G	Disease causing	0.998	0.31 Tolerated	0	0	0...,136,16,Sci_Rep_2015_Aug_26_5_13187.txt
p.V200M,"...e is the NLRP3 variant V198M (or, more precisely, p.V200M, rs121908147), detected in the control pop...",11,1017,Sci_Rep_2015_May_19_5_10200.txt
p.V200M,"...e is the NLRP3 variant V198M (or, more precisely, p.V200M, rs121908147), detected in the control pop...",11,1017,Sci_Rep_2015_May_19_5_10200.txt
p.E148Q,"...Conversely, in family A, we identified a variant (p.E148Q, rs3732930, MAF 0.06) shared among the two...",27,575,Sci_Rep_2015_May_19_5_10200.txt
p.E148Q,"...Conversely, in family A, we identified a variant (p.E148Q, rs3732930, MAF 0.06) shared among the two...",27,575,Sci_Rep_2015_May_19_5_10200.txt
p.R211C,"... cold autoinflammatory syndrome-2, in patient R1 (p.R211C). This change, located in a well-conserved...",27,1096,Sci_Rep_2015_May_19_5_10200.txt
p.V198M,The NLRP3 variant p.V198M associated with CAPS does not cosegregate ...,29,19,Sci_Rep_2015_May_19_5_10200.txt
p.R274Q,"...tated changes in NLRP5, for patients 2940 and F1 (p.R274Q, and p.N255S, respectively). Again, patien...",33,423,Sci_Rep_2015_May_19_5_10200.txt
p.I384T,"...R families we identified a rare change in NLRP10, p.I384T (rs150112481, MAF 0.01) although only in p...",33,1214,Sci_Rep_2015_May_19_5_10200.txt
p.G786V,"...s missense change in NLRC4, better known as IPAF, p.G786V (rs149451729, MAF 0.03) in patient 2941; a...",33,2231,Sci_Rep_2015_May_19_5_10200.txt
p.C241G,"...AF 0.03) in patient 2941; a novel change in NOD1 (p.C241G) in patient 2942, again in the NACHT domai...",33,2304,Sci_Rep_2015_May_19_5_10200.txt
p.C241G,"...AF 0.03) in patient 2941; a novel change in NOD1 (p.C241G) in patient 2942, again in the NACHT domai...",33,2304,Sci_Rep_2015_May_19_5_10200.txt
p.R211C,"... the novel change found in patient R1, the NLRP12 p.R211C, which is present in a well-conserved doma...",44,69,Sci_Rep_2015_May_19_5_10200.txt
p.R352C,...n function. Recently a similar missense mutation (p.R352C) in the same NACHT domain of this gene was...,44,215,Sci_Rep_2015_May_19_5_10200.txt
p.E148Q,"...fically, we identified a change in the MEFV gene (p.E148Q) and in NLRP3 (p.Q703K), both common polym...",44,1011,Sci_Rep_2015_May_19_5_10200.txt
p.Q703K,"...a change in the MEFV gene (p.E148Q) and in NLRP3 (p.Q703K), both common polymorphisms with a possibl...",44,1034,Sci_Rep_2015_May_19_5_10200.txt
p.V200M,Variant V198M (p.V200M) in gene NLRP3 does not cosegregate with P...,85,16,Sci_Rep_2015_May_19_5_10200.txt
p.V200M,Variant V198M (p.V200M) in gene NLRP3 does not cosegregate with P...,85,16,Sci_Rep_2015_May_19_5_10200.txt
p.G786V,IPAF (NLRC4)	149451729	2941	p.G786V	0.004	LRR6,123,29,Sci_Rep_2015_May_19_5_10200.txt
p.T162M,"NLRP4	117212164	O1,O5	p.T162M	0.004	NACHT",131,23,Sci_Rep_2015_May_19_5_10200.txt
p.I384T,NLRP10	150112481	O1	p.I384T	0.001	NACHT,134,21,Sci_Rep_2015_May_19_5_10200.txt
p.I384T,NLRP10	150112481	O1	p.I384T	0.001	NACHT,134,21,Sci_Rep_2015_May_19_5_10200.txt
p.I384T,NLRP10	150112481	O1	p.I384T	0.001	NACHT,134,21,Sci_Rep_2015_May_19_5_10200.txt
p.C241G,NOD1 (CARD4)	novel	2942	p.C241G	0	NACHT,137,25,Sci_Rep_2015_May_19_5_10200.txt
p.S210L,"NOD4	16965150	2941, F1	p.S210L	0.03	before NACHT domain",139,24,Sci_Rep_2015_May_19_5_10200.txt
p.S306L,NWD1	149694092	F1	p.S306L	0.006	between WD and NACHT,142,19,Sci_Rep_2015_May_19_5_10200.txt
p.Val345Met,rs10911390	1q25.3	183616884	C/T	0.08	APOBEC4	p.Val345Met	exon 2	B	D,123,46,Sci_Rep_2015_Oct_13_5_14969.txt
p.L1491X,BCOR	stopgain SNV	NM_001123384:c.T4472A:p.L1491X	36	0.92	T66,130,41,Sci_Rep_2016_Apr_29_6_25264.txt
p.G2623E,...us mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Table 2) in the EYS gene (NM_001142800...,36,1224,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,...us mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Table 2) in the EYS gene (NM_001142800...,36,1224,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,...us mutations (c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E)) (Table 2) in the EYS gene (NM_001142800...,36,1224,Sci_Rep_2016_Jan_20_6_19432.txt
p.A2808T,"...rs of c.7868G>A (p.G2623E, father) and c.8422G>A (p.A2808T, mother) in family ARRP-49 and c.1871G>A ...",36,1681,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,"....A2808T, mother) in family ARRP-49 and c.1871G>A (p.S624L, father) in family ARRP-206. The inheritan...",36,1732,Sci_Rep_2016_Jan_20_6_19432.txt
p.S624L,"....A2808T, mother) in family ARRP-49 and c.1871G>A (p.S624L, father) in family ARRP-206. The inheritan...",36,1732,Sci_Rep_2016_Jan_20_6_19432.txt
p.A2808T,"...ir of compound heterozygous mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in EYS in fami...",48,396,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,"...us mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in EYS in family ARRP-49. Both mutation...",48,421,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,"...us mutations, c.8422G>A (p.A2808T) and c.7868G>A (p.G2623E), in EYS in family ARRP-49. Both mutation...",48,421,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,...rozygous mutation c.3329C>G18. The novel mutation p.G2623E in exon 40 identified in our study lies i...,48,944,Sci_Rep_2016_Jan_20_6_19432.txt
p.G2623E,...rozygous mutation c.3329C>G18. The novel mutation p.G2623E in exon 40 identified in our study lies i...,48,944,Sci_Rep_2016_Jan_20_6_19432.txt
p.G473V,"...18, the compound heterozygous mutations c.G1418T (p.G473V) and c.C2971T (p.L991F) were found, and th...",50,504,Sci_Rep_2016_Jan_20_6_19432.txt
p.G473V,"...18, the compound heterozygous mutations c.G1418T (p.G473V) and c.C2971T (p.L991F) were found, and th...",50,504,Sci_Rep_2016_Jan_20_6_19432.txt
p.Y2796X,RP:S-22	43	c.8388C>A	hom	p.Y2796X	stopgain	novel	LamG	NA/NA,113,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.Y2796X,RP:S-22	43	c.8388C>A	hom	p.Y2796X	stopgain	novel	LamG	NA/NA,113,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.C2396S,RP:S-34	36	c.7187G>C	hom	p.C2396S	missense	novel	EGF	Damaging (0.000)/Delet...,114,26,Sci_Rep_2016_Jan_20_6_19432.txt
p.M415V,... mutations: c.967T > C (p.S323P) and c.1243A > G (p.M415V) (Fig. 1A),19,1001,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,... mutations: c.967T > C (p.S323P) and c.1243A > G (p.M415V) (Fig. 1A),19,1001,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,... mutations: c.967T > C (p.S323P) and c.1243A > G (p.M415V) (Fig. 1A),19,1001,Sci_Rep_2016_Jul_20_6_30072.txt
p.W318S,"...pound heterozygous SLC12A5 mutations [c.953G > C (p.W318S) and c.2242_2244del (p.S748del)], who was ...",21,474,Sci_Rep_2016_Jul_20_6_30072.txt
p.W318S,"...pound heterozygous SLC12A5 mutations [c.953G > C (p.W318S) and c.2242_2244del (p.S748del)], who was ...",21,474,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"....S748del, respectively)15, transmembrane domains (p.A191V and p.M415V), and the large extracellular ...",23,554,Sci_Rep_2016_Jul_20_6_30072.txt
p.A191V,"...nal domain (p.E50_Q93del), transmembrane domains (p.A191V and p.M415V) and the large extracellular l...",45,727,Sci_Rep_2016_Jul_20_6_30072.txt
p.S323P,"...1V and p.M415V) and the large extracellular loop (p.S323P), thus might have less effect on trafficki...",45,782,Sci_Rep_2016_Jul_20_6_30072.txt
p.L311H,...sessed a homozygous missense mutation c.932T > A (p.L311H). Functional analysis concluded that the C...,49,312,Sci_Rep_2016_Jul_20_6_30072.txt
p.M415V,"... (p.A191V), c.967T > C (p.S323P) and c.1243A > G (p.M415V). All variant cDNAs were verified by seque...",64,326,Sci_Rep_2016_Jul_20_6_30072.txt
p.Ala191Val,"...Val	c.279 + 1G > C, p.Glu50_Gln93del; c.572C > T, p.Ala191Val	c.967T > C, p.Ser323Pro; c.1243A > G, ...",109,115,Sci_Rep_2016_Jul_20_6_30072.txt
p.Ser323Pro,"...u50_Gln93del; c.572C > T, p.Ala191Val	c.967T > C, p.Ser323Pro; c.1243A > G, p.Met415Val	c.953G > C, ...",109,139,Sci_Rep_2016_Jul_20_6_30072.txt
p.Met415Val,"...p.Ala191Val	c.967T > C, p.Ser323Pro; c.1243A > G, p.Met415Val	c.953G > C, p.Trp318Ser; c.2242_2244de...",109,165,Sci_Rep_2016_Jul_20_6_30072.txt
p.Arg2345Trp,c.7033C>T	45	p.Arg2345Trp	Missense	Maternal,114,14,Sci_Rep_2016_Mar_18_6_23213.txt
p.Arg175His,"...Furthermore, a number of GOF mutations, including p.Arg175His and p.Arg273His have been linked to th...",7,1404,Sci_Rep_2016_May_18_6_26191.txt
p.Arg175His,"...Furthermore, a number of GOF mutations, including p.Arg175His and p.Arg273His have been linked to th...",7,1404,Sci_Rep_2016_May_18_6_26191.txt
p.Arg248Trp,"...oximately 9% (6/68) of mutations (p.Arg248Gln and p.Arg248Trp) occurring at this codon, followed by ...",21,126,Sci_Rep_2016_May_18_6_26191.txt
p.A2064T,"...nse mutations found in family 2 and family 3, the p.A2064T mutation had not been reported previously...",39,72,Sci_Rep_2016_Oct_14_6_35414.txt
p.A2064T,...with the residue ALA-2064 located at chain B. The p.A2064T mutation would induce an additional hydro...,39,1185,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,...ional structure. The other two missense mutations p.N965S and p.G1977S were respectively first descr...,39,1524,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,...ure. The other two missense mutations p.N965S and p.G1977S were respectively first described in Dani...,39,1536,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,"...anish people. As the Danish founder mutation, the p.N965S mutation was found to account for 16.2% of...",39,1645,Sci_Rep_2016_Oct_14_6_35414.txt
p.N965S,"...anish people. As the Danish founder mutation, the p.N965S mutation was found to account for 16.2% of...",39,1645,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,...tations: two were nonsense mutations (p.R572X and p.Y856X); two were splice-site mutations (c.6479 +...,41,107,Sci_Rep_2016_Oct_14_6_35414.txt
p.Y856X,...tations: two were nonsense mutations (p.R572X and p.Y856X); two were splice-site mutations (c.6479 +...,41,107,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,43	c.5929G > A	p.G1977S	Het	Missense	PD(1.000)	DC(0.999)	D(0.000)...,78,16,Sci_Rep_2016_Oct_14_6_35414.txt
p.G1977S,43	c.5929G > A	p.G1977S	Het	Missense	PD(1.000)	DC(0.999)	D(0.000)...,78,16,Sci_Rep_2016_Oct_14_6_35414.txt
p.T158M,...is attenuated by RTT-specific mutations in MeCP2 (p.T158M and p.R168X) that impact the methyl-bindin...,45,1677,Transl_Psychiatry_2013_Oct_22_3(10)_e316.txt
